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ABSTRACT 
Purpose:  
Evidence of an association between osteoarthritis (OA) and mortality is conflicting; 
differences in definitions and anatomical sites explain some of the discordance. The 
high frequency and increasing prevalence of OA highlights the need to understand its 
impact and potential association with premature mortality. The aims of this study 
were to: (i) examine the strength and direction of the association between different 
clinical case definitions of OA and premature mortality at different anatomical sites 
(hand, hip, knee and foot) (ii) identify the role of potentially modifiable factors on the 
pathway between OA at each site and premature mortality using mediation (path 
analysis) within a Cox proportional hazard model (survival analysis). 
Methods: 
A population-based prospective cohort study was conducted using data from the 
North Staffordshire Osteoarthritis Project (NorStOP), in which primary care medical 
record data was linked to self-report information collected by questionnaire in adults 
aged 50 years and over (n= 8066). Different case definitions of OA at each site were 
derived based on whether individuals had consulted in general practice for OA, self-
reported pain in the hand, hip, knee or foot in the baseline questionnaire and 
indicated moderate to severe pain interference. A Cox proportional hazards analysis 
was performed to determine the total effect of each case definition of OA on mortality 
with adjustment for confounders (age, gender, education, occupation, non-steroidal 
anti-inflammatory drug use, ischaemic heart disease, self-reported cardiovascular 
disease, diabetes mellitus, smoking, chronic obstructive pulmonary disease and body 
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mass index). Within the Cox model, path analysis was used to decompose the total 
effects to assess the indirect and direct effects for potential mediators (walking 
frequency, depression, anxiety, insomnia, and social participation). Results are 
expressed as hazard ratios (HR); bootstrap resampling was used to generate 95% 
confidence intervals (95% CIs).  
Results: 
Mean age of participants was 65.2 (SD 9.8) years and 51.6% were female. 1515 
(18.8%), 1323 (16.4%), 1774 (22.0%) and 1387 (17.2%) had disabling hand, hip, knee 
and foot OA respectively.  Participants were followed up over 10 years during which 
time 1188 (14.7%) died. Disabling hand, knee and foot OA were significantly 
associated with premature mortality (adjusted HR 1.18 95% CI 1.02, 1.35; 1.16 95% 
CI1.02, 1.33; and 1.21 95% CI 1.05, 1.40 respectively); the increased HR for disabling 
hip OA was not significant (adjusted HR 1.06 95% CI 0.91, 1.23). Low walking 
frequency, depression, social participation were significant mediators of the 
relationship between premature mortality and OA (p<0.05). Taking knee OA to 
illustrate this, the indirect effects for low walking frequency, depression and social 
participation were 1.06 (95% CI 1.05, 1.09), 1.05 (95% CI 1.01, 1.08) and 1.09 (95% CI 
1.05, 1.13) respectively.  
Conclusions:  
This novel approach to understanding pathways within a survival model indicates that 
potentially modifiable factors explain the link between hand, knee, hip and foot OA 
and premature mortality. Increasing walking, exercise and activity in general may also 
iv 
 
reduce the impact of depression and improve social participation, and subsequent 
mortality.  
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1 INTRODUCTION 
1.1 OSTEOARTHRITIS: THE BIG PICTURE 
Osteoarthritis (OA) is the most common type of arthritis in the United Kingdom (UK) 
with 4% of adults aged 45 and over consulting for OA each year (Jordan et al., 2014). It 
most commonly affects peripheral joints including the knee, hip, hand and foot, and is 
characterised by pain on movement and morning stiffness (Arden and Nevitt, 2006). 
OA has a considerable impact on the quality of life of older adults and is the 11th 
highest cause of disability worldwide (Cross et al., 2014). Between 1990 and 2010, the 
rate of disability in the UK from OA rose by 16%, attributed to an ageing population 
(Murray et al., 2013). This has wide reaching effects on service provision and patient 
welfare. As well as impacting quality of life, OA has a significant impact on the 
economy. Oxford Economics (2010) estimated the direct cost of OA to the health 
service to be £5.2 billion. This considerable impact on the UK economy highlights the 
importance of OA and establishing effective management.  
1.2 WHAT IS OSTEOARTHRITIS? 
The traditional view that OA is a disease of ‘wear and tear’ of articular cartilage is now 
considered to be somewhat outdated. If OA was simply caused by wear of the articular 
cartilage within the joint, it would be expected most older members of the population 
would eventually get OA, whereas the prevalence lies around 50% (Porcheret et al., 
2011). It has been suggested that terms like ‘wear and repair’ or ‘wear, flare and 
repair’ better describe the metabolically active process of developing OA (Porcheret et 
al., 2011). Problems with the joint include a contribution from the bone, menisci, 
muscles, synovial fluid and ligaments as well as the articular cartilage (Hunter, 2006). 
2 
 
There is increasing evidence and discussion that OA is a disease of the entire ‘joint as 
an organ’, rather than a specific part of the joint (Loeser et al., 2012). Furthermore, 
there is debate surrounding the contribution of systemic factors to the development 
OA. The combined involvement of all of these elements more accurately represent the 
aetiology of OA, as opposed to the more restricted view referring to cartilage wear 
only.  
1.2.1 A synovial joint and osteoarthritis 
Each of the joints this thesis looks to explore (hand, hip, knee and foot) are synovial 
joints. These will be expanded on individually later in sections 1.3.1, 1.3.2, 1.3.3 and 
1.3.4. Although the ways in which the bones in each joint articulate are different, the 
core features of a synovial joint are essentially the same. A synovial joint arises at the 
end of two bones lined with articular cartilage. A fibrous capsule, continuous with the 
periosteum, lines the joint capsule. The inner layer of the fibrous capsule is the 
synovial membrane. The joint capsule is filled with synovial fluid (Drake et al., 2004). 
The following sections discuss key aspects of the OA pathology and process within a 
synovial joint. 
1.2.1.1 Synovium 
Despite OA not being classified as an inflammatory arthritis, synovial inflammation 
with immune cell invasion and cytokine secretion has been observed in osteoarthritic 
joints (de Lange-Brokaar et al., 2012). This inflammatory process has been implicated 
in the destruction of the joint, leading to OA. Synovitis, the inflammation of the 
synovium, has also been attributed to specific OA symptoms, including joint swelling, 
night pain and morning stiffness (Berenbaum, 2013). Inflammation has been observed 
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on the synovial membrane and in the synovial fluid. Increased amounts of 
mononuclear cells (macrophages, monocytes and activated B and T cells) have been 
found in the synovial fluid, along with associated synovial membrane hypertrophy, the 
formation of giant multinucleate cells and angiogenesis (Mathiessen and Conaghan, 
2017). These changes indicate that OA is not simply an acute inflammatory process, 
but involves chronic inflammation leading to destruction of the joint. Furthermore, 
inflammatory changes to the synovium have been specifically found around areas of 
degenerative cartilage, highlighting the relationship between inflammation and the 
development of OA (de Lange-Brokaar et al., 2012).  This is further evidence to support 
the proposition that simple ‘wear and tear’ does not fully explain the aetiology of OA. 
Orita et al. (2011) found increased pain in osteoarthritic joints were associated with 
increased levels of tumour necrosis factor a (TNF-a) within the synovium but could 
not explain why some patients with OA had higher cytokine levels in their joints than 
others. Despite the mechanism for inflammation being unknown, the knowledge that 
it contributes to OA impacts the management of the condition. Non-steroidal anti-
inflammatory drugs (NSAIDs), like ibuprofen and naproxen, are the second line 
pharmacological treatment, following paracetamol, recommended by the National 
Institute for Health and Care Excellence (NICE) (NICE, 2014).  
1.2.1.2 Bone and articular cartilage  
Bone and cartilage changes have long been considered the primary pathological 
process in the development of OA (Berenbaum, 2013; Sharma et al., 2003). The 
expansion of subchondral bone, bone marrow lesions (BMLs) and the thinning of 
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articular cartilage have all been shown to be an important part of the progression of 
OA (Ding, Cicuttini and Jones, 2007; Felson et al., 2012).  
BMLs are associated with changes in bone turnover and volume, as well as alterations 
to localised bone density. Subchondral bone in OA tends to be thicker but is less 
mineralised than bone without OA (Buckland-Wright, 2004).  BMLs have been found to 
be associated with the position and weight-bearing compartment of a joint; a medial 
BML is more likely to be in a varus knee, whereas a lateral BML is more likely to be in a 
valgus knee (Felson et al., 2003, Felson, 2013). This supports the theory that load has 
an important role in the development of BMLs and therefore OA. BMLs have been 
implicated both in causing pain from OA, but also in causing the variable symptoms of 
OA, such as pain and morning stiffness (Hunter et al., 2013; Yusuf et al., 2011). Haugen 
et al. (2011) found an increase in hand tenderness associate with BMLs. This suggests 
that BMLs can form upon both load and weight-bearing and are important in the 
development of OA across all the joint sites examined within this thesis.  
Subchondral bone, the bone distal to calcified cartilage, plays an important part in the 
development of OA (Li et al., 2013). Subchondral bone is dynamic; it alters depending 
on forces across the joint. Mechanical stress caused by changes in the load from 
injury, or as part of the pathological process of OA leads to changes in subchondral 
bone, leading to remodelling and expansion (Goldring, 2012).  Subchondral bone 
deterioration and expansion is associated with also subchondral bone sclerosis, which 
is a key radiographic feature of OA. The turnover of subchondral bone is significantly 
increased in patients with OA and is predictive of disease progression (Dieppe et al., 
1993), highlighting the important role that subchondral bone plays in OA.   
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Articular cartilage consists of chondrocytes and the extra-cellular matrix, including 
proteoglycans and a collagen network. Articular cartilage lines the joint space between 
the different bones. Failure of the chondrocytes to preserve the homeostasis of the 
extra-cellular matrix contributes to OA (Heijink et al., 2012). Although the initial trigger 
for this alteration to cartilage homeostasis is not known, it has been theorised that 
tissue injury leads to inflammation and the production of pro-inflammatory cytokine 
(Miller, Miller and Malfait, 2014). These cytokines then bind to chondrocytes causing 
them to release matrix metalloproteases which degrade the extra-cellular matrix of 
the articular cartilage tissue (Stannus et al., 2010).  
1.2.1.3 Load and Weight-Bearing 
Weight-bearing refers to how humans place their own body weight through joints; for 
example, upon standing weight is distributed across the lower limb joints and the 
lower back (Pierson, 2002). Load bearing refers to any joint that load can be passed 
across; this includes hand joints as well as lower limb joints (Shaaban et al., 2004). 
Both weight-bearing and load bearing have an important role to play in the 
development of OA. Repetitive joint load, either through occupation or sports, are 
associated with the development of OA (Arden and Nevitt, 2006; Spector et al., 1996; 
Vannini et al., 2016). For example, farming is strongly associated with hip OA with a 
hazard ratio (HR) of 1.63 after 1-5 years working as a farmer (Andersen et al., 2012). 
The suggested mechanisms of occupational groups developing OA surround excessive 
or repetitive joint loading. Mechanics, and load-bearing, have been attributed as one 
of the main predictors of OA progression (Felson, 2013). This is due to OA causing 
abnormal joint mechanics, such as valgus or varus malalignment at the knee, micro-
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cracks and bone marrow lesions (Felson, 2013).  These professions and modifications 
of load-based activity could represent target groups for preventative strategies for the 
development of OA.  
1.2.2 Muscular strength  
Muscular strength is important across a joint site; muscles both move the joint and 
provide stability upon joint motion and loading (Solomonow et al., 1987). The 
relationship between muscular strength and OA in the corresponding joint, particularly 
regarding quadriceps femoris and the knee, has been examined in depth (Kus and 
Yelden, 2019; Øiestad et al., 2015) Quadriceps femoris works to accommodate load 
and stabilise the knee joint. Reduced muscle strength and morphological differences 
were found in quadriceps femoris muscles of people with OA (Liikavainio et al., 2008; 
Serrão et al., 2015). In asymptomatic individuals with radiographic OA, atrophy of 
quadriceps femoris was more common when compared to control participants with no 
radiographic OA (Ikeda, Tsumura and Tonsu, 2005). Although significantly less 
literature has been published surrounding OA at other joints and muscle strength, 
there is evidence that muscle weakness and atrophy occurs at other osteoarthritic 
joints (Hurley, 1999). At the hip, significant weakness of both hip and knee extensors 
and flexors and hip adductors and abductors have been found in people with OA 
(Loureiro et al., 2018). Furthermore, atrophy of hip abductor muscles has also 
predicted the severity of hip OA (Loureiro, Mills and Barrett, 2013; Zacharias et al., 
2018). Tevald et al. (2016) also explored the relationship between muscles around 
different joint sites and the development of OA; a reduction in hip abductor strength 
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was found in patients with knee OA, highlighting that muscular weakness in the whole 
limb can contribute to developing OA in a joint.  
1.2.3 Systemic factors  
It has been proposed that OA is not simply the consequence of increased or aberrant 
joint loading but is also caused by a complex network of systemic factors, such as 
inflammation, obesity and poor metabolic regulation (Cicuttini and Wluka, 2014). In a 
study looking to establish the relative contribution of mechanical stress compared to 
systemic factors in developing OA, in both weight-bearing (the knee) and non-weight-
bearing joints (the hand), it was observed that mechanical stress was a more 
important risk factor in weight-bearing joints and systemic factors were more 
important in non-weight-bearing joints (Visser et al., 2015). This suggests that systemic 
factors do have a role to play in the pathogenesis of OA, but their contribution relative 
to excessive loading is unclear. Further discussion on obesity as a risk factor for OA can 
be found in 1.5.3.1.  
1.3 OSTEOARTHRITIS AT THE HAND, HIP, KNEE AND FOOT 
OA can occur at many different joints, but the most common anatomical locations 
affected by OA are the hand, hip knee and foot (Arden and Nevitt, 2006; Cushnaghan 
and Dippe, 1991). The unique function and anatomy of each joint site means that the 
aetiology and pathophysiology of OA at each location is slightly different.   
1.3.1 The hand joints and osteoarthritis 
The hand is a complex network of twenty-seven joints (Sharp et al., 1985). The three 
joints with the highest known prevalence per 100 of radiographic OA include the distal 
interphalangeal joint (DIP) at 35%, proximal interphalangeal joint (PIP) at 18% and 
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carpometacarpal joint (CMC) at 21% (Wilder, Barrett and Farina, 2006). Bouchard’s 
and Heberden’s nodes, found on the PIP joint and DIP respectively, are widely agreed 
to be related to osteophytes; small bony outgrowths on the joint margins (Alexander, 
1999; Cicuttini et al., 1998). The role of excessive use, or overuse, of specific hand 
joints and an association with OA remains unclear (Alexander, 1999; Felson, 2004). 
There is some evidence that both DIP and CMC OA may, in part, be explained by 
overuse of the joint (Alexander, 1999; Jacobson et al., 2008). It has been proposed 
that overuse of the tendons leads to tendon inflammation, both causing adjacent joint 
inflammation and altered biomechanics of the joint, eventually leading to OA (Stäbler, 
Heuck and Reiser, 1997). In contrast, other studies point to risk factors such a genetics 
and postulate moving a malpositioned joint rather than overuse as a contributor 
(Felson, 2004; Leung, Rainsford and Kean, 2014). Among all joint sites examined within 
this thesis, a genetic susceptibility to OA is most pronounced at the hand (Spector and 
MacGreggor, 2004). Felson (2004) has described a 50% heritability for hand OA and 
twin studies have shown that up to 65% of hand OA is contributed to by genetic 
factors (Spector and MacGreggor, 2004). Identified susceptible genes have been 
located on chromosome 6 (Jakowlev et al., 2007). Hand OA is also common as a 
‘secondary’ OA, particularly following rheumatoid arthritis (RA). RA is an autoimmune 
inflammatory condition that primarily affects joints. Although RA and OA have distinct 
pathophysiological mechanisms, the destruction around a joint from RA can then lead 
to OA in the same joint (Nuki, 1999). 
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1.3.2 The hip joint and osteoarthritis 
The hip joint is a ball and socket joint comprising of the articulation between the head 
of the femur and the acetabulum of the pelvis. As well as undergoing processes 
described above, such as synovial inflammation, BML formation and reduce muscular 
strength, the development of hip OA is associated with several congenital and 
acquired malformations of the hip. Developmental dysplasia of the hip (DDH) is a 
congenital condition caused by a shallow acetabulum. It is associated with the 
premature (under 40) development of hip OA (Weinstein, 1987). Although this is not a 
common cause of hip OA it does highlight that abnormal morphology of the 
articulating surface can lead to the development of OA. Over the last 15 years there 
has been increased interest in the contribution of hip anatomy to the onset of OA 
(Murphy et al., 2016). Much of this surrounds the labrum, a semi-circular piece of 
fibrocartilage that lines the acetabulum like a cuff. Ganz et al. (2003, 2008) proposes 
that minor anatomical differences contribute to the development of hip OA. Ganz et 
al. also discusses the impact of femeroacetabular impingement (FAI), which leads to 
damage of the anterosuperior labrum. Following this new theory into the 
development of hip OA, researchers have presented evidence both supporting and 
rebutting this theory (Ahedi et al., 2017; Bardakos and Villar, 2009). Worldwide, 
radiological studies have identified labral damage following different types of FAI, that 
progress to OA (Nicholls et al., 2011; Tanzer and Noiseux, 2004). Furthermore, the 
prevalence of FAI has been estimated to be 10-15%, which correlates with the 
estimated prevalence of hip OA (Arthritis Research UK, 2013; Leunig and Ganz, 2005). 
Criticism of this theory surrounds the lack of clinical evidence for FAI induced hip OA, 
with limited large population-based cohort studies carried out assessing FAI as an 
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independent risk factor for OA over time (Sankar et al., 2013). Despite this, labral 
injury does appear important in the development of hip OA. Felson (2004) has also 
described a 50% heritability in some cases of hip OA, therefore indicating that the 
aetiology of OA is multifactorial with numerous potential different factors contributing 
to the disease process.   
1.3.3 The knee joint and osteoarthritis 
The knee joint is a modified hinge joint. It comprises of two joints; the articulation 
between the tibia and femur, and the articulation between the patella and the femur. 
Prevalence of symptomatic knee OA is estimated to be 13% of females over 60, and 
10% of men over 60 (Heidari, 2011). Menisci are a feature of the knee joint not shared 
by the other joints examined in this thesis.  
Post-traumatic OA, via meniscal damage, has a part to play in describing the aetiology 
of OA in the knee. Both traumatic meniscal tears, degenerative meniscal injury and 
surgical management of meniscal injury via a meniscectomy have been reported to 
contribute to the development of knee OA (Englund and Lohmander, 2004). It has also 
been observed that individuals with OA are more likely to have meniscal damage on 
imaging studies, perhaps showing that the relationship between meniscal damage and 
OA is not entirely linear (Englund et al., 2008).  
There is growing evidence that injuries to the anterior cruciate ligament (ACL) can 
contribute to the development of OA (Paschos, 2017). In 65-75% of cases, traumatic 
ACL rupture and meniscus injury occur together (Slauterbeck et al., 2009). Following 
ACL or meniscal injury it is common to undergo surgery to repair the ligament. 
Although both surgical and conservative management can still lead to radiographic 
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knee OA 10 to 20 years following initial injury (Lohmander et al., 2007), a systematic 
review found a reduced rate of knee OA in those having operative management 
compared to non-operative management (Ajuied et al., 2014). This confirms the 
importance of joint mechanics in the development and progression of OA (Felson, 
2013).  
1.3.4 The foot joints and osteoarthritis 
The foot is a complex network involving 33 joints (Oxford University Hospitals, 2019). 
The anatomy of the foot is split into forefoot, midfoot and hindfoot, with OA affecting 
joints in each area.  
Roddy and Menz (2018) highlighted in a recent review that there remains a very 
limited number of studies investigating foot OA. Among adults aged 50 years and over, 
the population prevalence of symptomatic radiographic foot OA has been estimated 
as 7.8% in the metatarsophalangeal (MTP) joint, 6.8% in the 2nd cuneometatarsal joint 
and 5.8% in the talonavicular joint (Roddy et al., 2015). These joints, along with the 1st 
cuneometatarsal joint (prevalence 3.9%) and navicular first cuniform (prevalence 
5.2%) represent the five foot joints that are easiest to identify radiographic OA 
changes on, and have therefore been included in an atlas for measuring foot OA 
changes on x-ray (Menz et al., 2007).  
However, this may not actually represent all joints most affected by OA, as some joints 
are difficult to observe on plain radiograph (Menz et al., 2007). Therefore, it is likely 
that foot OA is under-identified in many joints of the foot. A systematic review from 
2010 identified 27 publications relating to radiographic foot OA. By comparison, 
review articles covering the same time period found 176 studies for radiographic hand 
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OA and 190 studies for radiographic knee OA (Marshall et al., 2008; Trivedi et al., 
2010). 
Despite this, foot pain is common in mid-to-older ages (Thomas et al., 2011), with 
approximately one in six having radiographic OA combined with foot pain in the last 
month in a corresponding region (Roddy et al., 2015). Furthermore, of the foot joints 
studied the focus has predominantly been on the first MTP joint, with few studies 
investigating OA in the midfoot. In a Cochrane review, only one randomised controlled 
trial (RCT) investigating the management of MTP OA was found (Zammit et al., 2010). 
This perhaps shows that foot OA is less well studied and understood than OA in other 
joints. Combined with the difficulty in radiographically identifying OA in many of the 
foot joints, foot OA is difficult to research. Furthermore, classical OA theories from 
large joints like the hip or knee are harder to apply to a complex interplaying network 
of joints like the foot.  
Numerous studies have looked at the association between foot posture and the 
development of first MTP OA, particularly looking at foot arches. One study found no 
link between foot arch height and the development of hallux rigidus (Zammit, Menz 
and Munteanu, 2009). However other studies have found that a flatter arch is 
associated with more severe radiographic OA at the first MTP joint (Menz et al., 2015). 
Furthermore, previous foot injury, obesity and other load bearing joint pain have been 
found to have to contribute to the development of foot OA (Thomas et al., 2015). It 
has been theorised that flatter arches leads to increased pressure across the midfoot, 
both causing increased pain and an alteration in the load across the joint, therefore 
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leading to OA (Lundgren et al., 2008). Like hip OA, this emphasises the important of 
joint positioning in the development of OA.  
1.4 DEFINING OSTEOARTHRITIS  
Given the multifactorial complexity of OA and its different aetiology, risk factors and 
clinical course across different joint sites, defining OA for both clinical and research 
purposes remains a challenge. For a cumulative and unified approach to OA research 
its definition is vital (Sharma, 2011). This has implications for the subsequent study of 
individuals and populations and cross-study comparison. The selected definition can 
impact on measures of frequency (incidence and prevalence) and the identification of 
cases recruited into research studies. This difficulty in defining OA is heightened by 
differences in OA between joint sites, as well as the differences in the progression, risk 
factors and prognosis of OA (Pereira et al., 2011). Perhaps the biggest contributor to 
the issue surrounding defining OA lies in the schism between the phenotype, clinical 
case definition and case definitions based in imaging. 
1.4.1 Phenotypes 
By definition, a phenotype is “the observable properties of an organism that are 
produced by the interaction of the genotype and the environment” (Driban et al., 
2010). The heterogeneity of the disease process and variety of aetiologies of OA has 
led to the widely held idea that OA has numerous phenotypes (Felson, 2010). Within 
each joint affected by OA there are numerous different observable traits and 
therefore potentially different phenotypes. There are many different proposed 
phenotypes of OA, including but not limited to: generalised versus joint specific OA; 
secondary versus primary OA; radiographic versus painful OA; and comorbidity based 
14 
 
diagnosis (Bierma-Zeinstra and Verhagen, 2011; Felson, 2010; Marshall et al., 2013). 
For an OA phenotype to both be meaningful to clinical practice and research, 
phenotypes should also be identified based on disease management or prevention 
and clear aetiological evidence (Felson, 2010).  
Two contrasting phenotypes are painful and non-painful OA (Felson, 2010).  
Collectively, previous literature demonstrates that radiographic OA and pain are often 
discordant (Bedson and Croft, 2008). This also highlights the relationship between 
diagnosis and phenotype; those who do not experience OA pain are less likely to 
consult and are therefore less likely to be diagnosed with OA. In accordance with NICE 
guidelines, in the UK OA can be clinically diagnosed without x-ray, and a phenotype of 
radiographic non-symptomatic OA would be seen infrequently in clinical practice 
(NICE, 2014) 
1.4.2 Case definition 
Case definition is an epidemiological set of criteria that determines whether an 
individual has the disease in question (Gregg, 2008). Various different case definitions 
are used across studies, including radiographic and clinical definitions, often making it 
difficult to compare studies directly. 
1.4.3 Imaging based definitions 
Radiological definitions for OA are all based on structural abnormalities within or 
surrounding the joint that can be identified through imaging. The most common 
radiographic definition for OA comes from the Kellgren and Lawrence grading system 
(Kellgren and Lawrence, 1957; Kohn, Sassoon and Fernando, 2016). The severity of OA 
on an x-ray is graded 0-4, with a score of more than 2 defining OA. This grading system 
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used five radiological characteristics to define and categorise OA; osteophytes, 
narrowing of joint space with associated subchondral sclerosis, pseudocysts, altered 
bone shapes (particularly of the femur) and periarticular ossicles (referring to the 
proximal and distal interphalangeal joints).  
The simplicity of the Kellgren and Lawrence grading system means it has been widely 
used throughout literature and provides an easy comparison between the results of 
different studies. However, this grading system is not without limitations (Kohn, 
Sassoon and Fernando, 2016). Alterations to the definitions corresponding to each 
severity have changed since conception, particularly to class 2, the OA diagnostic level. 
This means that older studies do not necessarily have the same radiological 
classification for OA that more recent studies do. (Kellgren and Lawrence, 1963; Kohn, 
Sassoon and Fernando, 2016; Lawrence, 1977). Spector and Cooper (1993) also 
criticise Kellgren and Lawrence’s emphasis on the osteophyte through its grading 
system, also highlighting that the original description of the grading system is not clear 
as to whether each numerical stage describes the progression of OA or not; this lead 
to misinterpretation of the grading system.  
Although Kellgren and Lawrence provide the most widely used radiographic definition 
and grading system for OA, more recent alternative grading systems have also been 
proposed, and other imaging techniques are becoming more commonplace in OA 
research. The Osteoarthritis Research Society International (OARSI) atlas provides 
images of different joints and rates them as either absent/present or as normal and 
then with 1+, 2+ and 3+ of change (Altman and Gold, 2007; Altman et al., 1995).   
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Figure 1.1: Anterior-posterior radiographs of the knee presented in the original 
Kellgren-Lawrence article  
(A) Representative knee radiograph of KL classification Grade 1, which demonstrates 
doubtful narrowing of the joint space with possible osteophyte formation.  
(B) Representative knee radiograph Grade 2, which demonstrates possible 
narrowing of the joint space with definite osteophyte formation.  
(C) Representative knee radiograph of Grade 3, which demonstrates definite 
narrowing of joint space, moderate osteophyte formation, some sclerosis, and 
possible deformity of bony ends.  
(D) Representative knee radiograph of Grade 4, which demonstrates large 
osteophyte formation, severe narrowing of the joint space with marked sclerosis, 
and definite deformity of bone ends.  
(Kellgren and Lawrence, 1957, reproduced with permission) 
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Radiographic rating using the Kellgren and Lawrence system has been found to be 
ineffective in grading foot OA. A radiographic foot atlas allowing grading to be more 
reliably scored by raters has been developed more recently (Menz et al., 2007). 
Magnetic resonance imaging (MRI) definitions of OA have been proposed (Hunter et 
al., 2011). Despite this, the time-consuming and expensive nature of MRI scans in 
comparison to plain radiographs explains their infrequent use in clinical practice 
(Dieppe, 2011). 
In addition to the exposure to radiation on assessment, a negative aspect of choosing 
a radiographic diagnosis of OA is the inconsistent association between observed 
structural change and pain (Hannan, Felson and Pincus, 2000). A recent systematic 
review on knee OA reported that between 19-45% of asymptomatic adults aged 40 
years had structural changes indicative of OA on MRI (Culvenor et al., 2018). Although 
this may demonstrate the early stages of OA, it is unlikely that patients would present 
to primary care in the absence of pain. Therefore, radiographic OA definitions have 
limited clinical relevance (Hunter and Bierma-Zeinstra, 2019).  
1.4.4 Clinical definition 
Although the radiological definition is well suited to research, the majority of OA in the 
UK can be diagnosed and defined clinically, as per NICE guidelines (2014). NICE (2014) 
defines OA as: activity-related joint pain, morning stiffness of less than 30 minutes and 
functional impairment. NICE also states that radiological investigations of the affected 
joint are not necessary if the clinician is confident with their clinical diagnosis but may 
be beneficial if looking for specific therapeutic targets or with atypical symptoms 
(Sakellariou et al., 2017).  The majority of the NICE guidelines are not joint-specific, 
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and instead define OA using the same criteria regardless of where in the body the 
suspected OA is.  
Another way of clinically defining OA via published classification criteria is the 
American College of Rheumatology (ACR). The ACR criteria do have joint-specific 
diagnosis, unlike the NICE criteria also have similar criteria for hand, hip, knee and foot 
OA. Their definition, as well as activity-related joint pain and functional impairment 
includes examination findings, including joint crepitus, radiographical findings and 
biochemical signs (Altman et al., 1986, 1990, 1991), unlike the NICE guidelines (NICE, 
2014). ACR has received criticism, as it picks up signs of late disease rather than early 
disease, when the disease process is potentially modifiable (Peat et al., 2006).  
1.4.5 Identifying cases of osteoarthritis in primary care 
 
There has been an increase in adoption of electronic healthcare records in clinical 
practice. This in turn has led to opportunity to use the data from electronic databases 
for research purposes (Parkin, 2016). In the UK primary care system, consultations and 
con-morbidities are coded on healthcare records via Read codes (NHS Information 
Authority, 2000). Read codes are a thesaurus of over 110,000 clinical terms available 
to compare co-morbidities and demographics of patients with a variety of different 
conditions, including OA (NHS Digital, 2018).  
Read code defined OA is a diagnosis made within primary care indicating doctor-
diagnosed OA. However, this does not necessarily explain how the diagnosis was 
made, or what diagnostic criteria was used to reach that Read code. For example, the 
diagnosis of Read code OA could be radiographic, clinical or a combination thereof. 
19 
 
This definition is limited by clinician subjectivity, patient subjectivity and the diagnostic 
criteria used. Read codes therefore risk misclassification; this can limit the clarity in 
research studies due to heterogeneity between patients classified with the same code. 
This highlights some inherent subjective limitations in using Read codes for OA clinical 
research questions. 
1.5 EPIDEMIOLOGY  
1.5.1 Prevalence  
Deriving prevalence estimates is important for quantifying the disease burden in a 
defined population (Szklo and Nieto, 2018). All cases of disease, new and old, are 
included in a prevalence estimate.  
Prevalence estimates are a vital source of information that can compare a disease 
across different populations and inform the economic planning of healthcare systems 
(Harder, 2014). They also provide a baseline measure prior to interventions for disease 
(Spencer et al., 2012).  
There are some challenges to measuring OA using prevalence. Different definitions of 
OA can lead to different prevalence estimates. For example, the Global Health 
Exchange Data (GHED; Institute for Health Metrics and Evaluation, 2017) estimated 
worldwide OA prevalence using a variety of case definitions in those aged over 55 to 
be 4.11%. Turkiewicz et al. (2014) estimated the prevalence of clinically defined OA in 
Skåne in those aged over 45 to be 26.6% and Muraki et al. (2009) estimated the 
prevalence of radiographic OA in those aged 60 and over in rural Japan to be between 
47.0% and 70.2%. This variety in prevalence estimates shows the importance of clinical 
definitions for OA. Furthermore, it has been established that clinically defined OA has 
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a fluctuating time course; patients can be symptomatic on some days and 
asymptomatic on others with ‘flares’ of OA pain (Parry et al., 2018).  
This can lead to problems when using clinically defined OA for point-prevalence 
estimates, particularly when using self-report data collection methods, as point-
prevalence estimates do not consider the long-term effects of a chronic disease like 
OA and therefore the estimates may be inaccurate (Coggon, Rose and Barker, 2003).  
As highlighted in Figure 1.2, the prevalence of OA is greater in high income continents 
including Europe, the Americas and the Western Pacific Region. In the GHED study 
(Institute for Health Metrics and Evaluation, 2017) data is collected using systematic 
data and literature searches by disease, meaning that many different case definitions 
of OA have been used in this database. Therefore, there are multiple explanations for 
the results from GHED. The increased prevalence in affluent areas could be due to 
higher research activity, and therefore there is more information to draw conclusions 
from. Furthermore, data collection and record keeping is likely to be better in more 
Figure 1.2- Osteoarthritis unadjusted prevalence by WHO region  
(Institute for Health Metrics and Evaluation, 2017) 
© Global Health Exchange Data, permissions granted 
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affluent areas. This increased prevalence could also be explained by a reduced life 
expectancy in poorer countries, particularly those in Africa; as OA is associated with 
age, this could explain the reduced prevalence in these areas. The GHED is a good 
example of the positives and negatives of using prevalence estimates. 
1.5.2 Incidence 
The nature of OA as a disease process means that incidence can be difficult to define 
and quantify, and, like prevalence, varies depending on the case definition used and 
the anatomical areas investigated. A recent systematic review identified a significantly 
smaller number of papers addressing OA incidence in comparison to prevalence, in 
which only 8 of 72 papers presented data on incidence (Pereira et al., 2011). 
Furthermore incidence was defined and measured in different ways, making meta-
analysis impossible (Pereira et al., 2011). As it is difficult to determine true onset of OA 
as a disease process and given its often gradual and progressive clinical course, 
incidence can be difficult to define (Chaisson et al., 1997). Radiographic definitions of 
OA tend to over-estimate incidence. Felson (1995) demonstrated that by changing the 
case definition between symptomatic and radiographic OA, the incidence appeared to 
double; in women 2% per year developed radiographic incident OA and 1% developed 
symptomatic incidence OA. In this study, incidence of radiographic OA was defined as 
a Kellgren and Lawrence score of less than two at baseline and a score of two or more 
at follow–up (Felson et al., 1995). Felson et al. (1995) defined symptomatic OA as 
reporting OA symptoms upon questioning. This highlights the discordance between 
radiographic and clinical OA definitions. 
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1.5.3 Risk factors 
As discussed previously, there are many risk factors that have been implicated in the 
development of OA. A recent systematic review specifically looked at the risk factors 
for knee OA and found significant results for raised body mass index (BMI), female 
gender and previous knee injury, but not for smoking or concurrent hand OA 
(Silverwood et al., 2015). Risk factors can be viewed as modifiable and non-modifiable. 
This is important for the general management of OA. Modifiable risk factors represent 
targets to manage OA and slow down or potentially halt the disease progression. Local 
risk factors, including previous joint injury and malposition, have been discussed 
above.  
1.5.3.1 Modifiable Systemic Risk Factors  
Obesity has been shown to significantly contribute to the development and 
progression of OA (Zhang and Jordan, 2010). The World Health Organisation (WHO) 
described obesity as a main priority for healthcare worldwide, highlighting that the 
worldwide prevalence of obesity has risen from 21.5% in 1975 to 38.9% in 2016, with 
the highest prevalence areas being Europe and the Americas (WHO, 2018). The 
Chingford survey (Hart and Spector, 1994) showed that for every 2 units of BMI the 
risk of OA increased by 36%. More recent findings show every 5 kilograms (kg) of 
weight gain increasing the risk of OA by 36% (March and Bagga, 2004). This increase in 
the prevalence of obesity, combined with the ageing population, will ensure that the 
number of people with OA will continue to rise.  
However, the mechanism by which obesity leads to OA is not clear. Obesity was 
associated with OA in the knee and CMC joints but not in PIP joints in the Chingford 
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study (Hart and Spector, 1993). In another study obesity was associated hand and 
knee OA but not hip OA (Grotle et al., 2008). Furthermore, the BMI of patients 
undergoing knee arthroplasty is higher than those undergoing hip arthroplasty for OA 
(Culliford et al., 2015), perhaps highlighting that obesity affects weight-bearing joints 
differently. Although it may seem logical that obesity would affect weight-bearing 
joints more, simple load theory does not explain the impact on the CMC joint, 
highlighting that obesity must contribute to the development of OA via a separate 
mechanism as well.  
It has suggested a culmination of different mechanisms leading to the development of 
OA (Vincent et al., 2012). The low volume of muscle mass associated with obesity, 
mechanical forces and systemic inflammation have all been implicated in the 
development of OA. Systemic inflammation via hyperleptinaemia and a decrease in 
adiponectin leads to the widespread release of pro-inflammatory cytokines including 
TNF-a, interleukin (IL)6, IL-1ß and c-reactive protein (CRP) (Schrager et al., 2006). 
Increases in the systemic levels of each of these cytokines have been found to be 
predictive of the development of OA over time (Livshits et al., 2009; Sharif et al., 
2000). It has therefore been suggested that weight loss is a core treatment of OA.  
Low levels of physical activity have also been reported to contribute to development 
and progression of OA (Petrella, 2000). Most studies in this area look into the effect 
that exercise programmes have on reducing pain or radiographic progression of OA 
(Hunter and Eckstein, 2009).  
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1.5.3.2 Non-Modifiable Systemic Risk Factors 
OA is a disease associated with increased age. NICE (2014) states that for a typical 
diagnosis of OA, the patient is aged over 45 years. Despite OA being associated with 
increased age, it is not an inevitable consequence of ageing. Incident rates for OA rise 
quickly after the age of 50 but begin to subside in the over 70s (Oliveria et al., 1995).  
OA is more common in women, particularly those who are post-menopausal. Although 
the post-menopausal period for most women also corresponds to the over 50 increase 
in OA incidence, there is still a higher incidence than in men. Women also have a 
greater severity of OA than men, when calculated by standardised mean differences 
(Srikanth et al., 2005). MRI studies have shown women have a reduced volume of knee 
cartilage than men, perhaps explaining the increase in OA in this joint specifically, but 
this has not been shown in other joints. There has been conflicting evidence on the 
effects of oestrogen and OA, as well as the impact of oestrogen on pain receptors for 
OA (Cirillo et al., 2006; Nevitt et al., 2001).  The precise reason why OA is more 
common in women has not been established.  
1.6 MANAGEMENT OF OSTEOARTHRITIS 
There are numerous options for managing OA including non-pharmacological, 
pharmacological and surgical approaches. The core treatments include weight loss, 
patient education and exercise, before escalation to more complex treatments 
including medications, intra-articular injections and joint surgery (Figure 1.3).  
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Exercise is central to OA management, involving both muscular conditioning and 
generalised aerobic exercise (Deyle et al., 2000; NICE 2014). It is very important to try 
to prolong the lifespan of the joint and halt or reduce the disease process, given the 
limitations of joint replacement surgery (NICE, 2014). Surgical limitations include: 
operative failure, the lifespan of the replaced joint outlasting the patient and risk of 
post-operative complications (National Health Service, 2016). Exercise and physical 
activity can also help combat some reversible local and systemic risk factors for OA, 
such as obesity and reduced muscle strength. Despite this, OA was the main reason for 
99% of knee replacements and 90% of hip replacements with 112836 knee 
replacements and 105306 hip replacements performed in 2017 in the UK, an increase 
from the previous year (National Joint Registry, 2018).  
 
Figure 1.3- NICE (2014) recommended management of osteoarthritis (Figure 
used with permission) 
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The invasive nature of these procedures and the risk of requiring a revision surgery 
highlights the importance of first exhausting all other management options to 
preserve the original joint. 
Education is paramount to ensure any interventions are effective and are well 
understood by the patient (Martin et al., 2005). The controversy surrounding NSAID 
prescription and their impact on the cardiovascular system illustrates the importance 
of high-quality approaches to the non-pharmacological management of OA (Bavry et 
al., 2011). 
1.7 SUMMARY 
OA is a joint condition which has a number of case definitions and phenotypes. The 
incidence and prevalence of OA is high for all definitions. No matter how OA is 
defined, it is important to look at its consequences and determinants. The impact of 
OA on individuals is important to them and will drive healthcare consultation and the 
need for interventions. Given that the population is ageing, there will be an increasing 
number of adults with OA which will escalate the burden on society and health 
resources. An understanding of the magnitude of impact of OA, and of what factors 
influence this, will enhance the development of potential strategies to reduce the 
burden of the condition. The following chapter makes the case for premature 
mortality being an important outcome measure for OA and examines the current 
‘state-of the-science’ on the relationship between OA and mortality. 
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CHAPTER 2: MEASURING THE IMPACT OF OSTEOARTHRITIS 
2.1 IMPACT OF OSTEOARTHRITIS 
Identifying and measuring the extent of the impact of osteoarthritis (OA) is important 
to understand how it affects people and to drive interventions to reduce the burden 
on them and society; OA impacts on mental, physical and social health and quality of 
life. 
2.1.1 Mental Health  
 
The World Health Organisation (WHO) defines mental health as a state of well-being 
where individuals can cope with day-to-day stresses, work productively and contribute 
to their community (WHO, 2014).  An increasing awareness of mental health 
problems, especially amongst older people, has led to increased focus on the 
association between chronic disease, like OA, and mental health problems (Moussavi 
et al., 2007). Results from a recent Korean study (n= 8271) highlighted an association 
between OA and impaired mental health, including depression, stress perception and 
suicidal ideation, (Jung et al., 2018). Depressive symptoms are associated with an 
increase in the severity of symptoms and radiographic changes of OA (Rathbun et al., 
2017). A recent systematic review identified that 20% of adults with OA experienced 
anxiety and depression, however this study was unable to establish directional 
causality (Stubbs et al., 2016).  The interplay between mental health conditions and 
OA can also reduce quality of life (Rosemann et al., 2007a). Pain levels fluctuate more 
in those with OA and mental health problems, suggesting that anxiety and depression 
alter pain threshold levels (Neogi et al., 2010). As chronic pain can lower mood and 
increase anxiety levels (Creamer and Hochberg, 1998; Hansen and Streltzer, 2005), the 
cycle of worsening mental health and increased OA symptoms continues.  
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There are multiple implications of having poor mental health in the context of OA. The 
core management options for OA (education, exercise and weight loss) require 
significant motivation to understand and engage with (Beebe et al., 2010; Robson et 
al., 2013). Patients with depression struggle to take part in physical exercise, therefore 
reducing their muscle strength and increasing the risk of their OA progressing 
(Rosemann, Laux and Kuehlien, 2007b).  
2.1.2 Physical Health 
 
OA is an important cause of functional limitation in older adults and impacts on daily 
activities, such as walking and climbing stairs (Guccione et al., 1994; Murray et al., 
2010). Although physical activity is part of the core management of OA, only 30% of 
primary care clinicians regularly recommend exercise for OA (Maserejian et al., 2014). 
Walking is an important basic skill and can be assessed in a variety of ways in 
sedentary adults. Methods of assessment includes direct methods, such as diaries or 
accelerometry, or indirect methods, such as self-report questionnaires (Tudor-Locke 
and Myers, 2001). When using accelerometry, individuals with hip and knee OA have 
been found to have significantly reduced step counts, in comparison to age-matched 
controls (Winter et al., 2010). Whilst using step counts measured by accelerometry is 
an accepted objective method to gauge the amount of steps taken per minute, hour 
and day, it is expensive to implement in large population-based studies. The 
association between OA and reduced walking frequency has also been observed using 
self-report methods of data collection (King et al., 2018). There has been criticisms 
surrounding self-report methods for walking frequency, stating that these approaches 
often fail to measure routine or light activity or fail to measure the lower end of 
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sedentary activity (Mâsse et al., 1998; Tudor-Locke and Myers, 2001). Despite this, 
self-report questionnaires represent a more efficient mode of data collection for use 
in large population-based studies. Questionnaires designed for OA, including the 
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) for hip 
and knee OA and the Oxford Knee Score (OKS) for knee OA attempt measure low 
levels of activity (Bellamy et al., 1988; Dawson et al., 1998). The relationship between 
OA and walking frequency appears to be bidirectional; that is, those who walk less are 
more at risk of developing OA, and those with OA have a reduced walking frequency 
(King et al., 2018; Leong and Sun, 2014).  
Stair climbing is also an important measure for establishing the physical impact of OA. 
Stair climbing is more physically demanding than walking and requires a good degree 
of lower limb range-of-motion and muscle strength (Nadeau et al., 2003; Riener et al., 
2002; Rowe et al., 2000). An inability to climb stairs can have a significant impact on 
patients, and lead to difficulties with self-care, and may require patients to modify 
their house, or move house, to live comfortably. In a sample of participants with 
clinically defined OA, those with mild to moderate pain had a better ability to climb 
stairs than those in more severe pain (Whitchelo, McClelland and Webster, 2014). 
Both reduced walking frequency and stair climbing are a consequence of lower limb 
OA, however hand OA can also have significant effect on physical function. Hand OA 
can lead to deficits in fine motor skills, including opening tins or doors, buttoning a 
shirt and fastening jewellery (Kjeken et al., 2005). Specific self-report measurement 
tools help quantify the activity restriction caused by hand OA, including the 
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Australian/Canadian Hand OA Index (AUSCAN) function subscale and the Functional 
Index for Hand OA (FIHOA) (Bellamy et al., 2002; Dreiser et al., 1995).  
2.1.2.1 Pain and physical limitation 
Pain caused by OA often leads to physical limitation (Neogi, 2013), and the optimal 
approach to adequate analgesia is at the centre of current debate. NICE (2014) 
guidelines suggest the use of NSAIDs (non steroidal anti-inflammatory drugs; topical 
and oral), cyclo-oxygenase 2 (COX-2) inhibitors, paracetamol and, if this does not 
work, opioids. There is increasing evidence that gabapentinoid neuromodulating 
agents (gabapentin or pregabalin) have some effect in OA, with promising results in 
animal models (Vonsy, Ghandehari and Dickenson, 2009).  An increase in 
gabapentinoid neuromodulating agent prescriptions over the last 10 years has been 
attributed to OA (Appleyard et al., 2019).  
Optimal analgesia is integral to OA management.  As well as making day-to-day 
activities more comfortable, controlling pain increases the likelihood that patients will 
exercise and adhere to physiotherapy, thus helping to manage the condition (Alami et 
al., 2011).  
2.1.3 Social Health  
WHO highlighted the importance and impact of social health by including social 
participation in the International Classification of Functioning, Disability, and Health 
(ICF; WHO, 2002). In the ICF, social health was defined as the involvement in 
meaningful activities that fulfil aspects of an individual’s identity, and roles in family 
and community life (WHO, 2002). The effects of OA and co-morbidities associated with 
OA, including reduced mobility, chronic pain and mental health problems, restrict 
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individuals’ participation within society (Wilkie et al., 2007a). There are few measures 
that assess social participation; the Keele Assessment of Participation (KAP) reflects 
the ICF measures of social health to quantify social participation (Wilkie et al., 2005). 
Social participation was significantly restricted if an individual with OA was unable to 
mobilise outside of the home (Wilkie et al., 2007b). This reduced mobilisation was not 
just a result of joint pain, but also a result of comorbidities and environmental 
barriers, like public transport or devices to assist walking (Wilkie et al., 2007b). 
Reduced mobilisation means that people are unable to go to work, do their own 
shopping or take part in social activities. Furthermore, individuals with disabling OA 
(OA with pain interference) were more likely to retire prematurely than those with 
non-disabling OA, thus reducing their social participation (Wilkie et al., 2014).  
2.1.4 Quality of Life  
Quality of life is defined as “the extent to which [a] life is comfortable and satisfying” 
(Collins English Dictionary, 2019). Health related quality of life (HRQOL) encompasses 
any aspect of life that relates to physical or mental health (Centres for Disease Control 
and Prevention, 2018). There are numerous important reasons for measuring HRQOL. 
In chronic diseases such as OA, cancers or chronic respiratory conditions, HRQOL 
became a key target in managing disease outcomes, as these conditions cannot be 
‘cured’. HRQOL quantifies the burden of disease and helps measure the effect of 
interventions on participants lives (Centres for Disease Control and Prevention, 2018). 
Furthermore, HRQOL is an important and individualised measurement method for 
patients. A commonly used method of measuring HRQOL is the Short Form-36 (SF-36; 
Ware, 1993). The SF-36 allows participants to define their levels of health; for example 
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in the question “In general, would you say your health is: excellent; very good; good; 
fair; poor”. There is no definition of the word health, allowing the participant to define 
this themselves. This therefore presents HRQOL, as a target for disease intervention 
and for patient satisfaction.  Symptomatic knee OA has been significantly associated 
with poor HRQOL in older adults (Alkan et al., 2014, Kawano et al., 2015). 
Furthermore, Takegami et al. (2017) highlighted the relationship between the 
radiographic progression of OA and reduced HRQOL. This association between OA and 
reduced HRQOL is also observed in clinical definitions of OA (Hoogeboom et al., 2013). 
This affirms the importance of good management to reduce OA progression to 
improve HRQOL. A study examining health-related quality of life among OA 
participants, via a quality of wellbeing scale, found that patients with OA had a 
significantly lower quality of wellbeing score compared to community dwelling adults 
without OA (Groessl, Kaplan and Cronan, 2003). Furthermore, those with OA had a 
comparable score to participants with depression or advanced cancer (Groessl, Kaplan 
and Cronan, 2003).  
2.1.4.1 Activities of Daily Living 
OA also impacts on activities of daily living (ADLs) and instrumental activities of daily 
living (IADLs). ADLs include basic activities such as personal care and self-feeding that 
are essential for day-to-day survival (Lawton and Brody, 1969). IADLS also include 
cooking, shopping and are essential for independent living in the community 
(Williams, 2011). Reduced independence with ADLs is detrimental to HRQOL (Lyu and 
Wolinsky, 2017). A study of 10000 patients found that over 80% of those with clinically 
defined OA were six times more likely to report limitations with ADLs compared with 
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those without OA (Fautrel et al., 2005). The physical, psychological and economic 
impact of this is wide reaching. An inability to perform basic activities, like ADLs, leaves 
an individual requiring extra care, either from family members or from outside 
agencies. 
2.1.4.2 Insomnia 
Insomnia has significant implications for patients; reduced sleep is associated with 
reduced productivity, work absenteeism and increased rates of healthcare utilisation 
(Léger et al., 2002; Léger et al., 2006; Roth and Ancoli-Israel, 1999). Insomnia is both a 
physical and psychological complication of OA and significantly affects HRQOL (Kyle, 
Morgan and Espie, 2010). Previous studies have found that up to 81% of those with OA 
struggle to maintain their sleep (Wilcox et al., 2000). Spira et al. (2015) highlighted the 
abnormal circadian rest and activity rhythms in those with OA and insomnia, and 
postulated that dysregulated circadian rhythm could eventually lead to premature 
mortality, via increases in leptin and ghrelin leading to cardiovascular disease (Paudel 
et al., 2011; Taheri et al., 2004). Multiple studies have investigated the relationship 
between reduced sleep and pain perception. Reduced sleep, particularly Rapid Eye 
Movement (REM) sleep, has been shown to increase pain perception (Lautenbacher, 
Kundermann and Krieg, 2006; Roehrs et al., 2006). Finan, Goodin and Smith, (2014) 
reported that pain simultaneously reduces sleep and increases stress, therefore 
causing a cycle of poor sleep leading to increased pain. Studies have investigated the 
effect of insomnia on pro-inflammatory cytokines in OA patients, to establish the 
mechanism of insomnia related hyperalgesia.  However, no significant evidence of a 
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relationship between knee OA, insomnia and cytokine levels, such as interleukin (IL)6 
and IL10, was seen (Quartana et al., 2015).  
2.1.5 Mortality  
A full appreciation of the natural history of OA is vital to identify factors to improve OA 
management. Although there is a growing body of literature on the natural course of 
the condition, less is known about the direct link between OA and mortality.  OA is 
now recognised as a serious condition and is associated with other comorbidities, such 
as cardiovascular disease (CVD) and diabetes, which are associated with premature 
mortality (Cleveland and Callahan, 2017; Osteoarthritis Research Society International, 
2016). Previous studies have attributed the increased mortality rate in those with OA 
to concomitant risk factors (Cleveland and Callahan, 2017). However, more recent 
studies implicate OA itself as the cause of premature mortality, independent of these 
risk factors (Watson et al., 2003). OA affects a large proportion of the population in 
the UK, and this is likely to increase as the population ages (Murray et al., 2013). 
Despite this, there are no large scale public health initiatives for OA. If those with OA 
have a higher level of mortality than those without OA, the importance of a national 
approach to combatting OA will be justified. Identifying and addressing modifiable 
factors will reduce mortality as a result of OA (Juni, Reichenbach and Dieppe, 2006; 
Nüesch et al., 2011). 
Previous studies looking at the association between OA and premature mortality have 
investigated both all-cause and cause-specific mortality, with conflicting results. Some 
studies appear to show no clear relationship between OA and all-cause mortality, 
whereas other find an association between all-cause mortality and OA (Nüesch et al., 
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2011; Xing et al., 2016). Investigating the relationship between OA and cause-specific 
mortality provides evidence towards potential mechanisms for the relationship 
between OA and premature mortality. Like all-cause mortality, there is no unity in 
evidence reporting an association between cause-specific mortality and OA (Hawker et 
al., 2014; Haugen et al., 2015). 
There are a number of studies evaluating the association between premature 
mortality and OA. To identify all previous literature examining OA and premature 
mortality, two systematic literature searches were untaken.  
2.2 AIMS AND OBJECTIVES OF SYSTEMATIC LITERATURE SEARCHES 
Due to the publication of more recent studies examining the association between OA 
and premature mortality, previous systematic reviews in this area were deemed no 
longer comprehensive. Consequently, up-to-date systematic searches and narrative 
synthesis were undertaken. 
2.1.1 Aims 
To synthesise information in published literature and determine the direction of the 
association between OA and mortality.  
2.1.2 Objectives 
 
1. To identify published systematic reviews of the association between OA and 
premature mortality (Search 1).  
2. To identify original studies that have examined the association between OA 
and premature mortality, published following the search strategy end dates of 
the systematic reviews identified in Search 1 (Search 2). 
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3. To narratively synthesise the information from both searches and determine 
the strength and direction of association between OA and mortality. 
2.3 WHY PERFORM SYSTEMATIC LITERATURE SEARCHES? 
A systematic search, when designed properly, should identify all relevant literature on 
a research question and allows synthesis of all empirical evidence via explicit and 
systematic methods to reduce bias (Antman et al., 1992; Oxman and Guyatt, 1993). 
Therefore, a systematic search provides a thorough way of identifying and analysing 
current literature on the associations between OA and premature mortality, and 
summarising this data via a meta-analysis. Large amounts of data can be amalgamated 
succinctly within one document, providing an efficient way of summarising 
information. Combining data from primary studies via meta-analysis may provide a 
more precise estimate of the relationship between OA and premature mortality than 
any one study (Pogue and Yusuf, 1998). Furthermore, systematic searches help to 
identify gaps in current knowledge; if no gaps are found this highlights that further 
work may not be necessary (Garg, Hackman and Tonelli, 2008). However, there are 
limitations in performing systematic searches. The data found in a systematic search is 
only as reliable as its constituent studies and the rigor with which the search was 
conducted. Moreover, meta-analysis of studies with high heterogeneity in design and 
quality may lead inaccurate estimates of the true relationship between OA and 
premature mortality (Lau, Ioannidis and Schmid, 1998). In these circumstances, 
narrative synthesis is useful to interpret the data (Cochrane Collaboration, 2011). 
Systematic searches also do not account for publication bias (Garg, Hackman and 
Tonelli, 2008).  
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2.4 METHODS FOR THE SYSTEMATIC LITERATURE SEARCHES 
 A protocol was first developed to identify all systematic reviews examining the 
association between OA and mortality, and then for individual studies published more 
recently. These systematic searches were performed in line with Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Liberati et al., 
2009). 
Two systematic searches were performed. Search 1 aimed to identify existing 
systematic reviews in peer-reviewed journals, whereas Search 2 aimed to identify 
original peer-reviewed articles published more recently than those included in the 
systematic reviews from Search 1. Both searches involved four stages: 
Stage 1: Formulation of search strategy and identification of studies. 
Stage 2: Screening of titles against eligibility criteria. 
Stage 3: Reviewing potential eligibility of abstracts identified in Stage 2. 
Stage 4: Reviewing potential eligibility of full-text articles identified in Stage 3. 
2.4.1 Search Strategy 
In stage 1 a comprehensive search strategy was conducted by one researcher (BS). The 
search strategy used text terms for osteoarthritis (osteoarthritis/, osteoarthr*, OA, 
arthrit* and joint pain), mortality (mortality/, mortalit*, premature mortality, death) 
and in search 1 study type (systematic review, systematic, review). Subject headings 
(i.e. medical subject headings [MeSH]) were also used. A full list of search terms for 
search 1 can be found in Appendix 1. A full list of search terms for search 2 can be 
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found in Appendix 2. One notable exclusion in search terms in search 2 is study type, 
as this search was not specifically looking for systematic reviews.  
2.4.2 Information Sources 
Two sources of information were used to find relevant articles. Firstly, both searches 
used OVID SP interface (OVID Technologies Inc, 2019). This includes over 100 different 
databases, including MEDLINE and EMBASE. Databases were searched as part of 
Search 1 between database inception to 13th November 2018. For Search 2, databases 
were searched from 1st January 2015 to 18th December 2018. This start date was 
selected following the completion of the first search and represents the search end 
date of the most recent systematic review identified on OA and mortality.  Secondly, a 
hand search of the reference lists of all included studies was also completed.   
Citations identified following both searches were exported into RefWorks ProQuest 
(RefWorks, 2009). RefWorks stored these citations and identified duplicated articles 
prior to the title and abstract screening. 
2.4.3 Eligibility Criteria  
The inclusion criteria for both systematic searches were a clear focus on the 
investigation of OA and mortality.   
Search 1 inclusion criteria: 
• Systematic review 
• Examination of the relationship between OA and mortality 
• Published at any time 
• Written in any language 
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Search 2 inclusion criteria: 
• Examined the relationship between OA and mortality 
• Published from January 2015 to December 2018 (time of the last search 
identified in Search 1 to when this search was completed) 
• Written in any language 
Search 1 exclusion criteria 
• Non-systematic review papers 
Search 2 exclusion criteria 
• Systematic review papers 
Both searches followed the PECO (population, exposure, comparison and outcome) 
framework (Huang, Lin and Demner-Fushman, 2006). The PECO for this review was: 
Population: Adults (18+ years) 
Exposure: osteoarthritis  
Comparison: no osteoarthritis 
Outcome: mortality  
2.4.4 Identification of literature 
Stage 2 involved the screening of titles against the eligibility criteria. Titles that met 
criteria or potentially met the criteria were taken forwards to Stage 3: reviewing the 
abstracts for eligibility. Literature that met the criteria were retained for Stage 4 which 
was to review full-text articles. Any articles that could not be definitively included or 
excluded based on the eligibility criteria were always retained in the next stage of 
review.  
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2.4.5 Data Extraction 
Following the identification of relevant articles in Stage 4, data extraction commenced. 
All data extraction for both systematic searches was performed independently by the 
thesis author. Extracted information included the following; lead author name, 
publication year, country and continent in which the study was based, study 
population and type of study (clinical or community based), mean age of population, 
percentage female in population, main findings, case definition of OA used, anatomical 
site of OA, and confounders adjusted for. Following Search 1, all included studies 
identified by each systematic review were obtained and subjected to the same data 
extraction process. A narrative synthesis was then performed. 
2.4.6 Narrative synthesis 
Due to heterogeneity between study design, population sample, setting and reported 
measures, a narrative synthesis approach was used to analyse the data from the 
systematic searches, as meta-analysis would have been difficult (Popay et al., 2006). 
Tabulation was used to allow easy comparison between studies in multiple different 
domains, including results, case definition and anatomical location (Jones, 2004). 
‘Vote-counting’ (i.e. counting how many studies found a certain outcome) was also 
used to establish, in summary, the direction of the relationship between OA and 
premature mortality (Ragin, 2014).  
2.5 RESULTS 
2.5.1 Search 1: Identification of reviews 
The systematic search identified 1623 papers. One additional paper was identified 
from hand searching references and 1611 were excluded during the review as they did 
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not meet the inclusion criteria during title and abstract screening. Papers were 
excluded at this stage if they were clearly not a systematic review, did not focus on 
mortality or did not focus on OA. The full texts of 13 articles were screened and a 
further 10 of these were excluded. This is illustrated in Figure 2.1. Three systematic 
reviews met the inclusion criteria (Hochberg et al. 2008; Veronese et al. 2016; Xing et 
al. 2016), with their extracted data presented in Table 2.1. 
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Figure 2.1- PRISMA flow chat for the results of search strategy 1 (Liberati et al., 
2009). 
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Table 2.1- Systematic reviews of OA and mortality and their included studies. 
Systematic 
Search ID 
Study ID Geography Population   Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Group 
Results  Confounders 
Hochberg, 
(2008) 
Monson 
and Hall 
(1976) 
United 
States, 
North 
America 
Hospital 
based 
cohort  
(n= not 
reported) 
Not 
reported 
72.6 Not 
reported 
Clinician 
diagnosed  
USA 
population 
expected  vs 
observed  
SMR for all-
cause 
mortality 111 
Not reported 
 Lawrence 
et al. (1989) 
United 
States, 
North 
America 
Community 
based 
NHANES I 
and NHEFS 
cohorts  
(n= 6912) 
Not 
reported 
67.5 Knee Radiographic 
(Kellgren and 
Lawrence 
grades 2-4) 
No OA on x-
ray mortality 
vs observed 
Women RR 
1.45 p=0.02 
Men RR 1.2 
p=0.22 
Age, duration of 
follow up 
 Cerhan et 
al. (1995) 
United 
Kingdom, 
Europe 
Radium dial-
painting 
works  
(n= 320) 
57.1 100 Hands, 
feet, 
cervical 
spine, 
lumbar 
spine, 
pelvis, and 
knees 
Radiographic 
(Kellgren and 
Lawrence 
grades 2-4) 
No OA on x-
ray 
HR 1.45 (95% 
CI 1.12, 1.87)  
Age, diabetes, 
smoking, alcohol 
use, and BMI 
 Haara et al. 
(2003, 
2004) 
Finland, 
Europe 
Population 
register  
(n= 8000) 
Not 
reported 
54.5 Hand 
 
Radiographic 
(Kellgren and 
Lawrence 
grades 2-4) 
 
 
 
No OA on x-
ray 
Females: RR: 
1.23 95% CI 
1.01 to 1.51 
Men: RR 0.89, 
95% CI 0.68 to 
1.16 
 
 
Age, education, 
physical stress 
at work, BMI, 
and smoking 
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Table 2.1- Continued… 
Systematic 
Search ID 
Study ID Geography Population   Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Group 
Results  Confounders 
 Watson et 
al. (2003) 
United 
Kingdom, 
Europe 
GRPD  
(n= 
2370000) 
M: 54.5 
F: 57.2 
62.3 Not 
reported 
Clinical 
diagnosis 
No arthritis 
vs arthritis 
SIR per 1000 
patient-years: 
male 19.5, 
female 15.9 
 
 
Age and gender 
 Kumar et al. 
(2007) 
United 
Kingdom, 
Europe 
Clinical 
cohort  
(n= 1113) 
Not 
reported 
Not 
reported 
Knee and 
hip 
Clinical 
diagnosis 
RA siblings  RR of IHD-
mortality 1.96 
95% CI 1.21, 
3.25 
 
Age 
Veronese 
et al. (2016) 
Barbour et 
al. (2015) 
United 
States, 
North 
America 
From Study 
of Osteo-
porotic 
Fractures, 
community 
based 
(n= 9704) 
 
No 
baseline 
XR= 73.6 
Baseline 
XR= 71.4 
100 Hip Radiographic 
(Kellgren and 
Lawrence 
grades 2-4) 
 
No RHOA on 
x-ray 
RHOA 
associated 
with 
mortality: HR 
1.14 95% CI 
1.05, 1.24 
Age, current 
smoking, health 
status, history of 
diabetes, stroke, 
chronic 
obstructive 
pulmonary 
disease, 
osteoporosis, 
oestrogen use, 
calcium use, 
BMI, fracture 
history 
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Table 2.1- Continued… 
Systematic 
Search ID 
Study ID Geography Population   Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Group 
Results  Confounders 
 Castano 
Betancourt 
et al. (2013) 
conference 
abstract 
 
The 
Nether-
lands, 
North 
America 
Rotterdam 
Study I and 
II, 
community 
based 
cohort  
(n= 9150) 
 
- 100 Hip or knee Radiographic 
(definition not 
given) 
No OA on x-
ray 
HR: 1.19, 95% 
CI: 1.06, 1.33 
 
Diabetes, 
dementia, 
analgesic use, 
difficulties in 
functional 
activities and 
walking 
disability 
 
 
 
 Cacciatore 
et al. (2014) 
 
Italy, 
North 
America 
Osservatorio 
Geriatrico 
Regione 
Campania, 
community 
based 
cohort  
(n= 1780) 
73.8 57.5 
 
Hand, 
knee, hip 
and spine 
Clinical and 
radiological 
(definition not 
given) 
No clinical or 
radiological 
OA  
HR 1.28, 95% 
CI 0.99, 1.39 
Age, female sex, 
BMI, WC, heart 
rate, pulse blood 
pressure, 
Charlson co-
morbidity index, 
number of 
drugs, NSAIDs, 
corticosteroids 
and GDS. 
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Table 2.1- Continued… 
Systematic 
Search ID 
Study ID Geography Population   Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Group 
Results  Confounders 
 Haugen et 
al. (2015) 
 
United 
States, 
North 
America 
Framingham 
Heart Study, 
community 
based 
cohort  
(n= 1348) 
 
62.2 
 
53.8 
 
Hand Radiographic 
OA and self-
reported pain 
the in same 
joint (Kellgren 
and Lawrence 
grades 2-4) 
No clinical or 
radiological 
OA 
Radiographic: 
HR 0.82 95% 
CI 0.63, 1.07 
Clinical: HR 
0.79 95% CI 
0.57, 1.10 
 
Age, sex, cohort, 
BMI, total 
cholesterol: HDL 
ratio, current 
lipid lowering 
treatment, 
increased blood 
pressure, 
current 
antihypertensive 
treatment, 
elevated fasting 
or non-fasting 
blood glucose, 
current 
antidiabetic 
treatment (oral 
or insulin), 
current use of 
NSAIDs, daily 
use of aspirin, 
current/ 
previous 
smoking, alcohol 
use  
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Table 2.1- Continued… 
Systematic 
Search ID 
Study ID Geography Population   Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Group 
Results  Confounders 
 Kluzek et al. 
(2015) 
 
United 
Kingdom, 
Europe 
Chingford 
Cohort 
Study, 
community 
based 
cohort  
(n= 1003) 
No OA or 
pain= 55.2 
OA only= 
58.7  
Pain only= 
56.4 
Symptom- 
atic OA= 
59.6 
100 Hand and 
knee 
Clinical 
diagnosis and 
radiographic 
(Kellgren and 
Lawrence 
grades 2-4) 
 
Compared 
with no 
radiographic 
or clinical OA, 
radiographic 
OA only and 
clinical OA 
only. 
Pain positive, 
radiographic 
positive 
All-cause 
mortality HR 
= 1.97 (95% CI 
1.23 to 3.17) 
 
Age, body mass 
index, typical 
cardiovascular 
risk factors, 
occupation, past 
physical activity, 
existing CVD 
disease, glucose 
levels and 
medication use. 
 Liu et al. 
(2015) 
Combined in this review, constituent studies included in Xing et al. (2016 ) review below 
 Veronese et 
al. (2016) 
 
 
Italy, 
Europe 
 
 
Progetto 
Veneto 
Anziani 
(PRO.V.A. 
study), 
community 
based 
cohort  
(n= 2927) 
OA group= 
77.5  
Non-OA 
group= 
74.6 
OA 
group= 
66.4  
Non-OA 
group= 
48.2 
Hand, hip 
and knee 
Clinical 
diagnosis and 
radiographic 
(definition not 
given) 
No clinical or 
radiographic 
OA  
HR 0.95 (95% 
CI: 0.77, 1.15) 
 
Age, gender, 
BMI, education, 
alcohol, monthly 
income, physical 
activity, CVD, 
fractures, COPD, 
orthostatic 
hypotension, 
hypertension, 
DM, frailty, 
cancer, number 
of medications, 
smoking, ADLs, 
MMSE, GDS, 
GNRI 
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Table 2.1- Continued… 
Systematic 
Search ID 
Study ID Geography Population   Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Group 
Results  Confounders 
Xing et al. 
(2016) 
Liu et al. 
(2015a)  
 
The 
Nether-
lands, 
Europe 
Genetics 
ARthrosis 
and Prog-
ression 
(GARP), 
compares 
siblings  
(n= 384) 
60 82 Hand, hip, 
knee or 
spine 
Clinical 
diagnosis 
No clinical 
OA. For all-
cause 
mortality 
expected 34 
and observed 
16.  
SMR 0.54, 
(95% CI 0.37, 
0.79) 
Age and sex  
 Barbour et 
al. (2015) 
Included in Veronese et al. (2016) above 
 Liu et al. 
(2015b) 
China, Asia Wunchan 
Osteo-
arthritis 
Study, 
community 
based 
cohort 
 (n= 1025) 
- - Knee Clinical 
diagnosis and 
radiographic 
(Kellgren and 
Lawrence 
grades 2-4) 
Compared 
with no 
radiographic 
or clinical OA, 
radiographic 
OA only and 
clinical OA 
only. 
All-cause 
mortality for 
SxOA 1.9 (95 
% CI 1.0, 3.5) 
All-cause 
mortality for 
radiographic 
OA 1.2) 95% 
CI 0.7,1.9) 
Baseline age, 
sex, BMI, 
income level, 
education, levels 
of occupational 
physical activity 
and 
comorbidities. 
 Liu et al. 
(2015c) 
The 
Nether-
lands, 
Europe 
 
 
Osteo-
arthritis 
Care Clinic 
Study, 
clinical 
cohort  
(n= 460) 
61 88 Hand, hip, 
knee or 
spine 
 
Clinical 
diagnosis 
 
 
No clinical 
OA. For all-
cause 
mortality 
expected and 
observed  
SMR 0.45 
(95% CI 0.25, 
0.82) 
Age and sex 
(combined with 
GARP cohort) 
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Table 2.1- Continued… 
Systematic 
Search ID 
Study ID Geography Population   Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Group 
Results  Confounders 
 Cacciatore 
et al. (2014) 
Included in Veronese et al. (2016) above 
 
 
 
 Haugen et 
al. (2015) 
Included in Veronese et al. (2016) above 
 
 
 
 Haara et al. 
(2003) 
Included in Hochburg (2008) above 
 
 
   
 Nüesch et 
al. (2011) 
 
 
United 
Kingdom, 
Europe 
Somerset 
and Avon 
Survey of 
Health, 
community 
based 
cohort study  
(n= 1163) 
 
- 56.7 Hip or knee 
 
 
Clinical 
diagnosis and 
radiographic 
(Kellgren and 
Lawrence 
grades 1-4) 
 
Compared to 
general 
population 
SMR 1.55 
(95% CI 1.41, 
1.70) 
 
Age and gender 
 Tsuboi et 
al. (2011) 
Japan, Asia Hokkaido 
town, 
community 
based 
cohort study  
(n= 789) 
 
 
No OA: 
67.5 
OA: 65.5 
58.3 Knee Clinical 
features 
No clinical 
OA 
OR death 
after 10 years 
2.31 (95% CI 
1.41, 3.80) 
Age, gender, 
BMI, and 
lifestyle 
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Table 2.1- Continued… 
Systematic 
Search ID 
Study ID Geography Population   Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Group 
Results  Confounders 
 Holbrook et 
al. (1990) 
 
 
United 
States, 
North 
America  
Rancho 
Bernardo, 
California, 
community 
based 
cohort study  
(n= 519) 
- 54.9 Hand, hip, 
knee or 
spine 
Clinical 
features 
 
 
No self-
reported 
arthritis  
HR 0.82 (95% 
CI 0.69, 0.98) 
Age 
 Veronese et 
al., (2016) 
 
Included in Veronese et al. (2016) above 
Abbreviations: SMR = standardised mortality ratio, SIR = standard incident ratio, CI = confidence intervals, HR = hazard ratio, SxOA = symptomatic osteoarthritis, CVD = 
cardiovascular disease, COPD = chronic obstructive pulmonary disease, DM = diabetes mellitus, ADLs = activities of daily living, MMSE = mini mental state exam, BMI = body 
mass index, IHD = ischaemic heart disease, RHOA = right hip osteoarthritis, HDL = high density lipoprotein, GDS = geriatric depression scale, NSAIDs = non-steroidal anti-
inflammatory drugs, RA= rheumatoid arthritis, USA= United States of America, GNRI = geriatric nutrition risk index, RR = relative risk.
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2.5.1.1 Study Characteristics from Search 1 
 
The three systematic reviews found in Search 1 identified 24 different papers that have 
examined the association between OA and mortality (Table 2.1). Each study reports on data 
from different study cohorts. The three systematic reviews did not identify the same 
studies. Four studies were included in both the Xing et al. (2016) review (of eleven studies) 
and Veronese et al. (2016) review (of seven studies); only one study was included in both 
the Xing et al. (2016) review and the Hochberg, (2008) review (of six studies). Veronese et 
al. (2016) combined two cohorts led by Liu et al. (2015a,c), however these were reported 
individually in Xing et al. (2016) review. The Liu et al. (2015a,c) studies are two cohorts 
presented in one paper, and were examined individually, as in the Xing et al. (2016) 
systematic review. Haara et al. (2003, 2004) had one cohort described across two papers, 
and therefore was only included once, as in the Hochberg (2008) systematic review. Most 
studies were from community-based cohort studies (n=15), with fewer studies from clinical 
cohorts (n=3). 
Four studies identified female only cohorts (Barbour et al., 2015; Castano Betancourt et al., 
2013; Cerhan et al., 1995; Kluzek et al., 2015), with all other studies identifying a larger 
number of female participants. All of the studies were based in developed countries: United 
States of America (USA) (n=5), UK (n=5), the Netherlands (n=3), Italy (n=2), Japan (n=1), 
China (n=1) and Finland (n=1). All studies that stated a mean participant age reported a 
mean age over 50 years.  
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2.5.2 Search 2 
2.5.2.1 Study Selection Process for Search 2 
The search identified 10,323 papers. No additional papers were identified from hand 
searching references. 10,033 were excluded during the review as they did not meet the 
inclusion criteria during title and abstract screening. Papers were excluded at this stage if 
they were the incorrect study design, did not focus on mortality, did not focus on OA or 
were published prior to January 2015. This is illustrated in Figure 2.2. The full texts of 19 
articles underwent screening; 15 of these were excluded. A total of three papers were 
included (Cleveland et al., 2019; Mendy et al., 2018; Turkiewicz et al., 2016), with their 
extracted data presented in Table 2.2. 
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Figure 2.2- PRISMA flow chat for the results of search strategy 1 (Liberati et al., 2009). 
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Table 2.2- Studies included in Search 2 
Study ID Geography Population Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Population 
Results Confounders 
Mendy et 
al. 2018 
United 
States, 
North 
America  
 
 
Community 
based cohort 
study 
National 
Health and 
Nutrition 
Examination 
Surveys 1 and 
2  
(n= 51938) 
 
- 66.7 Knee Radiographic 
and self-
reported joint 
pain (Kellgren 
and Lawrence 
grades 2-4) 
For 
radiographic 
OA, no 
radiographic 
OA (67.0 vs 
56.0). For 
self-
reported 
joint pain, 
no self-
reported 
joint pain 
(40.9 vs 
13.9). 
HR for all-
cause 
mortality in 
self-
reported OA 
vs no OA 
0.95 (95% CI 
0.87, 1.05) 
HR for all-
cause 
mortality in 
radiographic 
OA vs no OA 
1.06 (95% CI 
0.99, 1.14) 
 
 
 
 
 
 
 
Age, gender, 
race/ethnicity, 
BMI, smoking, 
physical 
activity, 
poverty income 
ratio, DM, 
hypertension 
and history of 
myocardial 
infarction or 
stroke 
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Table 2.2- Continued… 
Study ID Geography Population Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Population 
Results Confounders 
Turkiewicz 
et al. 2016 
Sweden, 
Europe 
Skåne region, 
mandatory 
register. 
Community 
based cohort 
study  
(n= 524136) 
63.3 53 Knee and 
hip 
Consulted for 
knee/hip OA 
No 
consultation 
for hip or 
knee OA.  
Hip OA 
Male HR 
0.90 (95% CI 
0.87, 0.94) 
Female HR 
0.90 (95% CI 
0.86, 0.93) 
Overall HR 
0.90 (95% CI 
0.87, 0.92) 
Knee OA 
Male HR 
0.89 (95% CI 
0.86, 0.92) 
Female HR 
0.85 (95% CI 
0.83, 0.87) 
Overall HR 
0.87 (95% CI 
0.87, 0.92) 
 
 
Sex, income, 
highest level of 
achieved 
education, 
marital status, 
residential 
area, and year 
of first health-
care visit, IHD, 
cerebrovascular 
disease, DM, 
cancer, COPD 
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Table 2.2- Continued… 
Study ID Geography Population Age 
(mean) 
Sex (% 
female) 
Anatomical 
Site 
Case 
Definition of 
Osteoarthritis 
Reference 
Population 
Results Confounders 
Cleveland 
et al. 2019 
United 
States, 
North 
America  
 
Community 
based cohort 
study, 
Johnston 
County 
Osteoarthritis 
Project  
(n= 4182)  
 
 
 
61 63.2 Knee Radiographic 
and clinical 
examination 
Clinical OA is 
compared to 
those 
without 
clinical OA. 
Radiographic 
OA is 
compared to 
those 
without 
radiographic 
OA.  
HR 
radiographic 
OA all-cause 
mortality 
0.99 (95% CI 
0.90, 1.09) 
HR clinical 
OA all-cause 
mortality 
1.13 (95% CI 
1.01, 1.26) 
HR severe 
radiographic 
OA all-cause 
mortality 
0.96 (95% CI 
0.86, 1.08) 
Enrolment 
wave, age, sex, 
race, 
education, 
knee injury, 
cancer, NSAIDs, 
hypertension, 
smoking, liver 
disease, alcohol 
use, 
depression, 
physical 
activity, BMI, 
DM, CVD 
Abbreviations: CI = confidence intervals, HR = hazard ratio, OA = osteoarthritis, BMI= body mass index, DM = diabetes mellitus,  
CVD = cardiovascular disease, NSAIDs= non-steroidal anti-inflammatory drugs, COPD = chronic obstructive pulmonary disease.
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2.5.2.2 Study characteristics from Search 2  
The search returned the original studies examining the association between OA and 
premature mortality from January 2015 to the search date. One study used a more 
recent dataset from a cohort found in Search 1 (Lawrence et al., 1989; Mendy et al., 
2018). The study settings were heterogeneous, with studies set in different locations 
across the world. The three studies from Search 2 all included a higher percentage of 
females. Studies were conducted in the USA (n=2) and Sweden (n=1). All studies were 
community-based cohort studies, with similar mean ages. As with Search 1, all studies 
included more female participants. 
2.5.3 Narrative synthesis: ‘vote-counting’ the direction of the association between 
OA and premature mortality 
  
Different methods for quantifying association were used in the studies. The direction 
and strength of the association between OA and mortality significant varied between 
studies. Of the 21 studies, there was a significant association between OA and 
premature mortality (hazard ratio [HR] or standardised mortality ratio [SMR] greater 
than 1 with the lower bound confidence interval [CI] above 1) in nine studies (Barbour 
et al., 2015, Castano Betancourt et al., 2013; Cerhan et al., 1995; Haara et al., 2003, 
2004; Kluzek et al., 2015; Kumar et al., 2007; Liu et al., 2015b; et Nüesch al., 2011; 
Tsuboi et al., 2011). Four of these studies were female only cohorts or only found 
significant results in a sex stratified analysis for female participants (Barbour et al., 
2015; Castano Betancourt et al., 2013; Haara et al., 2003; Kluzek et al., 2015,). Eight of 
these studies examined the association between OA and all-cause mortality, however 
Kumar et al. (2007) only explored the association of OA with ischaemic heart disease 
(IHD) specific mortality. Five studies found statistically insignificant results (HR or SMR 
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greater or lesser than 1 with confidence intervals that included unity) (Cacciatore et 
al., 2014; Cleveland et al., 2019; Haugen et al., 2015; Mendy et al., 2018; Veronese et 
al., 2016). Four studies found OA was protective against premature mortality (HR or 
SMR less than 1 and upper bound confidence intervals below 1) (Holbrook et al., 1990; 
Liu et al., 2015a; Liu et al., 2015c; Turkiewicz et al., 2016). Three studies could not be 
interpreted due to a lack of quantitative estimates (Lawrence et al., 1989; Monson and 
Hall, 1976; Watson et al., 2003). 
2.5.4 Narrative synthesis: exploration of potential sources of heterogeneity  
The high heterogeneity between studies can be explained by the different population 
characteristics, OA case definitions, anatomical location, approach to analysis and 
potential confounders included.  
2.5.4.1 Population Characteristics 
Age 
The mean age of the populations included were all over 50, however a range of ages 
were reported. The lowest sample mean being 54.5 years (Watson et al., 2003), the 
highest 77.5 years (Veronese et al., 2016).  
Sex 
All studies included a higher percentage of females, and four studies had female only 
cohorts (Barbour et al., 2015; Castano Betancourt et al., 2013; Cerhan et al., 1995; 
Kluzek et al., 2015). However, most studies adjusted for age and sex via multivariate 
analysis, thus minimising the effects these factors had.  
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Geographical location 
All of the studies were based in high income countries: USA (n=7), UK (n=5), 
Netherlands (n=3), Italy (n=2), Japan (n=1), China (n=1), Finland (n=1) and Sweden 
(n=1). The majority of studies were conducted in western countries. The results from 
these studies may therefore not be generalisable to eastern regions or less affluent 
countries. 
Clinical cohort vs community cohort 
A combination of community-based cohort studies and clinical cohorts were found in 
Search 1 and Search 2, further adding to the heterogeneity. The clinical cohort studies 
included in this systematic search are susceptible to selection bias. Participants under 
clinician care for OA are more likely to have other co-morbidities in comparison to the 
general population or sibling controls. The settings of community-based studies were 
varied, including country based (Watson et al., 2003) via CPRD, region based 
(Cleveland et al., 2019; Lui et al., 2015b; Nüesch et al., 2011; Turkiewicz et al., 2016) 
and town based (Tsuboi et al., 2011) approaches. This increased the heterogeneity 
between studies.  
2.5.4.2 OA Case Definitions  
A variety of case definitions of OA were employed across the studies identified in both 
Searches 1 and 2. Broadly these are radiographic OA (n= 5), clinical OA (n= 8) and a 
combination of radiological and clinical OA (n= 8). Some studies presented individual 
results for radiographic and clinical case definitions within the same cohort, therefore 
ten studies examined radiographic case definitions (Barbour et al., 2015, Castano 
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Betancourt et al., 2013; Cerhan et al., 1995; Cleveland et al., 2008; Haara et al., 2003, 
2004; Haugen et al., 2015; Lawrence et al., 1989; Liu et al., 2015b; Mendy et al., 2018; 
Monson and Hall, 1979), eleven studies examined clinical case definitions (Cleveland 
et al., 2008; Haugen et al., 2015; Holbrook et al., 1990; Kumar et al., 2007; Liu et al., 
2015a;  Liu et al., 2015b; Liu et al., 2015c;  Mendy et al., 2018; Turkiewicz et al., 2016; 
Tsuboi et al., 2011; Watson et al., 2003) and four studies examined combined clinical 
and radiographic case definitions that could not be separated (Cacciatore et al., 2014; 
Kluzek et al., 2015; Nüesch et al., 2011; Veronese et al., 2016). Following the removal 
of studies that were unable to be interpreted due to a lack of quantitative estimates 
(Lawrence et al., 1989; Monson and Hall, 1976; Watson et al., 2003), four studies 
found a significant association between radiographic OA definitions and mortality 
(Barbour et al., 2015, Castano Betancourt et al., 2013; Cerhan et al., 1995; Haara et al., 
2003, 2004), and four studies found a significant association between clinical OA case 
definitions and mortality (Cleveland et al., 2008; Liu et al., 2015b; Kumar et al., 2007; 
Tsuboi et al., 2011). One study using a combined case definition found a significant 
association between OA and mortality (Nüesch et al., 2011). Statistically insignificant 
results were found in three studies investigating radiological case definitions 
(Cleveland et al., 2008; Liu et al., 2015b; Mendy et al., 2018), one study investigating 
clinical case definitions (Mendy et al., 2018) and three studies using a combined case 
definition (Cacciatore et al., 2014; Kluzek et al., 2015; Veronese et al., 2016). Results 
suggesting OA was protective against premature mortality was found in one study 
with a radiographic case definition (Haugen et al., 2015), and five studies with a clinical 
case definition (Haugen et al., 2015; Holbrook et al., 1990; Liu et al., 2015a; Liu et al., 
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2015c; Turkiewicz et al., 2016). No studies found a protective relationship between OA 
and premature mortality in combined case definitions.  
The biggest contributor to heterogeneity between the included studies was the 
differences in OA definition used. Within each of these broad categories OA is defined 
differently. For example, in the mixed definition some studies produced an analysis for 
both radiographic and clinical OA definitions, whereas others created a case definition 
based upon radiographic and clinical parameters combined. For example, although 
most radiological case definitions applied Kellgren and Lawrence (1957) grading, one 
study did not (Veronese et al., 2016). Both Mendy et al. (2018) and Cleveland et al. 
(2019) adopted the Kellgren and Lawrence (1957) grading system for radiographic OA, 
however Cleveland et al. (2019) used sub-categories (≥2 as OA diagnosis, ≥3 as severe 
diagnosis), and Mendy et al. (2018) did not use the severe sub-category. This makes 
these studies difficult to compare. 
Requiring participants to have radiographic assessment necessitates certain level of 
functional activity, and therefore risks excluding participants with reduced functional 
ability. This potentially introduces bias, increasing heterogeneity within results. As 
discussed in 1.4.4, a symptomatic or clinical case definition is almost entirely 
dependent on the diagnostician and therefore has high variability between cases, 
making comparison difficult.  
2.5.4.3 Anatomical sites  
A variety of different joint sites were investigated across all eighteen studies. Joint 
sites investigated include: knee (n= 16), hip (n= 11), hand (n= 9) and foot (n=1). Some 
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other joints sites beyond this thesis were also discussed, for example, different parts 
of the spine (n= 5). Two studies did not specify joint site. 
2.5.4.4 Analysis 
Most papers used either HRs or SMRs as an outcome measure.  
2.5.4.5 Confounding 
Most papers included some adjustment for confounding, however a minority did not 
adjust for any confounders. One paper had no adjustment (Monson and Hall, 1976). 
Two papers adjusted for age only (Holbrook et al., 1990; Kumar et al., 2007). All other 
studies included at least age and sex as confounders. Many papers included numerous 
adjustments for lifestyle factors, but these were difficult to compare across studies. 
For example, when adjusting for body mass index (BMI), it was not clear whether BMI 
was used as a categorical or continuous variable in each analysis. This also makes the 
studies difficult to compare and therefore heterogeneous.  
2.6 DISCUSSION 
The studies identified from both searches report conflicting evidence of the 
relationship between OA and premature mortality. It is unclear if there is a case 
definition (radiographic or clinical definition) of OA where there is a positive 
association between OA and mortality and whether this is dependent on anatomical 
area. Some studies discuss potential reasons for why there may be stronger 
associations, although they have not examined these potential mechanisms (discussed 
below).  
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Each study applied a slightly different case definition, preventing straightforward 
comparison. Some studies used both clinical and radiological case definitions allowing 
comparison between definitions within the study, providing an insight into the effect 
of OA definition on the relationship between OA and mortality. Kluzek et al. (2015) 
reported the effect of having clinically defined OA, combined with no radiologically 
defined OA, had a significant association with CVD specific mortality (adjusted HR 2.93 
95% CI 1.47, 5.85). However, when using both a joint pain and radiographic OA case 
definition with CVD specific mortality there is a HR of 1.97 (95% CI 1.23 to 3.17). This 
highlights that joint pain itself seems to be the best predictor of OA related mortality 
opposed to a radiological definition. This was further supported by Cleveland et al. 
(2019), who observed an adjusted HR for radiographic OA and mortality to be 0.99 
(95% CI 0.90, 1.09). However, when applying their symptomatic OA case definition, 
having pain, aching or stiffness in the knee joint on most days, this estimate became 
significant 1.13 (95% CI 1.01, 1.26). The presence of heterogeneity between studies 
using clinical case definitions was much higher; although some studies using 
radiographic definitions used slightly different Kellgren and Lawrence criteria, or 
unspecified radiological criteria, these are likely to be more comparable to clinical 
diagnosis. In the UK, radiographic case definition is used less frequently in clinical 
practice than clinical case definitions, in accordance with the NICE guidelines (NICE, 
2014). This supports further investigation into the association between clinical case 
definitions and premature mortality. 
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2.6.1 Anatomical area 
Of the nine studies that look at hand OA, three found that it was protective against 
premature mortality, three found a significant association between hand OA and 
premature mortality and three found non-significant results. These studies included 
different case definitions of hand OA, including clinical, radiographic and a 
combination of clinical and radiographic. Some of these studies only looked at hand 
OA (n= 2), whereas others looked at hand OA in combination with OA at other joint 
sites. The heterogeneous nature of the studies gives conflicting evidence about the 
direction of the association between hand OA and premature mortality.  
Like hand OA, heterogeneity presents conflicting evidence about the relationship 
between knee OA and premature mortality. This was the most frequently investigated 
joint site (n= 16). Overall, three studies found that knee OA was protective against 
premature mortality, eight found a significant association between OA and premature 
mortality and five studies found non-significant results. Some studies included knee 
only subgroup analysis, or knee only cohorts and others combined knee OA with other 
joint sites during survival analysis. This makes the results of the studies difficult to pool 
and interpret. This conflicting evidence means no clear conclusions can be drawn 
about the direction of the association between knee OA and premature mortality.  
Hip OA also presents conflicting results. Of the eleven studies looking at hip OA, three 
studies found hip OA was protective of premature mortality, five found a significant 
association between hip OA and premature mortality and three found an had a non-
significant association between OA and premature mortality. One study included 
description of the ‘pelvis’ (Cerhan et al., 1995). It is not clear whether this referred to 
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the hip joint or to other joints formed by the pelvic bones, like the sacroiliac joint. The 
heterogeneity between studies makes it very difficult to ascertain the direction of the 
relationship between hip OA and premature mortality.  
As discussed in 1.3.4 there seems to be limited research surrounding foot OA, which is 
supported by this systematic review. Only one study (Cerhan et al., 1995) looked at 
foot OA. This study found a significant association between OA and premature 
mortality but used a radiographic OA case definition. Furthermore, Cerhan et al., 
(1995) grouped each anatomical area together for a survival analysis. This highlights 
the lack of research into foot OA despite both its prevalence and clinical significance.  
2.6.2 All cause and cause-specific mortality 
The majority of papers do not specify cause of death, making it difficult to infer the 
mechanism of premature mortality. Mendy et al. (2018) found a significant association 
between both CVD and diabetes related mortality and knee OA, suggesting that OA 
leads to premature mortality by affecting these disease pathways. In the discussion of 
these studies, pathways were proposed explaining the association between OA and 
premature mortality. Nüesch et al. (2011) explored the relationship between CVD, 
walking distance and diabetes with OA, postulating that walking distance and diabetes 
both mediated the relationship between OA and CVD; reduced walking distance 
impacted cardiovascular health leading to CVD. Other studies have found links 
between the severity of OA and serious CVD events (Hawker et al., 2014). It has been 
suggested that the link between lower limb OA and CVD based mortality is simply 
based upon an inability to exercise. This does not explain how some studies found a 
significant link between symptomatic hand OA and cardiovascular events (Haugen et 
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al., 2015), given that hand OA does not impact mobility. Furthermore, Veronese et al. 
(2016) suggested that hand OA was a moderator in their systematic review. Although 
this relationship between OA and exercise ability seems feasible in lower limb OA, the 
association with hand OA is more difficult to ascertain. 
2.6.3 Confounders and potential mechanisms 
The earliest systematic review (Hochberg, 2008) implicated CVD and 
gastroenterological pathology resulting from NSAID use as the reason for increased 
mortality in those with OA. Included studies adjusted for these measures as 
confounders: four papers specifically adjust for NSAID use, with two papers adjusting 
for any medication use, eight papers adjust for CVD and ten papers adjust for lifestyle 
factors such as smoking, alcohol use and BMI. The wide array of confounders used, 
with different measures and different definitions makes comparability between 
studies difficult and also makes pooled estimates from meta-analysis difficult to 
interpret. The proposed mechanism of OA contributing to CVD which then causes 
premature mortality provides little explanation of how OA may actually contribute to 
developing CVD, however more recent papers provide a mechanism for OA leading to 
premature mortality. The most recent papers found in Search 2 (Turkiewicz et al., 
2016; Cleveland et al., 2019; Mendy et al., 2018) suggest that the association between 
OA and premature mortality can be explained by the impact that OA has one physical 
activity, as discussed in section 2.1.2. As OA is a disease that can significantly impact 
physical activity, it seems logical that this may be a contributing factor as to why OA is 
associated with premature mortality. Only two papers adjusted for physical activity as 
a confounder, which highlights that effect of reduced physical activity in those with OA 
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has influenced the data found in these systematic searches. No studies adjusted for 
mental or social health parameters, and little consideration has been given as to how 
these may impact premature mortality as a result of OA.  
2.7 STRENGTHS AND LIMITATIONS  
The strength of this study is the systematic approach taken to searching for eligible 
articles. Both Search 1 and Search 2 involved a systematic method with a search 
criteria adapted from previous studies (Veronese et al., 2016, Xing et al., 2016) to 
identify relevant papers and systematic reviews. Conducting two separate searches, 
one for systematic reviews and one for primary studies, provided an efficient method 
for identifying relevant papers. 
The main limitation of these systematic searches was that the search and data 
extraction was performed by one reviewer, although strict search methods were 
adhered to. Only involving one reviewer increased the risk of bias being introduced 
into the screening process, and also meant there was no formal opportunity for the 
discussion of more borderline studies. There was also no formal quality assessment of 
the papers included.  
The searches included over 100 databases, including MEDLINE and EMBASE, ensuring 
a wide array of databases were examined.  However, it does remains possible that 
some journals may have not been included in these databases. A hand search of the 
reference sections of included papers was completed to minimise this risk and ensure 
the inclusion of all relevant papers. 
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The efficiency of this method relies on the assumption that the included systematic 
reviews included all papers prior to 2015. The three systematic reviews included did 
not find and include the same studies. In particular the Veronese et al. (2016) and Xing 
et al. (2016) review were conducted within a year of each other but did not include all 
of the same studies. This is due to a difference in the search terms, databases 
searched and inclusion criteria. The search strategy for the systematic searches in this 
chapter included more search terms than these reviews used, increasing the yield of 
the searches ensuring no papers were missed (Veronese et al., 2016; Xing et al., 2016). 
2.8 SUMMARY AND IMPLICATIONS FOR FURTHER RESEARCH 
The principal finding from these systematic searches was that there is considerable 
heterogeneity across previous research that has examined whether there is an 
association between OA and premature mortality. Multiple definitions of OA have 
been used across previous studies. Overall, clinically diagnosed OA was more strongly 
associated with premature mortality than radiographic OA only. This suggests that if 
there is a relationship between OA and mortality it occurs due to factors that drive 
clinical diagnoses. However, within this there are multiple different clinical definitions 
of OA and further investigation of the most efficient approach to case definition 
selection would appear worthwhile and important.  
Further research is therefore required to identify which definitions of OA are 
associated with mortality. None of these studies were able to directly compare 
different clinical case definitions within a single cohort, therefore the clinical case 
definition with the strongest association between OA and premature mortality is 
unclear. Looking at different case definitions within a defined cohort could provide an 
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opportunity to establish whether there is an association between OA and premature 
mortality and also to identify whether this is confined to one particular case definition.  
None of the included studies examined in this chapter specifically looked at what 
explains the relationship between OA and mortality. Although many studies proposed 
ideas of pathways linking OA and premature mortality, none of the studies examined 
this empirically. This indicates a potential gap in the evidence base. Some of the 
included confounders may actually be mediators of the association between OA and 
premature mortality. Limited discussion of mediators was included in some studies 
included in the systematic reviews, however this was not consistently addressed 
throughout (Nüesch et al., 2011; Veronese et al., 2016). As discussed in 2.1.5 a 
suggested cause-specific mortality measure is CVD. Hochberg, (2008) specifically 
looked at CVD-specific mortality and included four of the six papers in the systematic 
review with causes of death data in this narrative synthesis. This found that those with 
OA were more likely to die of CVD than any other cause. Examining the pathways 
between OA and premature mortality provides an opportunity to examine not only 
the association between OA and premature mortality, but also why this association 
may occur.  
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3 CHAPTER 3: AIMS AND OBJECTIVES, STUDY DESIGN AND 
THESIS STRUCTURE 
3.1 INTRODUCTION 
The strength and direction of the association between osteoarthritis (OA) and 
mortality is unclear. Previous studies (identified in Chapter 2) reported different 
strengths and directions of the association between OA and premature mortality. A 
key reason for this was heterogeneity between studies. The variety of case definitions 
applied in previous studies prevents a clear understanding of whether there is an 
association between OA and premature mortality, and why, if there is an association, 
it exists. Identifying which case definitions of OA are associated with premature 
mortality will help determine those at an increased risk of premature death. 
Identifying why this association between OA and premature mortality exists will help 
influence interventions that could reduce premature death as a result of OA.  
Examining the association of different case definitions of OA with premature mortality 
within one dataset will remove the difference between studies to help clarify the 
direction of association. In addition, the reason for why adults with OA have higher 
risk of premature mortality is unclear. Recent developments in methodology now 
allow examination of mediation of associations within survival analyses and present 
the opportunity to explore reasons for this increased risk. This thesis now presents 
empirical work exploring the associations between different case definitions and 
premature mortality, before examining why these associations may occur, through 
mediation analysis. These studies will help to identify who and what to target to 
reduce premature mortality in adults with OA.  
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3.2 AIMS AND OBJECTIVES 
The aims of the work described in this thesis are to determine the association between 
OA and premature mortality and to identify factors that mediate this relationship. The 
specific objectives are: 
Objective 1: To examine the strength and direction of association between different 
clinical case definitions of OA and premature mortality at different anatomical sites 
(hand, hip, knee and foot).  
i. To identify which case definitions of OA have the strongest association with 
premature mortality. 
ii. To compare these case definitions across different anatomical sites to establish 
the impact of anatomical location of OA on premature mortality. 
Objectives 2: To identify factors that mediate the association between OA and 
premature mortality at different anatomical sites (hand, hip, knee and foot). 
i. To determine factors, amenable to primary care, that mediate the relationship 
between OA and premature mortality.  
ii. To identify which factors mediate the relationship between OA and premature 
mortality across different anatomical sites. 
3.3 STUDY DESIGN 
This thesis utilises pre-existing data from a UK-based prospective cohort study; the 
North Staffordshire Osteoarthritis Project (NorStOP). This thesis describes two 
analyses.  
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The first analysis was performed to establish whether there is a relationship between 
OA and premature mortality, using different clinical case definitions of OA. This was 
performed across different anatomical sites, providing a comparison of mortality by 
case definition and site of OA. 
The second analysis looked to identify factors that mediated the association between 
mortality and different case definitions of OA at different anatomical sites. Results 
from this may provide insights that could influence how patients with OA and other 
long-term conditions are managed. 
3.4 THESIS STRUCTURE 
An outline of the following four chapters is described below: 
Chapter 4: The methods of original data collection for NorStOP are described. Analyses 
using different clinical case definitions within NorStOP and their relationships with 
premature mortality are examined.  Case definitions included OA consulters, 
symptomatic OA and disabling OA. Each case definition was applied to different 
anatomical sites, including the hand, hip, knee and foot. 
Chapter 5: This chapter describes the analysis of mediation of the association between 
an OA case definition, identified in Chapter 4, and premature mortality. Proposed 
mediators of this relationship are amenable to primary care and include reduce 
walking frequency, depression, anxiety, insomnia and reduced social participation. 
Chapter 6: The main findings from this thesis are highlighted and discussed with 
reference to existing literature. Strengths and limitations of the thesis are identified 
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and discussed. The implications for clinical practice and future research are 
considered.  
  
75 
 
4 CHAPTER 4: IS THERE AN ASSOCIATION BETWEEN 
OSTEOARTHRITIS AND PREMATURE MORTALITY? 
4.1 INTRODUCTION 
The systematic searches described in Chapter 2 identified an inconsistent relationship 
between osteoarthritis (OA) and premature mortality due to heterogeneity between 
studies. The systematic searches also identified that a variety of case definitions for 
OA were used across the different studies, with clinical definitions appearing to have a 
stronger relationship with mortality than radiographic case definitions. This chapter 
describes analyses that examine whether the relationship between OA with mortality 
is dependent on the case definition of OA, with the aim of identifying which case 
definitions have the strongest relationship. The analysis uses data from one dataset, 
the North Staffordshire Osteoarthritis Project (NorStOP), which removes differences in 
the magnitude of association due to study sample characteristics.  
4.2 AIMS AND OBJECTIVES 
4.2.1 Aims 
The chapter aims to examine the strength and direction of association between 
different clinical case definitions of OA and premature mortality at different 
anatomical sites (hand, hip, knee and foot). 
4.2.2 Objectives 
i. To outline the relevant aspects of NorStOP for the subsequent analyses. 
ii. To identify different case definitions within the NorStOP cohort. 
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iii. To identify which case definition of OA (OA consulter, self-reported joint pain, 
symptomatic OA or disabling OA) has the strongest association with premature 
mortality. 
iv. To establish confounders of the relationship between OA and mortality. 
v. To establish if the impact of OA on premature mortality is dependent on 
anatomical location. 
4.3 STUDY DESIGN OF THE NORTH STAFFORSHIRE OSTEOARTHRITIS PROJECT 
NorStOP is a longitudinal population-based cohort study of adults aged 50 or over. The 
aim of NorStOP was to examine the natural history of OA and joint pain specifically of 
the hand, knee, hip and foot. Data from two cohorts of NorStOP (NorStOP 1 and 
NorStOP 2) were used in the analyses described in this thesis. Baseline data of each 
cohort was collected at different time points; NorStOP 1 was collected in April 2002 
and NorStOP 2 was collected from between July/August 2002 to July/August 2003.  
4.3.1 Ethical Approval 
Ethical approval for NorStOP was granted from the North Staffordshire Local Research 
Ethics Committee (REC reference numbers 1351, 1430 and 05/Q2604/20) (Thomas et 
al., 2004a). 
4.3.2 Population and sampling frame 
 
During the development of NorStOP in 2001, North Staffordshire had four Primary 
Care Trusts, with an estimated combined population of 460,000 (Office for National 
Statistics, 2001). Six practices from the North Staffordshire General Practice Research 
Network were recruited for the study; three practices for NorStOP 1 and three for 
NorStOP 2. These were a mix of rural and urban practices. In mid-2017, the UK 
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population was estimated to be 66,040,200 people, with 58,437,363 people registered 
with a general practitioner (GP) (88.5%) (NHS Digital, 2017; Office for National 
Statistics, 2017), making the registers a good sampling frame for identifying 
representative samples of the local population.  
4.3.3 Data from the ‘Health Survey’  
 
The ‘Health Survey’ questionnaire was a self-complete postal questionnaire sent to all 
eligible participants. This initial questionnaire contained 3 sections:  
A. General Health (including physical function, mental health, social isolation, 
access to materials, good and services, demographic characteristics, 
occupational characteristics, anthropometric characteristics, lifestyle 
characteristics and cognition) 
B. Both generalised and joint-specific pain with medications used to manage this 
pain (via a manikin diagram and joint-specific questions) 
C. Study consent  
A more detailed description of questions included can be found in Appendix 3.  
4.3.4 Method of Administration 
In the two NorStOP cohorts, 20,293 adults were included in the original sampling 
frame (Figure 4.1) These were all adults aged 50 and over who were registered with 
one of the six general practices included in the study. Before mailing, the sampling 
frame was checked by the general practitioners from the practice for exclusions; 
patients were excluded if they were unable to complete the questionnaire due to 
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illness, had severe learning disabilities, had severe psychological disorders, or if they 
had previously declined taking part in research projects (n=79).  
In stage 1, those eligible (n=20214) were mailed a ‘Health Survey’ questionnaire. 
Following this, in stage 2, those responding to the stage 1 ‘Health Survey’ who both 
gave permission to be re-contacted and indicated they had hand, hip, knee or foot 
pain or a problem with their hands in the last 12 months were mailed a ‘Regional Pain 
Survey’, which had a more detailed assessment of the specific regional sites. Data from 
the ‘Regional Pain Survey’ questionnaire was not used in the analyses within this 
thesis.  Questionnaires were accompanied by a letter from the GP practice and a study 
information leaflet; reminder postcards were sent to those that had not responded 
after two weeks and at four weeks a repeat questionnaire was sent. 
In accordance with the Data Protection Act, Keele Primary Care Research Centre 
followed data security standards and guidelines. Personally identifiable information 
was only held to undertake mailing and was removed from databases as soon as 
possible.  
4.3.5 Questionnaire Processing  
 
On receipt of completed questionnaires, sex and date of birth were compared with 
surgery records, to ensure responses were from invited participants. Afterwards, 
questionnaires were put in secure storage. Data was entered using TeleformTM , an 
automatic data entry system. This method of data entry has high levels of data 
accuracy and was used to reduce potential information bias (Jinks, Jordan, and Croft, 
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2003). To check the accuracy of scanned data, one in five paper copies of the 
questionnaire were checked against the exported data. 
4.3.6 Data Cleaning 
Data was exported from the TeleformTM system and exported to iBM’s Statistical 
Package for the Social Sciences (SPSS). Data was then checked for anomalies, 
particularly in hand written responses, such as date of birth, sex, height, weight and 
age the participant left school. If birth or sex data were missing, information from the 
mailing list was used. Unrealistic values for height, weight and age of leaving school 
were marked as missing. Complete data cleaning processes followed the Keele 
University Data Cleaning Standard Operating Procedures. 
4.4 PARTICIPANT FLOW  
After GP exclusions, 20,214 adults over 50 were mailed a questionnaire in NorStOP 1 
and 2. During the mailing procedure a further 396 were excluded (due to death, GP 
screening, departure from GP practice or unknown addresses), therefore leaving an 
eligible baseline population of 19,818. Of these 13,986 (adjusted response 70.6%) 
responded at baseline. From these respondents, 3554 did not give consent for their 
primary care medical records to be accessed, leaving 10,432 participants. A further 
2366 participants had incomplete data for, mortality, mediators or covariates, leaving 
8066 for the analyses (Figure 4.1).  
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Figure 4.1-Flowchart of baseline response to NorStOP 
Identified from 6 GP 
practices (n= 20293) 
Mailed baseline 
health survey  
(n= 20214) 
 
Excluded prior to 
mailing (n= 79) 
55 deaths/departures 
24 from GP screening 
Excluded during 
mailing (n= 396) 
143 deaths/ 
departures 
53 withdrawn 
200 returned 
addressee unknown 
Non-responders  
(n= 5832) 
192 ill health, 
 478 refused 
5162 non-respondents 
Eligible baseline 
health survey  
(n= 19818) 
 
Responders  
(n =13986)  
 
Responders with 
consent to view 
medical records  
(n= 10432) 
 
No consent to view 
medical records  
(n= 3554) 
Number for analysis  
(n= 8066) 
 
Missing Data 
(n= 2366) 
1043 no vital status 
data 
1323 incomplete data 
for mediators or 
covariates 
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4.5 SELECTION BIAS 
4.5.1 Non-response bias 
A number of those contacted did not complete the initial baseline survey (n= 5832). 
Three reasons were cited for this; ill health (n= 192), refusal (n= 478) and non-
response (n= 5162). It is possible that these reasons for non-response may be due to 
OA; for example, the ill health may represent disabling OA or comorbidities associated 
with OA. Furthermore, the non-response group could represent some individuals that 
were physically unable to send any response to the survey due to their OA. 
Conversely, those with joint pain may be more likely to respond to the survey due to 
an interest in the outcomes, therefore over-estimating the prevalence of joint pain 
within the population. A number of participants also did not consent to having their 
primary care medical records reviewed as part of the study. This could represent 
participants that were worried about having certain co-morbidities (such as mental 
health problems) viewed negatively by the research team. These potential sources of 
selection bias could potentially affect the representativeness of the population sample 
(Szklo and Nieto, 2018).  
Non-response or non-consent to medical record review or the ‘Health Survey’ could 
also reflect participants failing to understand the question due to poor literacy skills. 
The survey was aimed at a reading age of 9 to overcome this problem. As this thesis 
only uses the baseline data from NorStOP, missing data from attrition does not affect 
the study. Overall selection bias may affect both the internal and external validity of 
this study. The internal validity may be compromised as the sample for analysis may 
not represent the proposed study population (i.e. adults aged 50 years and over living 
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in North Staffordshire). Similarly, this may affect generalisability to wider populations 
(for example the West Midlands or England) or to other locations. 
4.5.2 Missing data 
 
Missing data refers to the absence of information or missing values for a variable 
(Kang, 2013). There are various reasons why missing data can occur, including random 
error, researcher error and participant error. There was missing data for 2366 
participants who had consented to medical record review but did not provide 
complete data for covariates and mediators, or where vital status was unobtainable, 
and were therefore excluded from the full analysis. 
The characteristics of those with missing data may be different to those included in 
the analyses, which would indicate potential selection bias. The mean age and 
proportion of females and those who went onto further education were different in 
those with complete data to those worth missing data (p<0.05) (Table 4.1). Those with 
complete data were younger (65.16 years cf 69.57 years), more likely to have gone 
into further education (12.37% cf 9.55%) and less likely to be female (51.64% cf 
61.35%). 
Table 4.1- Sex, age and education characteristics between those 
with complete data and missing data at baseline 
 Complete data 
(n=8066) 
Consent but 
missing data 
(n= 2366) 
P value 
Sex (F) 51.64% 61.35% <0.001 
Age (mean) 65.16 69.57 <0.001 
Further 
education 
12.37% 9.55% <0.001 
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4.6 DEFINITIONS OF OA IDENTIFIABLE IN THE NORTH STAFFORDSHIRE 
OSTEOARTHRITIS PROJECT 
4.6.1 Operationalising OA; identifying case definitions 
As highlighted in Chapter 2, there are different case definitions of OA. The 
combination of medical record data and self-report data offers the opportunity to 
define OA in a number of ways; this involves combinations of information based on 
clinician diagnosis of OA (via the primary care medical record) and self-reported 
information on where joint pain occurs or pain interference, as well as other 
morbidities. Definitions are described below and organised with reference to:  
1. OA diagnosis in the participant’s primary care record: ‘OA Consulter’. 
2. Self-reported joint pain. 
3. Self-reported joint pain and OA diagnosis in the participant’s primary care 
record: ‘Symptomatic OA’. 
4. Self-reported pain interference and self-reported joint pain and OA 
diagnosis in the participant’s primary care medical record: ‘Disabling OA’.  
Each of these were then further defined by anatomical area (Table 4.2).  
4.6.2 OA consulters 
General practitioners in the study used the Read system to code all reasons for clinical 
encounters in primary care consultations (NHS Information Authority, 2000). The Read 
codes cross-map to International Classification for Diseases (ICD) 9/10. Morbidity data 
(i.e. symptoms and diseases) in this system are grouped into 19 Read chapters. Data 
on these diagnostic groups were aggregated starting in 2000, continuing through the 
time of the follow-up questionnaire in 2008. Individuals were defined as having OA if 
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they had at least one consultation during this period primarily for OA and allied 
disorders based on Read codes (N05 category) for primary care consultations (NHS 
Information, 2000). The code N05 for OA is an umbrella code encompassing over 100 
specific codes, including those for OA at specific joint sites and OA secondary to other 
diseases. As OA is a longstanding, gradually progressive chronic condition, it was 
assumed that a clinician-established diagnosis at any point during the study period 
implied that OA was likely present to at least to some degree during the entire period 
of observation. 
4.6.3 Self-reported joint pain  
Self-reported joint pain was defined by participants indicating in the ‘Health Survey’ 
questionnaire that they experienced pain in the hand, hip, knee and/or foot for one 
day or more during the past year.   
4.6.4 Symptomatic OA 
Symptomatic OA combined information on consultation and self-report as outlined 
above. Symptomatic OA was defined as consultation for OA (as identified in the 
medical records) and self-reported joint pain. This lead to seven definitions: 
symptomatic hand OA, symptomatic knee OA, symptomatic hip OA and symptomatic 
foot OA, combinations of joint pains lead to symptomatic upper limb OA only, 
symptomatic lower limb OA only and symptomatic upper and lower limb OA  
4.6.5 Disabling OA 
 
Disabling OA was defined by consultation to primary care for OA, self-report of joint 
pain and self-report of pain interference. Pain interference was measured using a 
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using a single item from the Medical Outcomes Study Short Form-12 (Ware et al. 
1996): “During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework?)”. This question has five 
responses, which were dichotomised for the purpose of this analysis: (i) Pain 
interference- ‘Moderately’, ‘Quite a bit’ or ‘Extremely’ and (ii) No pain interference- 
‘Not at all’ or ‘A little bit’. This lead to eight definitions: disabling OA at any site, 
disabling hand OA, disabling knee OA, disabling hip OA and disabling foot OA, 
combinations of joint pains lead to disabling upper limb OA only, disabling lower limb 
OA only and disabling upper and lower limb OA. 
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Table 4.2- Summary of case definitions used within the NorStOP cohort 
Osteoarthritis 
case definition 
Osteoarthritis in 
the primary care 
medical records 
Joint pain 
reported on 
‘Health 
Survey’ 
Pain 
interference 
reported on 
‘Health 
Survey’ 
Anatomical Area 
    Any Hand Knee Hip Foot 
OA Consulters x   x     
Self-reported 
hand pain 
 x   x    
Self-reported 
knee pain 
 x    x   
Self-reported hip 
pain 
 x     x  
Self-reported foot 
pain 
 x      x 
Symptomatic 
hand OA 
x x   x    
Symptomatic 
knee OA 
x x    x   
Symptomatic hip 
OA 
x x     x  
Symptomatic foot 
OA 
x x      x 
Disabling OA  x x x x     
Disabling hand OA x x x  x    
Disabling knee OA x x x   x   
Disabling hip OA x x x    x  
Disabling foot OA x x x     x 
Number of 
anatomical areas 
affected by 
disabling OA 
1            x x x x     
2            x x x x     
3            x x x x     
4            x 
 
x x x    
 
 
 
Symptomatic 
lower limb OA 
x x    x x x 
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Table 4.2- Continued… 
Osteoarthritis 
case definition 
Osteoarthritis in 
the primary care 
medical records 
Joint pain 
reported on 
‘Health 
Survey’ 
Pain 
interference 
reported on 
‘Health 
Survey’ 
Anatomical Area 
    Any Hand Knee Hip Foot 
Disabling lower 
limb OA 
x x x   x x x 
Symptomatic 
upper limb OA 
x x   x    
Disabling upper 
limb OA 
x x x  x    
Symptomatic 
upper and lower 
limb OA 
x x   x x x x 
Disabling upper 
and lower limb 
OA 
x x x  x x x x 
Number of 
anatomical areas 
with symptomatic 
OA 
1             x x  x     
2             x x  x     
3             x x  x     
4             x x  x     
Number of 
anatomical areas 
with disabling OA 
1             x x x x     
2             x x x x     
3             x x x x     
4             x x x x     
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4.6.6 Mortality Ascertainment  
Vital status of participants was collated from two different sources. Mortality was 
obtained from the Exeter patient registration system - a database of all patients 
registered with a GP in England and Wales (NHS Digital, 2018). Date of death is 
recorded by this system. Those whose mortality was unclear in 2012 were excluded 
from the dataset. Days in study was calculated from response to the questionnaire 
until date of death or census date (01/10/2012).  
4.6.7 Measurement of and rationale for proposed confounders 
A confounder is associated with both the exposure and the outcome, but is not on the 
causal pathway (Szklo and Nieto, 2018). In this case a confounder is associated with 
both OA and premature mortality and is not on the causal pathway. Without 
adjustment the results may be misleading. Comorbidities, socio-demographic and 
lifestyle factors associated with OA and premature mortality were included as 
confounders 
4.6.7.1 Age 
As discussed in 1.5.3.2, age has a strong association with OA (Oliveria et al., 1995). 
Furthermore, mortality increases with age (Office for National Statistics, 2017). Table 
4.3 on page 95 demonstrates that participants with disabling OA tend to be older than 
participants within the rest of NorStOP. Data pertaining to age was self-reported via 
the ‘Health Survey’ and checked against medical records. Age will be included in the 
model as a confounder.  
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4.6.7.2 Sex 
OA is more common in females, as discussed in 1.5.3.2. Table 4.3 on page 95 shows 
that a higher proportion of females are in the pain interference case definitions in 
comparison to the rest of the NorStOP cohort. Sex was self-reported via the ‘Health 
Survey’ and checked against medical records.  
4.6.7.3 Socioeconomic Status 
Education and occupation were surrogate markers of socioeconomic class (Galobardes 
et al., 2006). Socioeconomic status is associated with OA for lots of different reasons, 
including access to healthcare, links with other comorbidities, mental health problems 
and poor quality of life (Knight et al., 2011; Reyes et al., 2015). Socioeconomic status is 
also associated with other confounders listed here including body mass index (BMI) 
and smoking (Hiscock et al., 2012; Morgenstern, Sargent and Hanewinkel, 2009). 
Furthermore, low socioeconomic status is associated with premature mortality 
(Jensen et al., 2017). Data relating to this is self-reported via the ‘Health Survey’. Low 
education level was defined as those with a school education only. The Health Survey 
included questions “How old were you when you left school?” and “Did you go on 
from school to full-time education or university? Yes; No- If yes, what age did you 
finish full-time education?” A low socioeconomic class classified as those with a 
manual occupation. The Health Survey asked “What is your current employment 
status? Employed; not working due to ill-health or disability; retired; 
unemployed/seeking work; housewife; other” to ascertain working status. Short 
answer questions were then asked to classify work “If working, what is your job title?” 
and “If not working, or retired what was your last job?” These were then compared to 
90 
 
the Standard Occupational Classification framework to identify the proportion of 
respondents with a manual occupation (Office of National Statistics, 2002). As 
socioeconomic status is not on the causal pathway, both occupation and education 
will be adjusted for as binary confounders. 
4.6.7.4 Non-steroidal anti-inflammatory drug (NSAID) use 
As discussed in 2.1.2.1, there is a reduction in the prescriptions of NSAIDs for joint 
pain. This is due to their associations with renal and gastrointestinal problems 
alongside emerging evidence suggesting that they contribute to cardiovascular disease 
(CVD; Bavry et al., 2011; Trelle et al., 2011). Data on the prescription of NSAIDs was 
taken from the participants’ medical records. Medical record data categorised 
participants into one of three groups: no NSAID prescriptions, those with less than 10 
NSAID prescriptions and those with 10 or more NSAID prescriptions. NSAIDs will be 
included as a categorical confounder.  
4.6.7.5 Ischaemic heart disease (IHD) and self-reported CVD 
As discussed in 2.1.5, CVD is associated with OA. The systematic searches in Chapter 2 
highlighted that some papers considered cardiovascular specific mortality, with 
physical activity implicated as a potential mechanism (Cleveland et al., 2019; 
Turkiewicz et al., 2016; Mendy et al., 2018). Studies have found that the relationship 
between OA and CVD is not entirely clear. A recent systematic review discussed that 
OA is a risk factor for CVD (Wang et al., 2016). However, other studies found a non-
directional association between OA and CVD (Rahman et al., 2013). Furthermore, CVD 
is associated with premature mortality (Ordunez et al., 2015). Two measures of CVD 
were included as potential confounders. IHD refers to a diagnostic code for IHD on the 
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medical records, whereas self-reported CVD refers to participants indicating they had 
one or more cardiovascular diseases on the ‘Health Survey’. Given the unclear 
relationship between OA and CVD, it has been included as a binary confounder, with 
one medically defined and one self-reported measure.  
4.6.7.6 Diabetes mellitus  
OA is frequently a co-morbid condition with diabetes mellitus (Louati et al., 2015). 
Diabetes mellitus is also associated with premature mortality (Roglic and Unwin, 
2010). This association is attributed to their shared risk factors, such as raised BMI and 
CVD. Diabetes mellitus refers to those indicating that they had any type of diabetes 
mellitus on the ‘Health Survey’. It will be included as a binary confounder. 
4.6.7.7 Smoking  
Smoking is an important surrogate marker of socioeconomic status and contributes to 
the development of other diseases (Hiscock et al., 2012). Participants were asked on 
the ‘Health Survey’ to indicate whether they had never smoked, previously smoked or 
currently smoked. This was dichotomised to ‘never and previous’ and ‘current’. There 
has been limited evidence suggesting that smoking is protective against radiographic 
OA, but overall it appears to be a contributor to other risk factors (Felson and Zhang, 
2015). 
4.6.7.8 Chronic Obstructive Pulmonary Disease (COPD) 
COPD, commonly caused by smoking, is an important disease that is associated with 
both OA and mortality (Manino, 2002; Wshah et al., 2018). COPD was defined as self-
reported chest problems and/or cough with spit on the healthy survey and was 
dichotomised. COPD was included in the analysis as a binary confounder.  
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4.6.7.9 Body Mass Index (BMI) 
Participants were asked to provide a height and weight in the ‘Health Survey’, from 
which BMI was calculated and classified as follows; BMI of <20kg/m2 was classed as 
underweight; 20-24.9kg/m2 as normal; 25-29.9kg/m2 as overweight and over 30kg/m2 
as obese (Erens, Primatesta and Prior, 2001 As discussed in 1.5.3.1 increased BMI has 
an association with both OA and mortality (Bhaskaran et al., 2018, Zheng and Chen, 
2015). A low BMI is also associated with OA and mortality (Ghosh et al., 2017). In this 
analysis BMI was classed as a confounder and used as a continuous variable.  
4.7 DATA ANALYSIS 
4.7.1 Descriptive statistics  
 
The characteristics of individuals were summarised using frequencies and percentages, 
with means and standard deviations (SDs) used for continuous variables. Descriptive 
statistics were performed for each case definition. The data from this can be found in 
Table 4.3. 
4.7.2 Survival analysis  
 
Survival analysis is the analysis of times from a defined time origin (in this study 
defined as participant study entry) until occurrence of event of interest (in this study 
mortality). Survival data tend to follow a non-symmetrical distribution and usually a 
substantial proportion of survival times are censored (Kleinbaum, 1998; Hosmer Jr, 
Lemeshow and May, 2008). Censored observations are those which have not been 
fully observed, and the most commonly encountered form of censoring is right 
censoring. An observation is right censored if at the time of analysis the exact value of 
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survival time is unknown. This may occur if an individual is lost to follow-up or is still 
alive at the end of the study where mortality is the outcome. In this study, right 
censoring refers to participants that were alive on 01/10/12 (the census date).  
4.7.2.1 Cox proportional hazard models 
The Cox proportional hazard regression model (Cox, 1972)describes the relationship 
between time to event and covariates (represented by the hazard function h(t)). Both 
numerical and categorical predictor variables can be used, individually or 
simultaneously, giving rise to univariable and multivariable models respectively. 
Survival times may be characterised in terms of various functions, including hazard and 
survival functions. The general equation for a Cox hazard function is:  
ℎ(#) = ℎ0(#) × ()*(+1)1 + +2)2+. . . ++*)*) 
where t= time, h0 (t) >0 is the baseline hazard, x1, x2…are time-invariant predictor 
variables with the coefficients b1, b2,…measuring their effect; by its definition, a 
hazard function represents instantaneous event rate.  
A hazard ratio (HR) is a measure of the effect of a predictor variable on time to event 
of interest (death in this study). A hazard ratio of 1 implies no difference between 
categories of the exposure on survival; a hazard ratio greater than 1 shows an increase 
in the hazard for the exposed group compared to unexposed and a hazard ratio of less 
than 1 shows a reduction in the hazard for the exposed compared to the unexposed 
groups. 
A Cox Model was used to assess the association, in terms of HRs and corresponding 
95% confidence intervals (CIs), between each case definition of OA and mortality. First 
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of all, univariate analyses were performed to assess the unadjusted association 
between each OA definition and OA. Then multivariable analysis was performed, 
whereby the association between each definition and mortality was adjusted for 
confounders simultaneously.  
Cox model is proportional is because the hazard ratio for two individuals with 
covariates (x and x*) is exp([x-x*]b), which is constant over time. The assumption of 
proportionality needs testing throughout, which was done via Schoenfeld residuals 
(Schoenfeld and Herrman, 1982). A p value of more than 0.05 confirms the 
proportionality (i.e. the hazards for participants are the same across time).  
The independence of outcomes (in this case deaths) between each participant is also 
an assumption of the Cox proportional hazards model. The Kaplan Meier method was 
used to create Kaplan Meier curves, as ‘events’ (in this case, death) are assumed to be 
independent of each other (Kaplan and Meier, 1958). 
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Table 4.3- The characteristics of each case sample and the whole sample for each case definition of OA 
 NorStOP 
Cohort 
OA 
Consulters 
Self-reported joint pain Symptomatic OA Disabling OA 
 Hand Hip Knee Foot Hand Hip Knee Foot Hand Hip Knee Foot 
Number of participants (%) 8066   
(100%) 
4653 
(57.69%) 
3559 
(44.12%) 
2720 
(33.72%) 
4271 
(52.95%) 
3099 
(38.42%) 
2376 
(29.46%) 
1902 
(23.58%) 
2866 
(35.53%) 
2105 
(26.10%) 
1515 
(18.78%) 
1323 
(16.4%) 
1774 
(21.99%) 
1387 
(17.20%) 
Age (standard deviation) 65.16    
(9.76) 
65.55 
(9.62) 
65.51 
(9.75) 
66.01 
(9.57) 
65.58 
(9.81) 
65.97 
(9.83) 
65.69 
(9.66) 
66.33 
(9.48) 
65.79 
(9.65) 
66.09 
(9.64) 
66.99 
(9.83) 
67.14 
(9.71) 
67.24 
(9.82) 
67.09 
(9.78) 
Sex (% female) 4165 
(51.64%) 
2032 
(43.67%) 
1459 
(40.99%) 
1128 
(41.47%) 
1931 
(45.21%) 
1323 
(42.69%) 
891 
(37.50%) 
738 
(38.80%) 
1189 
(41.49%) 
829 
(39.38%) 
950 
(62.71%) 
813 
(61.45%) 
1039 
(58.57%) 
841 
(60.63%) 
Self-reported manual 
occupation 
4381 
(54.31%) 
2562 
(55.06%) 
1902 
(53.44%) 
1539 
(41.47%) 
2410 
(56.43%) 
1769 
(57.08%) 
1360 
(57.24%) 
1078 
(56.68%) 
1624 
(56.66%) 
1224 
(58.15%) 
907 
(59.87%) 
801 
(60.54%) 
1067 
(60.15%) 
828 
(59.70%) 
Self-reported school 
education only 
7068 
(87.63%) 
4108 
(88.29%) 
3159 
(88.76%) 
2425 
(89.15%) 
3806 
(89.11%) 
2767 
(89.29%) 
2117 
(89.10%) 
1700 
(89.38%) 
2562 
(89.39%) 
1892 
(89.88%) 
1387 
(91.55%) 
1212 
(91.61%) 
1627 
(91.71%) 
1275 
(91.93%) 
NSAIDs 
prescribed on 
primary care 
medical 
records 
None 5019 
(62.22%) 
2233 
(47.99%) 
1999 
(56.17%) 
1463 
(53.79%) 
2426 
(56.80%) 
1746 
(56.34%) 
1081 
(45.50%) 
846 
(44.48%) 
1306 
(45.57%) 
968 
(45.99%) 
683 
(45.08%) 
584 
(44.14%) 
800 
(45.10%) 
628 
(45.28%) 
< 10 2293 
(28.43%) 
1773 
(38.10%) 
1081 
(30.37%) 
847 
(31.14%) 
1288 
(30.16%) 
948 
(30.59%) 
888 
(37.37%) 
702 
(36.91%) 
1075 
(37.51%) 
789 
(37.48%) 
519 
(34.26%) 
467 
(35.30%) 
603 
(33.99%) 
485 
(34.97%) 
> 10 754    
(9.45%) 
647 
(13.91%) 
479 
(13.46%) 
410 
(15.07%) 
557 
(13.04%) 
405 
(13.07%) 
402 
(16.92%) 
354 
(18.61%) 
485 
(16.92%) 
348 
(16.53%) 
313 
(20.66%) 
272 
(20.56%) 
371 
(20.91%) 
274 
(19.75%) 
Ischaemic heart disease on 
the primary care medical 
records 
707    
(8.76%) 
504 
(10.83%) 
339 
(9.53%) 
290 
(10.66%) 
419 
(9.81%) 
313 
(10.10%) 
265 
(11.15%) 
236 
(12.41%) 
330 
(11.51%) 
243 
(11.54%) 
192 
(12.67%) 
184 
(13.91%) 
244 
(13.75%) 
184 
(13.27%) 
Self-reported cardiovascular 
disease 
3385 
(41.97%) 
2056 
(44.19%) 
1599 
(44.93%) 
1245 
(45.77%) 
1954 
(45.75%) 
1465 
(47.27%) 
1103 
(46.42%) 
890 
(46.79%) 
1343 
(46.86%) 
1022 
(48.55%) 
800 
(52.81%) 
699 
(52.83%) 
953 
(53.72%) 
757 
(54.58%) 
Self-reported diabetes 
mellitus 
470    
(5.82%) 
325 
(6.98%) 
226 
(6.35%) 
181 
(6.65%) 
297 
(6.95%) 
240 
(7.74%) 
177 
(7.45%) 
140 
(7.36%) 
227 
(7.92%) 
183 
(8.69%) 
127 
(8.38%) 
114 
(8.62%) 
162 
(9.13%) 
139 
(10.02%) 
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Table4.3- Continued 
 NorStOP 
Cohort 
OA 
Consulters 
Self-reported joint pain Symptomatic OA Disabling OA 
   Hand Hip Knee Foot Hand Hip Knee Foot Hand Hip Knee Foot 
Self-reported smoking 1237 
(15.34%) 
633 
(13.60%) 
516 
(14.50%) 
412 
(15.15%) 
625 
(14.63%) 
468 
(15.10%) 
304 
(12.79% 
268 
(14.09%) 
367 
(12.81%) 
278 
(13.21%) 
211 
(13.93%) 
201 
(15.19%) 
234 
(13.19%) 
197 
(14.20%) 
Chronic Obstructive 
Pulmonary Disease 
354    
(4.39%) 
234 
(5.03%) 
176 
(4.95%) 
134 
(4.93%) 
185 
(4.33%) 
163 
(5.26%) 
128 
(5.39%) 
111 
(5.84%) 
140 
(4.88%) 
97   
(4.61%) 
97   
(6.40%) 
87   
(6.58%) 
108 
(6.09%) 
97   
(6.99%) 
Body Mass 
Index 
20-24.9 
kg/m2 
2836 
(35.16%) 
1454 
(31.25%) 
1163 
(32.68%) 
816 
(30.00%) 
1278 
(29.92%) 
962 
(31.04%) 
704 
(29.63%) 
518 
(27.23%) 
792 
(27.63%) 
591 
(28.08%) 
402 
(26.53%) 
322 
(24.34%) 
431 
(24.30%) 
348 
(25.09%) 
<20kg/m2 306 (3.94%) 157 
(3.37%) 
120 
(3.37%) 
86 
(3.16%) 
123 
(2.88%) 
102 
(3.29%) 
70   
(2.95%) 
63   
(3.31%) 
65   
(2.27%) 
62   
(2.95%) 
52   
(3.43%) 
48   
(3.63%) 
49   
(2.76%) 
44   
(3.17%) 
25-29.9 
kg/m2 
3380 
(41.90%) 
2009 
(43.18%) 
1509 
(42.40%) 
1179 
(43.35%) 
1835 
(42.96%) 
1300 
(41.95%) 
1044 
(43.94%) 
835 
(43.90%) 
1248 
(43.55%) 
897 
(42.61%) 
638 
(42.11%) 
566 
(42.78%) 
751 
(42.33%) 
589 
(42.47%) 
>30kg/m2 1544 
(19.14%) 
1033 
(22.20%) 
767 
(21.55%) 
639 
(23.49%) 
1035 
(24.23%) 
735 
(23.72%) 
558 
(23.48%) 
486 
(25.55%) 
761 
(26.55%) 
555 
(26.37%) 
423 
(27.92%) 
387 
(29.2%) 
543 
(30.61%) 
406 
(29.27%) 
Abbreviations: North Staffordshire Osteoarthritis Project (NorStOP), Osteoarthritis (OA), NSAIDs (non-steroidal anti-inflammatory drugs), kilogram (kg), metre (m) 
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4.8 RESULTS 
4.8.1 Description of population 
In total, 8066 participants were included in the analysis from NorStOP 1 and 2. The 
mean age was 65.2 years and 51.6% of the population were female. At follow up, 1188 
(17.2%) had died. 12.4% of participants completed further education and 54.3% were 
classified as having manual occupations. Table 4.3 presents the characteristics of 
participants within each OA group. Some participants belonged to more than one OA 
group. There are more females within the disabling OA group than in the other OA 
case definitions. Participants with disabling OA were more likely to have a lower level 
of education, more likely to be overweight or obese and more likely to have a manual 
occupation than participants without disabling OA. 
4.8.2 Assumption testing 
The hazard ratios were proportional across time for all of the OA definitions except 
two; the p-values from the Schoenfeld test for OA Consulters was <0.01 and 
symptomatic lower limb OA was <0.01. All other case definitions had p-values of 
>0.05, showing proportionality. 
Figure 4.2 is a Kaplan Meier curve for the case definition OA Consulters. Kaplan Meier 
curves for each of the other definitions of OA can be found in Appendix 4. This Kaplan 
Meier curve illustrates the difference between the mortality rates in the OA consulters 
and the non-OA consulters. This graph shows that non-OA consulters (blue line) have a 
faster rate of mortality than the OA consulters (red line).  
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Figure 4.2- Kaplan Meier plot of survival in those who have consulted for 
osteoarthritis and those who have not  
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Table 4.4- Adjusted and unadjusted hazard ratios with confidence intervals for different 
clinical case definitions of OA and their effect on premature mortality 
 N= Unadjusted HR Adjusted* HR  
OA Consulters 4653 0.84 (0.75, 0.94) 0.84 (0.74, 0.94) 
Self-reported hand pain 3559 0.99 (0.88, 1.11) 1.03 (0.92, 1.16) 
Self-reported knee pain 3689 1.00 (0.90, 1.11) 1.03 (0.92, 1.15) 
Self-reported hip pain 2720 1.02 (0.91, 1.15) 0.99 (0.87, 1.12) 
Self-reported foot pain 3099 1.10 (0.98, 1.24) 1.04 (0.93, 1.17) 
Symptomatic hand OA 2376 0.92 (0.81, 1.05) 0.98 (0.86, 1.11) 
Symptomatic knee OA 2866 0.91 (0.80, 1.02) 0.92 (0.81, 1.04) 
Symptomatic hip OA 1902 0.97 (0.84, 1.10) 0.94 (0.82, 1.08) 
Symptomatic foot OA 2105 1.02 (0.90, 1.16) 1.01 (0.88, 1.15) 
Disabling OA  2396 1.38 (1.27, 1.55) 1.23 (1.08, 1.39) 
Disabling hand OA 1515 1.24 (1.08, 1.43) 1.18 (1.02, 1.35) 
Disabling knee OA 1774 1.28 (1.13, 1.46) 1.16 (1.02, 1.33) 
Disabling hip OA 1323 1.16 (1.00, 1.35) 1.06 (0.91, 1.23) 
Disabling foot OA 1387 1.32 (1.15, 1.52) 1.21 (1.05, 1.40) 
Number of anatomical 
areas affected by disabling 
OA 
1 375 1.52 (1.20, 1.92) 1.29 (1.02, 1.64) 
2 545 1.35 (1.10, 1.67) 1.16 (0.94, 1.44) 
3 658 1.46 (1.21, 1.76) 1.30 (1.07, 1.57) 
4 600 1.08 (0.87, 1.35) 1.05 (0.84, 1.32) 
Symptomatic lower limb OA 3746 0.93 (0.83, 1.04) 0.93 (0.82, 1.05) 
Disabling lower limb OA 2185 1.36 (1.20, 1.53) 1.21 (1.07, 1.38) 
Symptomatic upper limb OA 231 0.75 (0.51, 1.10) 0.88 (0.60, 1.30) 
Disabling upper limb OA 71 1.51 (0.89, 2.56) 1.29 (0.76, 2.19) 
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Table 4.4- Continued… 
 N= Unadjusted HR Adjusted* HR  
Symptomatic upper and lower 
limb OA 
2145 0.91 (0.80, 1.05) 0.95 (0.82, 1.09) 
Disabling upper and lower limb 
OA 
1444 1.29 (1.13, 1.50) 1.21 (1.04, 1.41) 
Number of anatomical 
areas with symptomatic 
OA 
1 2961 0.94 (0.79, 1.13) 0.97 (0.81, 1.67) 
2 2433 1.02 (0.85, 1.23) 1.02 (0.84, 1.22) 
3 1462 1.00 (0.81, 1.22) 1.00 (0.82, 1.23) 
4 141 0.94 (0.59, 1.50) 1.01 (0.63, 1.61) 
Number of anatomical 
areas with disabling OA 
1 399 1.49 (1.18, 1.88) 1.26 (1.00, 1.59) 
2 571 1.43 (1.17, 1.75) 1.23 (1.00, 1.51) 
3 686 1.49 (1.24, 1.79) 1.33 (1.10, 1.61) 
4 600 1.09 (0.88, 1.36) 1.06 (0.85, 1.33) 
Adjusted for: age, gender, education, occupation, non-steroidal anti-inflammatory drugs, 
ischaemic heart disease on medical records, self-reported cardiovascular disease, 
diabetes, smoking, chronic obstructive pulmonary disease and body mass index 
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4.8.3 OA Consulters 
Consultation for OA had a significant protective association with mortality (adjusted 
HR 0.84 95% CI 0.74, 0.94) (Table 4.4).  
4.8.4 Symptomatic OA 
Fewer participants were included in this analysis compared with OA consulters, 
representing the difference between those diagnosed with OA and those reporting 
symptoms of OA. In this definition, none of the joints investigated showed a significant 
association with premature mortality in the adjusted analysis (hand adjusted HR 0.98 
95% CI 0.86, 1.11; knee adjusted HR 0.92 95% CI 0.81, 1.04; hip adjusted HR 0.94 95% 
CI 0.82, 1.08; foot adjusted HR 1.01 95% CI 0.88, 1.15) (Table 4.4). Symptomatic OA 
was not associated with premature mortality in number of anatomical areas including, 
upper limb, lower limb and upper and lower limb OA.  
4.8.5 Disabling OA 
Overall, disabling OA and premature mortality had a significant association (adjusted 
HR 1.23 95% CI 1.08, 1.39). On an individual joint basis, most of the anatomical areas 
investigated had a significant association with premature mortality (hand adjusted HR 
1.18 95% CI 1.02, 1.35; knee adjusted HR 1.16 95% CI 1.02, 1.35; foot adjusted HR 1.21 
95% CI 1.05, 1.40). Hip OA did not have a significant association with premature 
mortality (hip adjusted HR 1.06 95% CI 0.91, 1.23).  
There was no trend with increasing number of joints and disabling OA. There was a 
significant association for one joint and three joints with disabling OA and premature 
mortality, however having two or four joints with disabling OA were not significantly 
associated with premature mortality (one joint adjusted HR 1.29 95% CI 1.02, 1.64; 
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two joints adjusted HR 1.16 95% CI 0.94, 1.44; three joints adjusted HR 1.30 95% CI 
1.07, 1.57; four joints adjusted HR 1.05 95% CI 0.84, 1.32).  
When categorising by limb, there was a significant association with premature 
mortality and lower limb disabling OA with but not with upper limb disabling OA with 
(lower limb adjusted HR 1.21 95% CI 1.07, 1.38; upper limb adjusted HR 1.29 95% CI 
0.76, 2.19). When looking at disabling OA across both regions (both upper and lower 
limb) the adjusted analysis also shows a significant association with premature 
mortality (adjusted HR 1.21 95% CI 1.04, 1.41). 
4.9 DISCUSSION 
The aim of this study was to examine the strength and direction of association 
between different clinical case definitions of OA and premature mortality at different 
anatomical sites. It identified that simply consulting for OA or having symptomatic OA 
does not predict mortality. However, disabling OA characterised by having pain 
interference, in addition to consultation to primary care for OA and self-report of joint 
pain, does predict premature mortality across all anatomical locations, except for the 
hip joint. 
4.9.1 OA Consulters 
Consultation for OA was protective of premature mortality (adjusted HR 0.84 95% CI 
0.74, 0.94). This could be explained because patients under the care of a GP are likely 
to have other health checks, and therefore co-morbidities treated. For example, a 
patient attending primary care who is diagnosed with OA should be initially managed 
using patient education and weight loss advice, if necessary (NICE, 2014). This may 
then impact other co-morbidities from developing or worsening, such as CVD or 
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diabetes mellitus, therefore reducing premature mortality. Those diagnosed with OA 
in primary care are likely to be a heterogeneous group. OA documentation on medical 
records relies on the clinician’s diagnosis, which may not link with criteria or be 
correct. Furthermore, this measurement does not provide information about the 
severity of the patient’s symptoms.  
4.9.2 Self-report of joint pain 
OA defined by self-report of joint pain was measured by indication in the NorStOP 
‘Health Survey’ that they had more than one day of pain in the last year in either the 
hand, knee, hip or foot. None of the analyses revealed a significant association with 
premature mortality using this case definition. As with the first definition, a 
consequence of this definition is the lack of information about the severity of the 
symptoms experienced by the patient. Another limitation of this case definition is the 
reliance on self-report alone without affirmation from primary care medical record 
data.  
4.9.3 Symptomatic OA  
Symptomatic OA was defined as OA on the primary care medical record and more 
than one day of pain in the last year in either the hand, knee, hip or foot. The analyses 
did not show a significant association between symptomatic OA and premature 
mortality at any anatomical location. The definition does not take into account the 
severity of the OA or symptomology of the participant. This definition also has a risk of 
misclassification, discussed below.  
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4.9.4 Disabling OA 
Self-report of pain interference was included in the disabling OA case definition. This 
was defined by OA diagnosis on the primary care medical records plus self-reported 
joint pain and self-reported pain interference. All definitions with these criteria were 
positively and significantly associated with mortality although the association with hip 
pain was not significant (adjusted HR 1.06 95% CI 0.91, 1.23). It is not clear why 
disabling hip OA does not have a significant association with premature mortality. 
Other studies have found a significant association between clinical hip OA and 
premature mortality (Nüesch et al., 2011). Disabling OA also showed a significant 
association with premature mortality when one or three anatomical areas were 
involved, the lower limb was involved, and the lower and upper limb were both 
involved. The disabling lower limb OA group reported combined hip, knee and foot OA 
within the case definition to show a significant association with premature mortality. 
In the disabling upper limb OA group, the participants reporting pain in any other joint 
were removed. Compared to the disabling hand OA group, which included those 
reporting joint pain in other anatomical areas, the number of participants with hand 
pain alone was 76 compared with 1515 with hand pain plus pain at other joint sites; 
the sample of those with disabling hand OA alone is very small. Disabling hand OA 
alone showed a non-significant but positive association with premature mortality 
(adjusted HR 1.29 95% CI 0.76, 2.19). The small numbers included in this analysis 
meant the power of the analysis was low, and although the result are not statistically 
significant they do indicate an association between disabling hand OA alone and 
premature mortality. The papers identified in the systematic review in Chapter 2 
reported contrasting findings for the relationship between hand OA and premature 
105 
 
mortality. Some papers reported no association between hand OA and premature 
mortality, as found in this study (Veronese et al., 2015). In contrast, other papers 
reported an association between hand OA and premature mortality, however it was 
unclear if those with hand pain in these studies also had pain in other joints (Haara et 
al., 2003, 2004, Haugen et al., 2015).  
4.9.5 Limitations 
As briefly discussed above, there are limitations to the use of medical records to 
identify OA. Firstly, OA coding in medical records relies on the diagnostic accuracy of 
the primary care clinician and therefore includes a risk of misclassification. Up to 8% of 
read codes have been found to be misclassified (Kang et al., 2015). Additionally, OA is 
under-reported on medical records, which further risks the misclassification of 
participants (Yu, Jordan and Peat, 2018). The case definition of symptomatic OA 
encompasses any pain felt within that joint for more than a day over the last year, and 
therefore includes a full spectrum of pain felt within the joint, from transient joint pain 
to pain every day. This therefore means that participants with minimal symptoms, or 
OA in a joint area not covered by NorStOP, could have been included in this group, 
further risking information bias. The NorStOP questionnaire also risks recall bias; 
participants may not remember episodes of joint pain and therefore not respond to 
this question. Finally, the disabling OA case definition also risks misclassification. The 
questions about the location of joint pain and pain interference were not linked; this 
potentially means that reported pain interference did not refer to pain felt in that joint 
in particular or pain attributed to OA. However, using pain interference within the 
106 
 
disabling OA case definition establishes the symptomology of the participant, 
decreasing the chances of misclassification of participants.  
4.10 SUMMARY  
This study has identified that the association between OA with mortality is dependent 
on the case definition. Overall, the strongest positive associations with premature 
mortality were with case definitions of OA that combined pain interference, self-
reported joint pain and OA consultation coded in the primary care medical records. 
This case definition had a significant association with premature mortality across most 
joint sites. Using disabling OA as a case definition is the best approach to identify more 
severe OA and its impact on daily life.  
Whilst this chapter has identified that disabling OA is associated with premature 
mortality, it has not identified what causes, or mediates, this association. Identifying 
pathways offers the potential to better target ways to reduce premature mortality for 
the large number of people with disabling OA. 
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5 CHAPTER 5: MEDIATION ANALYSIS AND RESULTS 
5.1 INTRODUCTION 
Osteoarthritis (OA) with pain interference (disabling OA) is associated with premature 
mortality. However, why this association, or that of other definitions of OA, occurs has 
not been previously explored. The studies identified in the systematic searches 
included confounders but did not explore the mechanism by which OA was associated 
with premature mortality. Examining mediators of the association between OA and 
mortality has not been previously conducted within a survival analysis setting. This 
chapter describes such analyses using a novel approach to mediation within survival 
analysis to identify factors that mediate the relationship between pain interfering OA 
and premature mortality. These factors present targets to reduce premature mortality 
in the large number of people in the community with pain interfering OA. 
5.2 AIMS AND OBJECTIVES 
5.2.1 Aims 
The overall aim of this chapter was to identify factors that mediate the relationship 
between OA and premature mortality.  
5.2.2 Objectives 
1. To test the hypotheses that the association between premature mortality and 
OA is mediated by low walking frequency, depression, anxiety, insomnia and 
low social participation. 
2. To identify if the mediators of the association between disabling OA and 
mortality differ by anatomical location (hand, hip, knee and foot).  
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5.3 MEASUREMENT AND RATIONALE OF PROPOSED MEDIATORS 
Following the study in Chapter 4, disabling OA was used as a case definition for OA in 
this chapter. In chapter 4, different case definitions, including OA consulter and 
symptomatic OA were analysed for their association with premature mortality. 
Disabling OA was the only case definition to have a significant association with 
premature mortality. The case definitions of OA used in this analysis were all 
significantly and positively associated with mortality (Table 5.1).  
Table 5.1- Case definitions of OA included in the mediation analysis 
Case definition Description 
Disabling osteoarthritis 
(n= 2396) 
Osteoarthritis coded on the primary care medical 
record, any self-reported joint pain and self-reported 
pain interference. 
Disabling hand 
osteoarthritis 
(n= 1515) 
Osteoarthritis coded on the primary care medical 
record, self-reported hand pain and self-reported pain 
interference. 
Disabling knee 
osteoarthritis 
(n= 1774) 
Osteoarthritis coded on the primary care medical 
record, self-reported knee pain and self-reported pain 
interference. 
Disabling hip osteoarthritis 
(n= 1323) 
Osteoarthritis coded on the primary care medical 
record, self-reported hip pain and self-reported pain 
interference. 
Disabling foot 
osteoarthritis 
(n= 1323) 
Osteoarthritis coded on the primary care medical 
record, self-reported foot pain and self-reported pain 
interference. 
Disabling lower limb 
osteoarthritis 
(n= 2185) 
Osteoarthritis coded on the primary care medical 
record, self-reported knee, hip or foot pain and self-
reported pain interference. 
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The hypothesis investigated in this study was that OA leads to a decrease in walking 
frequency, depression, anxiety, insomnia and reduced social participation, and then 
that these lead to premature mortality. Each mediator proposed was amenable to 
primary care intervention. The reasoning behind each mediator and the measurement 
of each mediator is discussed below. A summary of confounders and mediators can be 
found in Table 5.2 on page 113. Within the statistical software used, all mediators 
were required to be binary.  
5.3.1 Walking frequency  
Walking frequency is a marker of physical activity, a core treatment for OA (NICE, 
2014). Walking frequency may also represent motivation to perform activities 
(Farholm and Sørensen, 2016). As discussed in 2.1.2 there is an association between 
exercise and fewer symptoms of OA. OA predicts a reduction in walking frequency 
(Palazzo et al., 2016). Furthermore, reduced physical activity is associated with 
premature mortality (Lee et al., 2018). The proposed mediation pathway is therefore: 
disabling OA leads to reduced walking frequency, both from pain on movement and 
reduced motivation which then leads to premature mortality. Walking frequency was 
measured in the health survey questionnaire. Participants were asked the frequency 
(not the ability) they walked 10 continuous minutes per week. Response categories 
were: daily, every other day, twice a week, once a week or less, and not at all. This 
data was categorised a priori to less than once per week (infrequent) and a minimum 
of once a week or more (frequent).   
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5.3.2 Depression 
OA can lead to, or aggravate, depression (Sharma et al., 2016). OA, and the chronic 
pain associated with it, leads to low mood (Hansen and Streltzer, 2005). The 
association between depression and OA is discussed in 2.1.1. Depression is associated 
with premature mortality (Gilman et al., 2017). The Hospital Anxiety and Depression 
Scale (HADS) was used to measure depression. For the depression subscale scores can 
range from 0 to 21. Score of less than or equal to 7 indicated no depression; scores 8-
10 indicated possible depression and scores of 11-21 indicated probable depression. 
The categories of ‘possible’ and ‘probable’ were combined to give non-cases (scoring 
0-7) as reference group and cases (scoring 8 or more; Zigmond and Snaith, 1983). The 
proposed mediation pathway is that disabling OA causes to depression and therefore 
premature mortality. 
5.3.3 Anxiety 
OA can both cause and exacerbate anxiety (Sharma et al., 2016). As discussed in 2.1.1 
anxiety is associated with OA. Anxiety is associated with premature mortality (Meier et 
al., 2016). HADS was used to measure anxiety. For the anxiety subscale scores can 
range from 0 to 21. Score of less than or equal to 7 indicated no anxiety; scores 8-10 
indicated possible depression and scores of 11-21 indicated probable anxiety. The 
categories of ‘possible’ and ‘probable’ were combined to give non-cases (scoring 0-7) 
as reference group and cases (scoring 8 or more; Zigmond and Snaith, 1983). The 
proposed mediation pathway is that disabling OA leads to anxiety which then leads to 
premature mortality.  
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5.3.4 Insomnia 
Insomnia and reduced sleep, discussed in 2.1.4.2, are associated with both OA and 
premature mortality (Allen et al., 2008; Cappuccio et al., 2010). This was assessed in 
the ‘Health Survey’. Participants were asked whether they awoke feeling unrefreshed. 
Response options were not at all, some nights and most nights. This was then 
dichotomised into refreshed (not at all/some nights) and unrefreshed (most nights; 
Hayward, Jordan and Croft, 2012). The proposed mediation pathway is the pain 
interference from OA leads to insomnia with in turn leads to premature mortality.   
5.3.5 Social participation 
Social participation was included as a mediator in the analysis. Participation restriction 
can be defined as difficulties in life situations like working or shopping and is reduced 
in those with OA (Wilkie, Peat, Thomas and Croft, 2007).  Low social participation is 
association with premature mortality (Dalgard and Håheim, 1998). Social participation 
was measured using the Keele Assessment of Participation. The scores from this range 
from 0 to 11. This was dichotomised into no restriction (score = 0) and restriction 
(score > 0). The proposed mediation pathway for this is that OA with pain interference 
leads to reduced social participation and premature mortality. 
5.3.6 Confounders  
 
The same confounders were adjusted for in both this study and the study in Chapter 4 
(described 4.6.7). These were age, gender, education, occupation, non-steroidal anti-
inflammatory drug use (NSAID), ischaemic heart disease (IHD), self-reported 
cardiovascular disease (CVD), diabetes mellitus, smoking, chronic obstructive 
pulmonary disease (COPD) and body mass index (BMI). The analysis required that 
112 
 
confounders were either binary or continuous. NSAID prescriptions were used as a 
categorical variable in Chapter 4; this was dichotomised into any previous NSAID 
prescription and no NSAID prescription on the primary care medical records. Age and 
BMI were used as continuous variables. As the other covariates were already binary, 
these were not changed.  
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Table 5.2- Summary of the exposures, outcomes, mediators and confounders used 
in the analyses 
Concept Exposure Outcome Mediator Confounder 
Osteoarthritis x    
Mortality  x   
Age    x 
Sex    x 
Socioeconomic status    x 
Non-steroidal anti-
inflammatory drugs 
   x 
Cardiovascular disease*    x 
Chronic obstructive 
pulmonary disease 
   x 
Diabetes mellitus    x 
Body mass index     x 
Smoking    x 
Walking frequency   x  
Depression   x  
Anxiety   x  
Insomnia   x  
Social participation   x  
* including both self-reported cardiovascular disease and ischaemic heart disease on 
the primary care medical record 
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5.4 METHODS 
5.4.1 Mediation Analysis  
Mediation analysis aims to explain an association between an independent and 
dependent variable by the inclusion of a third variable, a mediator (Mackinnon, 
Fairchild and Fritz, 2007). A mediator is a factor that is both associated with the 
exposure and the outcome and is proposed be on the causal pathway (Mackinnon, 
Fairchild and Fritz, 2007). This contrasts with a confounder; a variable that is related to 
both the exposure and outcome but is not on the causal pathway. Figure 5.1 shows a 
simple mediation model.  
 
 
 
 
 
 
Mediation analysis sets out to test whether a change in the exposure causes a change 
in the mediating variable, which in turn causes a change in the outcome (Hayes, 2013). 
An example of this is in Figure 5.2.   
 
 
Direct Effect 
Indirect Effect 
Exposure Outcome 
Confounder 
Mediator 
Figure 5.1- A simple mediation model, showing the relationship between exposure and 
outcome going via the mediator 
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The mediation model presented in Figure 5.2 shows an association between A and B 
mediated by C. In this example C at least partially explains the association between A 
and B. The association between A and B could be partly explained by the direct 
pathway, z, and the indirect pathway xy. However, the whole association between A 
and B could be explained by the pathways xy, showing ‘complete mediation’; the 
whole of the association between A and B is via the mediator, C (Hayes, 2013).  
5.4.2  Exposure variables 
The different case definitions of OA used in this analysis from NorStOP are described in 
Table 5.2. These case definitions were chosen following an analysis in Chapter 4, 
showing the case definitions of disabling OA to have a significant association with 
premature mortality. 
The analyses in the chapter empirically examine hypothesised pathways from OA to 
mortality. Previous literature and clinical reasoning helps to design potential 
mediation pathways, which occurs via the indirect pathway. Baron and Kenny (1986) 
discuss that the strongest evidence of mediation occurring is when only the indirect 
Osteoa
rthritis 
B 
x 
A 
C y 
z 
Figure 5.2- A simple mediation model, where A= the exposure, B= the outcome, C= the 
mediator, x= the effect of the exposure on the mediator, y= the effect of the mediator 
on the outcome, xy= indirect effect, z= direct effect and xy+z= total effect 
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pathway remains statistically significant, and the direct pathway shows no effect; this 
is “full mediation”. A reduction in the direct effect and significant indirect effect would 
be termed “partial mediation”.  
Baron and Kenny (1986) assert that the basic approach to their mediation analysis is 
that there is a significant association between the exposure and the outcome before 
decomposing into the direct and indirect effects. In other words, Baron and Kenny 
(1986) maintain the importance of a significant total effect for a mediation analysis to 
be performed. However, Zhao, Lynch and Chen (2010) suggest that there is no need 
for a significant total effect for mediation analysis to be performed; a total effect can 
be decomposed into its direct and indirect constituents regardless of the significance 
of that initial figure, as mediation has potentially still occurred. As insignificant total 
effects were found for one anatomical site in chapter 4 (disabling hip OA; adjusted 
hazard ratio [HR] 1.06 95% confidence interval [CI] 0.91, 1.23), this thesis will still 
decompose the effects to establish whether mediation has occurred or not.  
5.4.3 Mediation analysis within survival analysis; Using Cox proportional hazard 
models for mediation analysis 
A mediation model within survival analysis has been proposed (Lange and Hansen, 
2012). This is based on a counterfactual framework and therefore models the total, 
direct and indirect of the exposure on the outcome.  
5.4.3.1 Counterfactual framework 
The counterfactual framework both considers the effect of an exposure on a 
participant and also what would have happened if this participant did not have this 
exposure (Robins and Greenland, 1992). Therefore, the framework replicates the 
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analysis to firstly include the exposure as it occurred with a participant with its original 
value and then to take the counterfactual, or opposite, value. Weights are calculated 
via logistic regression of a binary mediator on the exposure and baseline confounders 
via this equation: 
!"# = %(' = '"	|* = *"∗, - = -")%(' = '"	|* = *", - = -") 
Where A is the exposure of interest, M is the mediator and C is the baseline 
confounders. Within this example, * represents the counterfactual values. If the 
assumptions of Cox proportional hazard models are met, this model will give hazard 
ratios representing direct and indirect effects; the product of this is the total effects. 
This approach was used by Rochon et al., (2014) and has been used by Smith et al., 
(2018) within NorStOP. Mediation analysis was performed using the technique 
described by Rochon et al., (2014). Data cleaning for the mediation analysis was 
performed within Stata. The mediation analysis was performed in survival package of 
the statistical software R (Therneau and Lumley, 2015). Bootstrapping was then used 
to calculate standard error and confidence intervals.  
5.4.3.2 Bootstrapping 
Bootstrapping is a method of resampling that determines the accuracy of a result by 
calculating confidence intervals (Preacher and Hayes, 2008a). Bootstrapping estimates 
the indirect effect by taking a new sample from the original sample and repeating the 
analysis a specified number of times; in these analyses, this was repeated 100 times. 
Following the repeated analysis, values’ indirect effects were sorted from low to high 
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in order to calculate standard error of the indirect effects, and therefore confidence 
intervals (Preacher and Hayes, 2008b).  
5.5 ANALYSIS 
Firstly, associations between the predictor exposure (OA) and each mediating variable 
was examined using logistic regression to explain the direction of any mediating effect 
(i.e. a positive association (odds ratio greater than 1) between OA and low walking 
frequency means the HR (above 1) of the indirect effect refers to an increased risk of 
mortality as a result of OA and lower levels of walking frequency). All associations 
between OA and potential mediators are presented as odds ratios (OR) with 95% CIs. 
All analyses were adjusted for potential confounders (as per Cox modelling described 
in chapter 4: age, gender, education, occupation, NSAID use, IHD, self-reported CVD, 
diabetes mellitus, smoking, COPD and BMI).  
Results of the mediation analyses are presented as HR for the direct, indirect and total 
effects with associated 95% CIs. Mediation was indicated by the presence of a 
statistically significant indirect effect. This can occur whether the total effects are 
statistically significant, or not (Zhao, Lynch and Chen, 2010). In a case of full mediation, 
the direct effect then attenuates (becomes non-significant), indicating the full effect of 
the association between the exposure and outcome is via the indirect pathway and 
therefore the mediator.  
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5.6 RESULTS OF MEDIATION ANALYSIS 
Table 5.3- Pathways between 'general disabling osteoarthritis' and premature mortality via 
listed mediators (n=8066) 
 
 
 
 
Mediator 
Association 
between general 
osteoarthritis and  
potential mediator 
Adjusted OR 
(95%CI) 
 
 
 
 
Pathway 
 
 
 
 
Adjusted HR (95%CI) 
Walking frequency 
Frequent walker 
Non-frequent walker 
 
Reference 
2.33 (2.10, 2.59) 
Direct 
Indirect 
Total 
1.07 (0.95, 1.24) 
1.08 (1.05, 1.10) 
1.16 (1.01, 1.32) 
Depression  
No depression 
Depression 
 
Reference 
3.28 (2.90, 3.70) 
Direct 
Indirect 
Total 
1.11 (0.93, 1.30) 
1.05 (1.01, 1.08) 
1.16 (1.00, 1.33) 
Anxiety 
No Anxiety 
Anxiety 
 
Reference 
2.62 (2.35, 2.91) 
Direct 
Indirect 
Total 
1.16 (1.01, 1.32) 
1.00 (0.98, 1.03) 
1.16 (1.00, 1.32) 
Insomnia 
No insomnia 
Insomnia 
 
Reference 
2.82 (2.47, 3.21) 
Direct 
Indirect 
Total 
1.17 (1.03, 1.32) 
1.01 (0.98, 1.04) 
1.17 (1.03, 1.32) 
Social Participation 
Social Participation 
No social participation 
 
Reference 
3.32 (2.97, 3.90) 
Direct 
Indirect 
Total 
1.06 (0.95, 1.19) 
1.10 (1.06, 1.13) 
1.17 (1.05, 1.32) 
All models adjusted for age, gender, education, occupation, non-steroidal anti-inflammatory 
drug use, ischaemic heart disease, self-reported cardiovascular disease, diabetes mellitus, 
smoking, chronic obstructive pulmonary disease and body mass index.  
Significant indirect effects are highlighted in bold.  
OR = Odds ratio, HR = Hazard ratio, CI = Confidence Intervals 
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Table 5.4- Pathways between 'disabling hand osteoarthritis' and premature mortality via 
listed mediators (n=8066) 
 
 
 
 
Mediator 
Association 
between hand 
osteoarthritis and  
potential mediator 
Adjusted OR 
(95%CI) 
 
 
 
 
Pathway 
 
 
 
 
Adjusted HR (95%CI) 
Walking frequency 
Frequent walker 
Non-frequent walker 
 
Reference 
2.19 (1.94, 2.47) 
Direct 
Indirect 
Total 
1.07 (0.91, 1.24) 
1.06 (1.03, 1.09) 
1.13 (0.98, 1.32) 
Depression  
No depression 
Depression 
 
Reference 
3.05 (2.67, 3.48) 
Direct 
Indirect 
Total 
1.10 (0.93, 1.30) 
1.05 (1.02, 1.08) 
1.16 (0.98, 1.36) 
Anxiety 
No Anxiety 
Anxiety 
 
Reference 
2.82 (2.50, 3.18) 
Direct 
Indirect 
Total 
1.14 (0.97, 1.36) 
1.00 (0.97, 1.04) 
1.14 (0.99, 1.34) 
Insomnia 
No insomnia 
Insomnia 
 
Reference 
2.87 (2.50, 3.29) 
Direct 
Indirect 
Total 
1.14 (0.99, 1.32) 
1.01 (0.99, 1.04) 
1.16 (1.00, 1.35) 
Social Participation 
Social Participation 
No social participation 
 
Reference 
3.08 (2.71, 3.51) 
Direct 
Indirect 
Total 
1.06 (0.91, 1.11) 
1.09 (1.06, 1.12) 
1.16 (1.00, 1.32) 
All models adjusted for age, gender, education, occupation, non-steroidal anti-inflammatory 
drug use, ischaemic heart disease, self-reported cardiovascular disease, diabetes mellitus, 
smoking, chronic obstructive pulmonary disease and body mass index.  
Significant indirect effects are highlighted in bold.  
OR = Odds ratio, HR = Hazard ratio, CI = Confidence Intervals 
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Table 5.5- Pathways between 'disabling knee osteoarthritis' and premature mortality via 
listed mediators (n=8066) 
 
 
 
 
Mediator 
Association 
between knee 
osteoarthritis and  
potential mediator 
Adjusted OR 
(95%CI) 
 
 
 
 
Pathway 
 
 
 
 
Adjusted HR (95%CI) 
Walking frequency 
Frequent walker 
Non-frequent walker 
 
Reference 
2.31 (2.06, 2.60) 
Direct 
Indirect 
Total 
1.05 (0.91, 1.18) 
1.06 (1.05, 1.09) 
1.12 (0.98, 1.26) 
Depression  
No depression 
Depression 
 
Reference 
3.00 (2.64, 3.41) 
Direct 
Indirect 
Total 
1.08 (0.95, 1.23) 
1.05 (1.01, 1.08) 
1.13 (1.00, 1.32) 
Anxiety 
No Anxiety 
Anxiety 
 
Reference 
2.48 (2.21, 2.79) 
Direct 
Indirect 
Total 
1.12 (0.99, 1.28) 
1.00 (0.98, 1.03) 
1.12 (0.98, 1.29) 
Insomnia 
No insomnia 
Insomnia 
 
Reference 
2.75 (2.40, 3.15) 
Direct 
Indirect 
Total 
1.12 (0.98, 1.25) 
1.01 (0.98, 1.03) 
1.13 (0.97, 1.27) 
Social Participation 
Social Participation 
No social participation 
 
Reference 
3.06 (2.71, 3.46) 
Direct 
Indirect 
Total 
1.04 (0.90, 1.17) 
1.09 (1.05, 1.13) 
1.03 (0.98, 1.26) 
All models adjusted for age, gender, education, occupation, non-steroidal anti-inflammatory 
drug use, ischaemic heart disease, self-reported cardiovascular disease, diabetes mellitus, 
smoking, chronic obstructive pulmonary disease and body mass index.  
Significant indirect effects are highlighted in bold.  
OR = Odds ratio, HR = Hazard ratio, CI = Confidence Intervals 
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Table 5.6- Pathways between 'disabling hip osteoarthritis' and premature mortality via 
listed mediators (n=8066) 
 
 
 
Mediator 
Association 
between hip 
osteoarthritis and  
potential mediator 
Adjusted OR 
(95%CI) 
 
 
 
Pathway 
 
 
 
Adjusted HR (95%CI) 
Walking frequency 
Frequent walker 
Non-frequent walker 
 
Reference 
2.25 (1.97, 2.56) 
Direct 
Indirect 
Total 
0.97 (0.85, 1.08) 
1.06 (1.04, 1.09) 
1.03 (0.89, 1.16) 
Depression 
No depression 
Depression 
 
Reference 
2.80 (2.44, 3.20) 
Direct 
Indirect 
Total 
1.00 (0.86, 1.14) 
1.05 (1.02, 1.07) 
1.05 (0.90, 1.20) 
Anxiety 
No Anxiety 
Anxiety 
 
Reference 
2.46 (2.17, 2.79) 
Direct 
Indirect 
Total 
1.03 (0.89, 1.24) 
1.01 (0.99, 1.03) 
1.04 (0.89, 1.23) 
Insomnia 
No insomnia 
Insomnia 
 
Reference 
2.80 (2.42, 3.22) 
Direct 
Indirect 
Total 
1.04 (0.86, 1.20) 
1.01 (0.99, 1.04) 
1.05 (0.88, 1.21) 
Social Participation 
Social Participation 
No social participation 
 
Reference 
3.25 (2.83, 3.73) 
Direct 
Indirect 
Total 
0.94 (0.81, 1.10) 
1.10 (1.06, 1.12) 
1.04 (0.88, 1.22) 
All models adjusted for age, gender, education, occupation, non-steroidal anti-inflammatory 
drug use, ischaemic heart disease, self-reported cardiovascular disease, diabetes mellitus, 
smoking, chronic obstructive pulmonary disease and body mass index.  
Significant indirect effects are highlighted in bold.  
OR = Odds ratio, HR = Hazard ratio, CI = Confidence Intervals 
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Table 5.7- Pathways between 'disabling foot osteoarthritis' and premature mortality via 
listed mediators (n=8066) 
 
 
 
 
Mediator 
Association 
between foot 
osteoarthritis and  
potential mediator 
Adjusted OR 
(95%CI) 
 
 
 
 
Pathway 
 
 
 
 
Adjusted HR (95%CI) 
Walking frequency 
Frequent walker 
Non-frequent walker 
 
Reference 
2.27 (2.00, 2.58) 
Direct 
Indirect 
Total 
1.12 (0.99, 1.08) 
1.06 (1.04, 1.09) 
1.19 (1.04, 1.37) 
Depression  
No depression 
Depression 
 
Reference 
3.29 (2.87, 3.76) 
Direct 
Indirect 
Total 
1.14 (0.98, 1.32) 
1.05 (1.01, 1.09) 
1.20 (1.04, 1.35) 
Anxiety 
No Anxiety 
Anxiety 
 
Reference 
2.75 (2.42, 3.11) 
Direct 
Indirect 
Total 
1.19 (1.03, 1.37) 
1.00 (0.97, 1.03) 
1.19 (1.04, 1.36) 
Insomnia 
No insomnia 
Insomnia 
 
Reference 
2.74 (2.38, 3.16) 
Direct 
Indirect 
Total 
1.19 (1.06, 1.33) 
1.00 (0.98, 1.03) 
1.19 (1.07, 1.35) 
Social Participation 
Social participation 
No social participation 
 
Reference 
3.27 (2.86, 3.74) 
Direct 
Indirect 
Total 
1.11 (0.93, 1.29) 
1.09 (1.06, 1.13) 
1.21 (1.00, 1.40) 
All models adjusted for age, gender, education, occupation, non-steroidal anti-inflammatory 
drug use, ischaemic heart disease, self-reported cardiovascular disease, diabetes mellitus, 
smoking, chronic obstructive pulmonary disease and body mass index.  
Significant indirect effects are highlighted in bold.  
OR = Odds ratio, HR = Hazard ratio, CI = Confidence Intervals 
Table 5.8- Pathways between 'disabling lower limb osteoarthritis' and premature 
mortality via listed mediators (n= 8066) 
 
 
 
Association 
between lower 
limb osteoarthritis 
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Mediator 
and  potential 
mediator 
Adjusted OR 
(95%CI) 
 
Pathway 
 
Adjusted HR (95%CI) 
Walking frequency 
Frequent walker 
Non-frequent walker 
 
Reference 
2.33 (2.09, 2.59) 
Direct 
Indirect 
Total 
1.10 (0.97, 1.27) 
1.07 (1.04, 1.09) 
1.17 (1.02, 1.36) 
Depression  
No depression 
Depression 
 
Reference 
3.22 (2.84, 3.64) 
Direct 
Indirect 
Total 
1.13 (0.97, 1.28) 
1.04 (1.01, 1.08) 
1.18 (1.02, 1.34) 
Anxiety 
No Anxiety 
Anxiety 
 
Reference 
2.61 (2.34, 2.31) 
Direct 
Indirect 
Total 
1.17 (1.06, 1.34) 
1.00 (0.97, 1.02) 
1.17 (1.06, 1.34) 
Insomnia 
No insomnia 
Insomnia 
 
Reference 
2.76 (2.42, 3.15) 
Direct 
Indirect 
Total 
1.18 (1.05, 1.35) 
1.00 (0.98, 1.03) 
1.18 (1.06, 1.34) 
Social Participation 
Social Participation 
No social participation 
 
Reference 
3.36 (3.00, 3.77) 
Direct 
Indirect 
Total 
1.07 (0.92, 1.20) 
1.10 (1.07, 1.14) 
1.07 (1.02, 1.30) 
All models adjusted for age, gender, education, occupation, non-steroidal anti-inflammatory 
drug use, ischaemic heart disease, self-reported cardiovascular disease, diabetes mellitus, 
smoking, chronic obstructive pulmonary disease and body mass index.  
Significant indirect effects are highlighted in bold.  
OR = Odds ratio, HR = Hazard ratio, CI = Confidence Intervals 
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This analysis identified three factors that mediated the relationship between OA and 
premature mortality for all case definitions of OA: walking frequency, depression and 
social participation.  For each of these mediators in each case definition the direct 
effects (DE) attenuated (became non-significant). The reduction in the DE shows that 
the effect of OA on premature mortality has decreased once taking account of the 
mediator. Anxiety and insomnia did not mediate the relationship between premature 
mortality and any case definition of OA. 
5.6.1 Walking frequency 
Walking frequency was a significant mediator of the association between each case 
definition of OA and premature mortality; the indirect effects (IE) for disabling general 
OA was 1.08 (95% CI 1.05, 1.10;) with DE attenuating to 1.07 (95% CI 0.95, 1.24); 
disabling hand OA 1.06 (95% CI 1.03, 1.09) with DE attenuating to 1.07 (95% CI 0.91, 
1.24);  disabling knee OA 1.06 (1.05, 1.09) with DE attenuating to 1.05 (95% CI 0.91, 
1.18); disabling hip OA 1.06 (1.04, 1.09) with DE attenuating to 0.97 (95% CI 0.85, 
1.08); disabling foot OA 1.06 (1.04, 1.09) with DE attenuating to 1.12 (95% CI 0.99, 
1.08) and disabling lower limb OA 1.07 (1.04, 1.09) with DE attenuating to 1.10 (95% CI 
0.97, 1.27). Each anatomical area has a relatively similar IE and a similar reduction in 
DE. 
5.6.2 Depression 
Each included case definition showed depression to be a significant mediator between 
OA and premature mortality. This is demonstrated by statistically significant IE with 
attenuation of the DE (general OA IE 1.05 95% CI 1.01, 1.08, DE 1.11 95% CI 0.93, 1.30; 
hand OA IE 1.05 95% CI 1.02, 1.08, DE 1.10 95% CI 0.93, 1.30; knee OA IE 1.05 95% CI 
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1.01, 1.08, DE 1.08 95% CI 0.95, 1.23; hip OA IE 1.05 95% CI 1.02, 1.07, DE 1.00 95% CI 
0.86, 1.14; foot OA IE 1.05 1.01, 1.09, DE 1.14 95% CI 0.98, 1.32; lower limb OA IE 1.04 
95% CI 1.01, 1.08, DE. Each anatomical area has a relatively similar IE and a similar 
reduction in DE, however this was less marked than in the walking frequency analysis.   
5.6.3 Anxiety 
None of the included case definitions showed anxiety to be a significant mediator 
between OA and premature mortality. There was a non-significant IE at each 
anatomical site and a low effect on DE; in some cases the DE remained statistically 
significant showing that anxiety was not a mediator: (general OA IE 1.00 95% CI 0.98, 
1.03, DE 1.16 95% CI 1.01, 1.32; hand OA IE 1.00 95% CI 0.97, 1.04, DE 1.14 95% CI 
0.97, 1.36; knee OA IE 1.00 95% CI 0.98, 1.03, DE 1.12 95% CI 0.99, 1.28; hip OA IE 1.01 
95% CI 0.99, 1.03, DE 1.03 95% CI 0.89, 1.24; foot OA IE 1.00 95% CI 0.97, 1.03, DE 1.19 
1.03, 1.37; lower limb OA IE 1.00 95% CI 0.97, 1.02, DE 1.17 95% CI 1.06, 1.34). 
5.6.4 Insomnia 
None of the included case definitions showed insomnia to be a significant mediator 
between OA and premature mortality. There was a non-significant IE at each 
anatomical site and a low effect on DE: (general OA IE 1.01 95% CI 0.98, 1.04, DE 1.17 
95% CI 1.03, 1.32; hand OA IE 1.01 95% CI 0.99, 1.04, DE 1.14 95% CI 0.99, 1.32; knee 
OA IE 1.01 95% CI 0.98, 1.03, DE 1.12 95% CI 0.98, 1.25; hip OA IE 1.01 95% CI 0.99, 
1.04, DE 1.04 95% CI 0.86, 1.20; foot OA IE 1.00 95% CI 0.98, 1.03, DE 1.19 95% CI 1.06, 
1.33; lower limb OA IE 1.00 95% CI 0.98, 1.03, DE 1.18 95% CI 1.05, 1.35). Although 
each anatomical area had relatively similar IEs, the DEs varied across anatomical 
location with some DEs showing no attenuation and remaining statistically significant.    
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5.6.5 Social participation 
Each included case definition showed walking frequency to be a significant mediator 
between OA and premature mortality. This is demonstrated by statistically significant 
indirect effects (IE) with attenuation of DEs (general OA IE 1.10 95% CI 1.06, 1.13, DE 
1.06 95% CI 0.95, 1.19; hand OA IE 1.09 95% CI 1.06, 1.12, DE 1.06 95% CI 0.91, 1.11; 
knee OA IE 1.09 95% CI 1.05, 1.13, DE 1.04 95% CI 0.90, 1.17; hip OA IE 1.10 95% CI 
1.06, 1.12, DE 0.94 95% CI 0.81, 1.10; foot OA IE 1.09 95% CI 1.06, 1.13, DE 1.11 95% CI 
0.93, 1.29; lower limb OA IE 1.10 95% CI 1.07, 1.14, DE 1.07 95% CI 0.92, 1.20). For 
four anatomical areas (hand, knee, hip and foot OA) the total effects (TE) were not 
statistically significant (hand TE 1.16 95% CI 1.00, 1.32; knee TE 1.03 95% CI 0.98, 1.26; 
hip TE 1.04 95% CI 0.88, 1.22; foot 1.21 95% CI 1.00, 1.40). Overall, the low social 
participation had the largest effect size, indicated by the highest IE and the lowest DE.  
5.7 DISCUSSION 
The analyses showed walking frequency, depression and social participation mediated 
the relationship between OA and premature mortality. Anxiety and insomnia were not 
a significant mediator with premature mortality at any joint site.  
5.7.1 Walking frequency  
A pathway from OA to premature mortality via walking frequency, and perhaps 
physical activity in general, was well supported; it was a mediator for the association 
between OA and premature mortality at all anatomical areas investigated. This is 
consistent with previous literature examining reduced activity in those with OA 
(Dunlop et al., 2011) and associations between low physical activity and premature 
mortality (Lee et al., 2018). As walking frequency is a surrogate marker of physical 
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activity, it presents a potential target for reducing OA related mortality. The low 
walking frequency was classified in this study as 5-10 minutes of walking less than 
once a week; this is particularly low. This analysis suggests that increasing this low 
amount of walking would reduce premature mortality as a result of OA, which is more 
attainable to those with restricted mobility than completing the a certain amount of 
steps per day. It has been previously suggested that small amounts of frequent 
walking is associated with lower mortality (Simonsick et al., 2005). This presents a 
target for reducing mortality from OA that is both simple and attainable to patients.  
5.7.2 Depression 
Each case definition was associated with depression. Each analysis found a significant 
association between OA and depression. Although the different between the IE and DE 
was less marked than in the low walking frequency or low social participation analysis 
(i.e. the IE was lower and the DE was higher) the IE was found to be significant across 
all anatomical location with attenuation of the DE. This shows that depression was a 
significant mediator of the relationship between OA and premature mortality. HADS 
was a screening tool, rather than a diagnostic tool for depression. Although it has been 
widely validated, it does not represent the diagnostic threshold for depression, and 
therefore there is risk of misclassification. Depression also represents a potential way 
of modifying the relationship between OA and premature mortality. Identifying 
depressive symptoms and managing them could help reduce mortality as a result of 
OA. Management options for depression include psychological and pharmacological 
therapy, with some evidence that physical activity can alleviate depressive symptoms 
(Cooney et al., 2013; NICE, 2009) 
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5.7.3 Social participation 
Each case definition was associated with low social participation. Low social 
participation was the strongest mediator (i.e. the point estimate for the indirect effect 
was highest for social participation) in the association between OA and premature 
mortality, defined by the highest hazard ratios of the IE and lowest DE. Both general 
OA and lower limb OA also found a significant total effect with attenuation of the 
direct effect, showing the strength of this association. Social participation appears to 
be a surrogate marker of other mediators included in this analysis. However, it is a key 
target and could be the mechanism for maintaining physical activity, maintaining a 
sense of purpose and positive mood, which has further positive effects on health. 
Social participation is reduced in those with mental health problems, such as 
depression, and in those with a reduced capability of physical activity. Interventions 
focussed on increasing walking frequency, reducing depression symptom and 
facilitating social activities may help reduce mortality as a result of OA.  
5.7.4 Comparison with current literature  
There have been no other published studies that have investigated mediation with a 
survival model focusing on the association between OA and premature mortality. 
Other studies have examined mediation within a survival analysis. Smith et al., (2018) 
reported that the association between pain and mortality was mediated by lifestyle, 
health, social and psychological factors, however this study did not examine links with 
OA. Previous studies have used Cox proportional hazards regression analysis. One 
study found mortality was significantly associated with walking disability, supported by 
the results from this study (Hawker et al., 2014). Another study did not find a 
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significant relationship between OA and premature mortality, but did find that those 
with OA had an increased risk of IHD and heart failure in comparison to those without 
OA (Turkiewicz et al., 2016). This was suggested to be caused by a “modifiable 
intermediate factor” like physical activity, which would further support finding from 
this study (Turkiewicz et al., 2016). Therefore, this study represents the first to use 
mediation analysis within a Cox proportional hazards models to investigate the 
association between clinically defined OA and premature mortality. 
5.8 LIMITATIONS 
Successful application of the statistical technique in R to examine mediation within a 
survival model required all mediators to be dichotomous variables. This is a potential 
limitation as dichotomising variables may result in a loss of richness in the data set, 
particularly for continuous variables (Royston, Altman and Sauerbrei, 2006). There 
may be some misclassification for all variables in the study, which may occur due to 
the approach to dichotomising each variable.  
Mediation analysis assumes that the exposure, in this case OA, should be measured 
prior to mediators (Kline, 2015). Therefore, a limitation of this study is that both the 
exposure and mediators were measured at the same time, at baseline. Furthermore, 
as OA Read codes were identified from the participant’s primary care medical records 
at any point across the duration of NorStOP 1 and 2, formal clinician diagnosed OA 
may have been established after collection of the mediators. However, as OA is a 
longstanding, chronic condition, with a long period of development, OA on the 
primary care medical record at any point across the study period implied that OA was 
likely present at least to some degree during the entire duration of NorStOP 1 and 2.  
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It has been suggested that the bootstrapping to calculate confidence intervals should 
involve 1000 replications (Efron and Tibshirani, 1986), however due to time 
constraints this was not performed. Using 1000 replications could have made the 
confidence intervals smaller, providing more accurate results. It is unlikely that this 
would have made a significant different to the results shown above; most of the 
confidence intervals of the IE were narrow. 
The use of self-report measures in this study may be a limitation, as discussed in 4.9.5. 
There is risk of information bias within responses. For example, a participant declaring 
that they walked daily for over 10 minutes could represent someone who simply walks 
from room to room of their house across the day, totally 10 minutes overall due to 
misunderstanding the question. However, some of the included mediators, including 
depression, anxiety and insomnia, are best measured via self-report (Uher et al., 
2012).   
Each case definition included participants used in another case definition, as those 
with OA are likely to have more than one site affected (NICE, 2014). For example, if a 
participant has reported hand and knee pain, they will be included in both the hand 
and knee OA group. However, if a participant has reported knee and hip pain, whilst 
they will be included separately in the knee and hip analysis, they will only be included 
once in the lower limb analysis. The number of participants that reported an individual 
joint pain, opposed to pain at multiple sites, was very small. Using these smaller 
numbers would result in a diminishing of the analysis’ power.  
Given that the number of participants with specifically hand OA and OA at no other 
anatomical site is very small (n=71), it does not have the power that other anatomical 
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locations do. Although the results looking at the association between disabling hand 
OA alone and premature mortality were non-significant (adjusted HR 1.29 95% CI 0.76, 
2.19), there is still an association present. This, therefore, suggests that low walking 
frequency, depression and low social participation are mediators of the relationship 
between OA and premature mortality at hand joints alone.  
5.9 SUMMARY 
This study has identified factors that explain the link between OA and premature 
mortality; these represent targets for reducing this risk. This study has shown that low 
walking frequency, depression and low social participation represent targets within 
primary care to reduce the risk of mortality. Chapter 6 will outline the implications of 
these findings on clinical practice and future research. 
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6 CHAPTER 6: DISCUSSION 
6.1 INTRODUCTION 
This thesis aimed to determine if there was an association between osteoarthritis (OA) 
and premature mortality and to identify factors that mediate this relationship. Chapter 
4 examined the strength and direction of the association between different case 
definitions and premature mortality. Chapter 5 then examined if a number of 
mediator variables (factors amenable to management in primary care) explained the 
relationship between OA and premature mortality. This chapter discusses these 
findings in the context of previous literature and outlines implications for clinical 
practice and future research. 
6.2 SUMMARY OF RESULTS 
This thesis presents the results of analyses, using data from a large population-based 
cohort study, that has examined whether there is, and the reasons for, an association 
between OA and premature mortality. Two systematic searches identified systematic 
reviews and recent studies that examined the association between OA and premature 
mortality. The heterogeneity between these studies prevented pooling of estimates. It 
is difficult to draw a clear conclusion on whether there was an association between OA 
and mortality, however there was a sense that if such an association existed it may be 
dependent on case definition. The North Staffordshire Osteoarthritis Project (NorStOP) 
dataset presented an opportunity to examine whether a positive association was 
dependent on case definition (described in chapter 4). There was a positive association 
between OA and premature mortality in those with disabling OA. Disabling OA was 
defined as primary care medical record data indicating consultation for OA, self-
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reported of joint pain and self-reported of pain interference. Mediation analyses 
(described in chapter 5) identified that the association between disabling OA and 
premature mortality was mediated through walking frequency, depression and social 
participation.  
6.3 COMPARISON WITH EXISTING LITERATURE 
OA is a heterogeneous condition, which can be defined and researched using a variety 
of different case definitions (Pereira et al., 2011). The systematic searches in Chapter 2 
identified studies using both radiographic and clinical case definitions of OA. Most 
studies used a clinical definition or a combination of clinical and radiologic definitions. 
The systematic searches highlighted papers comparing two different case definitions 
and their associations with premature mortality. Although this was between 
radiographic and clinical case definitions in the systematic searches, the NorStOP 
cohort provided the opportunity to investigate the relationship of different case 
definitions with premature mortality. Case definitions investigated were: (i) OA 
diagnosis in medical records (OA consulter), (ii) self-reported joint pain (iii) OA in 
medical records and specific joint pain (symptomatic OA), and (iv) OA in the medical 
records and specific joint pain with pain interference (disabling OA). Disabling OA was 
found to have significant associations with premature mortality across multiple joint 
site, including the hand, knee, foot and lower limb combined. None of the studies 
included in the systematic review specifically looked at OA with pain interference, 
however Smith et al. (2018) found that pain interference was associated with 
premature mortality, whereas the report of pain or having widespread pain was not, 
affirming the importance of pain interference in the OA case definition. 
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It is not clear why hip disabling OA was not significantly associated in comparison to 
the other joint sites. The number of participants with hip OA was smaller than the 
other groups but would have been large enough to maintain statistical power.  
Furthermore, the point estimate for disabling hip OA was lower indicating that the 
difference in mortality between those with and without disabling hip OA was smaller 
than for other joints. The systematic searches in Chapter 2 found a total of 11 papers 
investigating the association between hip OA and mortality, with 8 studies finding a 
significant association between hip OA and premature mortality. However, the 
majority of these papers used a radiographic case definition. Most papers investigating 
clinically defined hip OA found a non-significant association with hip OA, as was found 
in Chapter 4 of this thesis.  
As discussed in 4.9, there was a non-significant association between disabling hand OA 
alone (i.e. in people that did not have hip, knee or foot pain) and premature mortality, 
however the sample size was small. This is contradictory to findings from Veronese et 
al. (2016), hypothesising that hand OA is a moderator in the relationship between OA 
and premature mortality. Furthermore, studies looking specifically at hand OA in the 
systematic search found an association with premature mortality, but OA at other 
joint sites were not considered in the analysis or adjusted for (Harra et al., 2003, 2004; 
Haugen et al., 2015). Overall, this highlights that the case definition of disabling OA is 
important regardless of anatomical site.  
Chapter 5 focused on mediation of ‘disabling OA’ at different anatomical sites. Walking 
frequency, depression and social participation were significant mediators across the 
anatomical sites investigated. This is the first study exploring mediation of the 
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association between OA and mortality within a Cox proportional hazards model, and 
one of a few studies that have examined mediation within a survival analysis. 
Other studies have reported that they have examined whether walking frequency is a 
mediator of the association between OA and premature mortality. The Wuchuan 
Osteoarthritis Study (WOS), a study identified from the systematic searches, examined 
whether walking frequency was a mediator of the relationship between OA and 
premature mortality in secondary analysis of the cohort (Liu et al., 2017). However, 
the analysis of mediation in the WOS used regression modelling rather than a survival 
model as used in this thesis. The sample size in the WOS study was small (n= 1025), 
and fewer participants had died at the time of this analysis (n= 99). This led to an 
imprecise estimate of indirect effect 1.92 (95% CI 0.86, 4.26). The study described in 
this thesis had a much larger overall sample size (n= 8066), with each case definition 
including more participants than in the WOS study. More participants had died over 
the follow up period within NorStOP, increasing the precision of indirect effects in 
comparison to WOS. Physical function and physical activity have also been examined 
as mediators of the association between OA and premature mortality; again, this was 
examined using regression modelling; where indirect effects were not estimated 
(Barbour et al., 2015). Physical function was found to be a ‘partial mediator’ of the 
association between OA and all-cause mortality, whereas physical activity was not 
found to be a significant mediator (physical function adjusted hazard ratio [HR] 1.06 
95% confidence interval [CI] 1.02, 1.10; physical activity adjusted HR 1.01 95% CI 0.97, 
1.05). The WOS also examined if non-steroidal anti-inflammatory drugs (NSAIDs) were 
a potential mediator of the association between OA and premature mortality; in this 
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study NSAIDs were included as a confounder. In the WOS, NSAIDs were associated 
with both OA and premature mortality but some studies have implicated NSAIDs in 
mortality from CVDs in those with OA (Atiquzzaman et al., 2018; Bavry et al., 2011; 
Trelle et al., 2011). Both Barbour et al. (2015) and Liu et al. (2017) found that NSAID 
use was not a significant mediator of the relationship between OA and premature 
mortality. Liu et al. (2017) included very small numbers in their analysis (63 
participants with 15 deaths), leading to insufficient power for calculations. Barbour et 
al. (2015) had a much larger population included in the mediation analysis (n= 7889) 
and still found NSAIDs to be an insignificant mediator. In the study described in this 
thesis, NSAIDs were used as a confounder and adjusted for in the multivariate analysis. 
Moreover, the use of drugs, like NSAIDs, as a mediator could be seen as inappropriate: 
NSAIDs may be best included as an effect modifier. An effect modifier is when the 
magnitude of the effect of the exposure on the outcome differs depending on the 
level of a third variable (Szklo and Nieto, 2018). If the relationship between OA and 
premature mortality was significantly different in those taking NSAIDs compared to 
those not taking NSAIDs, it could be considered an effect modifier. These studies did 
not discuss this, and effect modification was not investigated in this thesis. Although 
NSAIDs were included as a categorical covariate in Chapter 4, they were dichotomised 
into yes and no for the sake of the mediation analysis in Chapter 5. The 
dichotomisation of the data loses information about the amount of NSAID 
prescriptions a participant has had but was necessary for the analysis. Based on the 
previous studies, including NSAIDs as a confounder seemed to be justified: NSAIDs 
have not been found to mediate the relationship between OA and premature 
mortality in other prospective cohort studies.  
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Depression was also found to be a significant mediator between all anatomical 
definitions of disabling OA and premature mortality. Although no other study has 
examined depression as a mediator, the importance of comorbid depression and OA 
on the association with mortality has been previously investigated. In comparison to 
OA alone, comorbid depression and OA increased the risk of mortality with an age 
adjusted mortality rate of 3.03% (95% CI 2.18, 3.88; Lee et al., 2007). Lee et al. (2007) 
did not examine the pathways between OA and premature mortality via depression. 
Smith and colleagues (2018) reported that depression was a significant mediator of 
the association between ‘troubling pain’ and premature mortality in the English 
Longitudinal Study of Ageing, although this is not specifically OA related pain, it 
supports the findings from the study in this thesis.  
Low social participation was found to be a significant mediator of the association 
between OA with pain interference and premature mortality. No previous studies have 
examined OA and premature mortality mediated by low social participation. A 
previous study has examined both activity limitation and depression as mediators in 
the relationship between OA physical symptoms and social participation (Machado, 
Gignac and Badley, 2008). Reduced walking frequency and low mood can reduce both 
ability and motivation to take part in society (Ball et al., 2007; Sharma et al., 2003) and 
both reduced walking frequency and depression are associated with OA, as discussed 
in 5.3.1 and 5.3.2. The Cox proportional hazard modelling used in this thesis could not 
account for more than one step mediation, and therefore the hypothesis that reduced 
social participation from OA is itself caused by depression and reduced walking 
frequency could not be tested. 
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Overall, the low walking frequency, depression and low social participation were 
significant mediators of the association between OA and premature mortality, 
regardless of anatomical site.  
6.4 STRENGTHS AND LIMITATIONS 
Each of the constituent studies included in this thesis have a variety of strengths and 
limitations. The main strengths and limitations have been discussed in the 
corresponding chapter to each study. However, some common strengths and 
limitations are discussed below. 
6.4.1 The NorStOP cohort 
NorStOP is an established cohort, with a census date seven years prior to the analysis 
in this thesis. The main strengths of NorStOP include that it has collected data on a 
wide array of self-reported factors which have been combined with both primary care 
medical record data and mortality data from the Office for National Statistics. NorStOP 
provides the opportunity to investigate lots of different health outcomes in older 
adults and their potential socio-demographic and behavioural determinants. However, 
data analysis of an existing cohort is not optimal for answering research questions in 
comparison to a cohort designed to specifically answer the research question. A 
limitation of this work was that the diagnosis of OA was not always established prior 
the measurement of the mediator; the predictor variable should be measured prior to 
the mediator (Kline, 2015). In a cohort designed specifically for a mediation analysis, 
this would be an essential part of the protocol, but it was not in NorStOP. However, as 
OA is a longstanding, gradually progressive chronic condition, it was assumed that a 
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clinician-established diagnosis at any point during the study period implied that OA 
was likely present at least to some degree during the entire period of observation.  
There were also be confounders of the association of OA and mortality that have not 
been included in this study. Other medication other than NSAIDs may confound the 
relationship between OA and premature mortality. Using a combination of self-report 
disease and diseases on the primary care medical records could help validate the self-
report methods used. An example of this is the use of self-reported cardiovascular 
disease (CVD) and ischaemic heart disease (IHD) from the primary care medical 
records used in this study. The data was not available to confirm other diagnoses in 
other covariates in this way. Medication records could also support confounder 
ascertainment; in medications prescribed for a specific disease, such as anti-
hyperglycaemic drugs in diabetes, this would confirm the disease following self-report.   
Information on cause of death was not available on this study. Other studies have 
examined the link between OA and cause-specific mortality (e.g. mortality due to CVD) 
or attributed the mortality from OA to CVD (Hochberg, 2008; Turkiewicz, Kiadaliri and 
Englund, 2019). As discussed below, only one step mediation is possible using the 
mediation technique used in this study; finding cause-specific mortality within 
NorStOP may help illuminate the pathway from the proposed mediators to mortality. 
However, the reduced cost and efficiency of using an existing cohort, especially for the 
purpose of this thesis, means that the limitations are outweighed by the strengths of 
the NorStOP cohort. In addition, a key strength of this study is the identification that 
walking frequency is a key mediator which may also reduce the incidence and 
progression of other comorbidities such as cardiovascular disease and the subsequent 
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mortality; this indicates the need to focus on key modifiable targets and not only the 
morbidity.    
The age and sex distribution within the NorStOP population were found to be similar 
to both the North Staffordshire area and England and Wales in 2001 (Office for 
National Statistics, 2001; Thomas et al., 2004b). Furthermore, the general health of 
the NorStOP cohort was similar to another cohort from the same time period in a 
different part of the UK (Pettit et al., 2001). However, this data may not be 
representative of international populations. Moreover, in the 17 years since NorStOP 
began collecting data, the population of the UK has changed dramatically. Between 
2001 and 2017 the population of the UK had increased by approximately 12.2%; the 
largest increase in the population in this time period was in the over 65 group, with 
the total percentage of the population over 65 increasing from 16% to 18.2% (Office 
for National Statistics, 2001, 2017). As this study included age as a covariate, the 
effects of this are likely to be small. Between 2001 and 2011 the percentage of people 
identifying as ‘White British’ in the UK population had reduced from 85.6% to 80.5% 
(Office for National Statistics, 2001, 2011). Data closer to the present day is not 
available, however it is predicted that this reduction in the ‘White British’ population 
will continue at the next census date in 2021 (Wohland et al., 2010). This therefore 
makes the population of NorStOP different to current and future population of the UK. 
These results may therefore not be generalisable to the present day. However, there is 
no evidence that association between OA and premature mortality is different by 
ethnicity, therefore this is also unlikely to have an effect of the results presented in 
this thesis.  
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6.4.2 Mediation analysis 
This study identified factors that mediated the association between OA and premature 
mortality. This novel analysis allows insight into the relationship between OA and 
premature mortality. As alluded to in Section 6.3, this method of mediation analysis, 
using Cox proportional hazard models, only allows for a one step mediation process. 
However, a single mediator is unlikely to be the only mediator on a specific pathway 
between OA and premature mortality. For example, OA leads to reduced walking 
frequency which could then cause depression, reduce social participation or worsen 
an existing co-morbidity which then leads to premature mortality. The proposed 
pathways for mediation analysis are based on theoretical events over time in a 
sequence that is conceivable. For example, the suggested pathway is that OA leads to 
reduced walking frequency which in turn leads to premature mortality. However, the 
converse relationship between OA and walking frequency is also true; that reduced 
walking frequency leads to OA (Leong and Sun, 2014). It is difficult to test models of 
relationships that involve feedback loops (Streiner, 2005). The models have therefore 
been overly simplified for the analysis, highlighting a further limitation of this study. 
The individual study of mediators gives no information about the influence of 
mediators on each other and is therefore a limitation of this study. Other studies have 
proposed that premature mortality as a result of OA is a caused by CVD (Hochberg, 
2008; Turkiewicz, Kiadaliri and Englund, 2019). To test this would require a two-step 
mediation pathway, which is currently not possible (discussed below).  
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6.5 IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH 
6.5.1 Implications for practice 
The high prevalence of OA and the ageing UK population means that the increased risk 
of mortality affects a large and increasing number of people over the coming years. 
Chapter 1 highlighted the import risk factors in the aetiology of OA. One of the most 
effective ways of reducing mortality from OA is therefore to minimise the progression 
of OA in the first place. Increasing physical activity and losing weight can help reduce 
the onset and progression of OA; there are therefore both primary and secondary 
prevention strategies (Cooper et al., 2001; Leong and Sun, 2014). Chapter 4 showed 
that simply having OA on the medical record or reporting joint pain was not 
significantly associated with premature mortality; only disabling OA was. As listed in 
the most recent National Institute for Health and Care Excellence (NICE) guidelines 
providing patient education about weight-loss, exercise and managing co-morbidities 
reduces the progression of OA and helps to manage OA symptoms (NICE, 2014). The 
studies in this thesis have found the impact of OA causes premature mortality. The 
sequalae of disabling OA (reduced walking frequency, depression and low social 
participation) cause premature mortality. This is an important consideration in primary 
care settings; both reducing the progression and impact of OA is key to reducing 
premature mortality. Patients presenting with OA should be flagged up and monitored 
accordingly to reduce the risk of death from OA.  
Each of the mediators included were chosen as they are amenable to primary care, 
where the vast majority of OA is managed (Dziedzic et al., 2009). The findings from this 
thesis indicate that interventions targeting physical activity, particularly frequent 
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walking, are important in reducing premature mortality as a result of OA. Although 
patients may worry that physical exercise can exacerbate their OA pain, the opposite is 
true. A Cochrane review found that physical activity can be as effective as NSAIDs in 
reducing pain from OA (Fransen et al., 2015). Furthermore, low or moderate intensity 
exercise, including walking, have been found to reduce the symptoms of OA 
(Bosomworth, 2009). Public Health England currently recommends that GPs are 
familiar with local physical activity schemes such as ‘Walking for Health’, which 
provides 1800 guided walking groups across England designed for older adults (Public 
Health England, 2018). Walking group interventions would also increase social 
participation, and therefore simultaneously target two of the mediators found in this 
study. 
Despite physical activity being a key intervention in the management of OA, 
qualitative research has shown that GPs felt that giving specific advice on physical 
activity was outside of their expertise and remit (Din et al., 2015). Within the UK there 
are some physical activity programmes for clinicians to refer patients to, but often 
these are on a local scale or disease specific, such as for cardiac rehabilitation (Bethell, 
Lewin and Dalal, 2009; Murphy et al., 2012). Outside of the UK, guidance from the 
Swedish National Institute of Public Health provides a comprehensive guide for 
primary care clinicians to advise patients on physical activity for various diseases 
(Swedish National Institute of Public Health, 2010). This guide focuses on multiple 
different diseases, including OA. For OA it recommends different levels of physical 
activity from walking to dancing dependent on the patient’s co-morbidities. No such 
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guide currently exists in the UK; this may partly explain why GPs struggle to give advice 
on physical activity.  
There is an increased focused on the role of Allied Health Professionals (AHPs) within 
primary care, through schemes such as First Contact Practitioners (Chartered Society 
of Physiotherapy, 2019). This scheme aims for patients with musculoskeletal (MSK) 
problems, to see a physiotherapist in primary care rather than a GP. The scheme aims 
to include self-management advice, social prescribing, and information about physical 
activity and fitness for work (Chartered Society of Physiotherapy, 2019). This scheme 
currently is designed for acute problems, but there is scope to develop this service into 
chronic diseases, like OA, in the future. Physiotherapy both reduces pain and improves 
function in patients with OA and is therefore an important intervention on the 
pathway between OA and premature mortality (Page, Hinman and Bennell, 2011).  
Previous studies have examined exercise referral schemes that aim to increase 
physical activity in adults. However, a narrative review showed that exercise referral 
schemes had a small effect on increasing physical activity in sedentary adults, due to 
poor compliance and high dropout rates (Nguyen et al., 2016). The mortality data 
included in this thesis may provide some patients with motivation to comply with 
physical activity; in a review of communicating risk information, ‘loss framed’ 
information (such as giving a mortality risk) was found to be more effective than ‘gain 
framed’ information (such as saying exercise will reduce joint pain) in changing a 
patient’s behaviour (Edwards et al., 2001). Furthermore, the mediators found in this 
study give patients a target to reduce their risk of mortality.  
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The study in this thesis has also highlighted the importance of assessing mental health 
in patients with OA. Depression in those with OA is associated with more severe joint 
pain (Lin, 2008). Therefore, interventions to stop the progression of OA are also likely 
to reduce low mood as a result of OA. Depression is usually managed via psychological 
and pharmacological therapy, with some evidence that physical activity can alleviate 
depressive symptoms (Cooney et al., 2013; NICE, 2009). Identifying and managing low 
mood in patient with OA is a key factor in reducing premature mortality as a result of 
OA.  
Increasing social participation is a key factor in reducing mortality from OA.  Barrier to 
social participation include difficulty moving and low mood, and therefore 
interventions to reduce depression and increase physical activity may be effective in 
increasing social participation. Social prescribing (linking patients from primary care to 
community services) may be key to improving social participation (Bickerdike et al., 
2017). There are lots of different community schemes available, including exercise 
based schemes, arts based schemes and education based schemes, that could provide 
opportunities for older adults to both become more involved in their community and 
to reduce their risk of mortality as a result of OA (Thompson, Camic and Chatterjee, 
2015).  
6.5.2 Areas for future research 
As discussed above, one limitation of this study is that the time line between 
exposure, mediator and outcome may not have occurred as hypothesised. For 
example, this study hypothesises that OA leads to reduced walking frequency which 
leads to premature mortality. However, reduced walking frequency may have led to 
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OA in the first place (Leong and Sun, 2014). One potential future research area would 
be a prospective cohort study, designed to identify mediators after the onset of OA 
with participant follow-up until death. This would be a very time consuming and 
expensive study; it would require recruiting participants prior to developing the 
symptoms of OA at a young age and following them up repeatedly over 30-40 years 
until their death with repeated questionnaires. This study does not seem feasible due 
to the large sample size that would be required, the cost and attrition bias.  Another 
option would be to use the Clinical Practice Research Datalink (CPRD) to establish the 
date of OA diagnosis and a group without OA diagnosis. The database could then be 
examined for potential mediators diagnosed after that date, and mortality 
ascertained. This would be a faster and cheaper way of conducting a large study with a 
representative sample of the UK population. However, different case definitions of OA 
would not be available using this method nor would clear measurement of mediators 
(e.g. social participation or how often per week people walk for five to ten minutes or 
more). Given a key finding from this study is that it is ‘OA with pain interference’ that 
is associated with premature mortality, at present there is no clear method for 
identifying pain interference in CPRD.  The findings suggest that a combination of 
patient reported data and medical record data enhances the understanding of the 
impact of OA.   
Development of the technique of performing mediation analysis within a Cox 
proportional hazard model would be valuable. It would be useful to examine a two-
step mediation process (discussed above). The two step mediation pathways in this 
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case may be that OA leads to reduced walking frequency, which in turn causes CVD 
and then premature mortality. 
Finally, the significant mediators found in this study present a target to tailor an 
intervention. A study designed to increase walking frequency could recruit those 
identified as having OA with pain interference from primary care into a physical 
activity group. A personalised activity programme could be delivered to ensure 
participants increase their physical activity within their personal abilities. These 
participants could then be followed up until death to assess mortality in comparison to 
those without the intervention.  As discussed above, studies with physical activity 
interventions tend to have high dropout rates. 
6.6 CONCLUDING MESSAGES 
OA is the most common joint condition and the number of adults with the condition is 
expected to increase in the future due to an ageing population and an increase in the 
prevalence of risk factors. It is now considered to be a serious disease and there is 
increasing interest in its links with mortality. This study identified that OA is 
associated with mortality when it is disabling. It also identified that anatomical site 
does not impact on mortality; whether OA is disabling or not is the key. Targets for 
reducing mortality for people with disabling OA are increasing walking frequency 
and social participation and reducing depression. 
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APPENDIX 1: SEARCH CRITERIA FOR SYSTEMATIC SEARCH 1 
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APPENDIX 2: SEARCH CRITERIA FOR SYSTEMATIC SEARC
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APPENDIX 3: COMPONENTS OF ‘HEALTH SURVEY’ QUESTIONNAIRE 
Concept Measurement Method  Details 
Perceived general health 12 Item Short-Form Health Survey (SF-12) 
(Ware et al., 1996) 
Physical and mental component summary 
scores 
Anxiety and depression Hospital anxiety and depression scale (HADs) 
(Zigmond and Snaith, 1983) 
Anxiety and depression sub-scales 
Demographic characteristics Date of birth, gender 
Marital status 
Living arrangements 
Ethnic origin 
- 
Single, married, divorced, widowed, cohabiting 
Alone, not alone 
White, afro caribbean, chinese, asian, african, 
other 
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APPENDIX 3: CONTINUED… 
Concept Measurement Method  Details 
Occupational Characteristics Current employment status 
 
Current or recent job title 
Socio-economic classification  
Educational attainment 
 
Employed, not working due to ill health, 
seeking employment, retired, housewife, 
other 
 
- 
 
Using Standard Occupational Classification 
(Office of National Statistics, 2002) 
 
Anthropometric characteristics Self-reported weight 
Self-reported height 
 
 
- 
- 
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APPENDIX 3: CONTINUED… 
Concept Measurement Method  Details 
Lifestyle characteristics Alcohol intake 
Smoking status 
Income adequacy 
Daily, weekly, monthly, annually, never 
Current, previous, never 
Strain, need to be careful, can manage, 
comfortably, well off 
 
Comorbidities  Self-reported chest problems, heart problems, 
deafness, eyesight, raised blood pressure and 
diabetes 
- 
Symptoms Falls, memory difficulties, cough with spit, 
breathless when walking, dizziness, weakness 
in arms/legs 
 
In the last 3 months  
Cognition Functional Limitations Profile (FLP) 
(Bergner et al. 1981) 
Alertness subscale form 
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APPENDIX 3: CONTINUED… 
Concept Measurement Method  Details 
Sleep Problems  Four Items Self Report Scale 
(Jenkins et al. 1988) 
- 
Bodily pain Self-completed manikin  
 
 
Specific site questions 
"In the past 4 weeks have you had pain that 
has lasted for one day or longer in any part of 
your body?" 
"Have you had any problems in your hands or 
pain in your hands/knees/hips/feet in the last 
year? 
Medication use Painkillers, creams, natural medicines  Usage in past 4 weeks – daily, most days, some 
days, few days, no days 
Physical function MOS Short Form-36  
(Ware and Sherbourne, 1992) 
- 
Consent For both further contact and to check GP 
records 
- 
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APPENDIX 4: KAPLAN MEIER CURVES FOR EACH OSTEOARTHRITS 
CASE DEFINITION 
Definition Kaplan Meier Curve 
OA Consulter 
 
Self-reported 
hand pain 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Self-reported 
knee pain 
 
Self-reported 
hip pain 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Self-reported 
foot pain 
  
Symptomatic 
hand OA 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Symptomatic 
knee OA 
 
 
Symptomatic 
hip OA 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Symptomatic 
foot OA 
 
Disabling OA 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Disabling 
Hand OA 
 
 
Disabling 
Knee OA 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Disabling Hip 
OA 
 
 
Disabling 
Foot OA 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Number of 
anatomical 
areas 
affected by 
symptomatic  
OA 
 
 
Number of 
anatomical 
areas 
affected by 
disabling OA 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Disabling 
lower limb 
OA 
 
 
Symptomatic 
lower limb 
OA 
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APPENDIX 4: CONTINUED… 
Definition Kaplan Meier Curve 
Symptomatic 
upper limb 
OA, lower 
limb OA and 
combined 
upper and 
lower limb 
OA  
 
 
Disabling 
Symptomatic 
upper limb 
OA, lower 
limb OA and 
combined 
upper and 
lower limb 
OA  
 
Abbreviations: OA (Osteoarthritis) SR (self-reported), OC (OA Consulter), PI (pain interference), UL 
(upper limb), LL (lower limb) 
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